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Abstract 
 
Peripheral nerve injuries can lead to a major loss of function and affect quality of 
life. Current autologous treatments and commercially available products such as 
nerve guide conduits all have limitations. The aim of this study was to develop 
biocompatible, non-immunogenic nerve grafts using low concentration SDS to 
decellularise porcine peripheral nerves. Initially the porcine nerve anatomy was 
defined. Acellular nerves were then used as the basis for an in vitro study of 
perfused flow within the tissue for the introduction of Schwann cells - as the 
delivery of these cells is reported to stimulate axon regeneration. Furthermore, an 
in vivo study using a rat sciatic nerve injury model was conducted to evaluate the 
regenerative capacity of acellular porcine grafts.   
Histology confirmed an absence of cells and retention of the native nerve 
histioarchitecture. DNA levels were reduced by >95 % throughout the 
decellularised tissue. Immunohistochemistry showed retention of important 
extracellular matrix proteins such as collagen, laminin and fibronectin. In vitro 
biocompatibility studies indicated the acellular nerves were not cytotoxic to human 
dermal fibroblasts and primary rat Schwann cells. Uniaxial tensile testing showed 
a significant increase in ultimate tensile strength (UTS) and strain between native 
and acellular nerve tissues. In addition, mechanical testing of the nerves revealed 
porcine peroneal nerves to have a higher UTS value in comparison to the porcine 
tibial nerves. Analysis of the nerves using transmission electron microscopy 
concluded that the mechanical properties of nerves could not be determined 
exclusively by their ultrastructure or collagen fibril diameter. 
Porcine acellular nerve grafts were used as an in vitro and in vivo model for 
the introduction of primary rat Schwann cells. The in vitro nerve model confirmed 
that reseeded Schwann cells under perfusion maintained their phenotype and had a 
lower rate of cell death when compared to static conditions. A rat sciatic nerve in 
vivo gap injury model demonstrated that porcine grafts were able to promote axonal 
regeneration; however, they were not as effective as the autologous graft. In 
summary, acellular peripheral nerve tissue was found to have excellent potential 
for development of a tissue engineered graft to aid peripheral nerve regeneration.  
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1. Introduction  
Injuries to the peripheral nerves are common and debilitating, affecting 2.8 % of 
trauma patients (Noble, Munro et al. 1998). Whilst the capacity of regeneration is 
a possibility, any defect size greater than  5-10 mm often results in poor functional 
recovery (Pfister, Gordon et al. 2011). 
For treatment of larger gap injuries autologous nerve grafts are considered 
the “gold standard”, however limitations of this technique include donor site 
morbidity and the need for multiple surgeries. Research into peripheral nerve 
regeneration has therefore focused on the use of alternative treatments in the form 
of nerve guide conduits (NGC) and acellular grafts, with the Food and Drug 
Administration (FDA) and Conformit Europe (CE) approving a relatively small 
number of NGCs (manufactured from naturally derived or synthetic material) and 
acellular grafts for clinical peripheral nerve repair (Kehoe, Zhang et al. 2011, 
Kehoe, Zhang et al. 2012).  
Clinical data demonstrates that NGC have the ability to promote nerve 
repair up to 25 mm however drawbacks include toxic degradation products, lack of 
mechanical properties and overall limited efficacy in nerve regeneration compared 
to autologous nerve grafts (Weber, Breidenbach et al. 2000). It is postulated that a 
reason for the NGCs limited efficacy in nerve regeneration is its lack of surface 
topography such as the extracellular matrix (ECM) and basal lamina. It is 
hypothesised that substrate topography plays a signiﬁcant role on cell morphology, 
behaviour, and cell-substrate interaction, as well as cell-cell interactions (Spivey, 
Khaing et al. 2012).  
Use of cadaveric or donor nerve tissues can provide an ECM that mimics 
the native nerve tissue as well as offering the potential for size/length and 
motor/sensory specificity (Moore, MacEwan et al. 2011). These grafts contain an 
endoneurial microstructure and ECM components which can provide the same 
level of guidance and regenerative support as nerve autografts.  The immunogenic 
components from the donor nerve graft can be removed through a processing 
condition called decellularisation to produce a non-immunogenic acellular nerve 
graft.  
AxoGen Inc is the only medical device company which offers comercially 
available acellular allografts for peripheral nerve regeneration, the Avance® Nerve 
Graft.  Avance®  utilises the decellularised ECM from donated human peripheral 
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nerve tissue which has been processed  using a combination of treatments including 
chemical decellularisation (detergent processing) to selectively remove cellular 
components and debris.   
Clinical studies have shown the Avance ®  graft  surpassing the  NGCs  in 
terms of nerve regeneration and  myelination (Whitlock, Tuffaha et al. 2009). 
Nonetheless the acellular graft does have its limitations. The use of human nerve 
donor tissue is fraught with complications in terms of gaining approval and cost. 
Furthermore clinical studies have shown that the Avance® graft  only supports 
nerve regeneration over limited distances (up to 60 mm) (Saheb-Al-Zamani, Yan 
et al. 2013). Moreover, when compared to native nerve autografts the Avance® 
graft still only possessed reduced regenerative capacities (Whitlock, Tuffaha et al. 
2009).  
In recent years’ focus has shifted in the use of xenogeneic ECM as scaffolds 
or grafts due to ease of harvesting and availability. The use of xenogeneic material 
has been used in a variety of biomedical applications such as heart valves (Booth, 
Korossis et al. 2002) and  Matristem® for ulcer repairs (Badylak and Gilbert 2008). 
In addition, acellular xenogeneic nerve tissue from rat, rabbit and pigs have been 
widely used for peripheral nerve studies (Gutmann and Sanders 1943, Osawa, 
Tohyama et al. 1990, Hudson, Liu et al. 2004, Whitlock, Tuffaha et al. 2009, 
Zhang, Luo et al. 2010).  
The limited regeneration reported in the Avance ® graft  is most likely due 
to the grafts dependency on in situ Schwan cells to support axonal regeneration 
(Moore, MacEwan et al. 2011). Schwann cells play a crucial role in supporting 
axonal growth and migration. Following injury, these cells become activated, 
undergoing a phenotypic change from myelinating to growth supportive to help 
lead regenerating axons towards the distal nerve stump.  It has therefore been 
hypothesised that the repopulation of the grafts with Schwann cells can help 
improve axon regeneration as well as extending the workable length of acellular 
grafts (Hadlock, Sundback et al. 2001, Zhang, Blain et al. 2002, Chang, Hsu et al. 
2005).   
This study describes the development of an acellular xenogeneic nerve graft 
through the combination of physical, chemical and enzymatic processess. 
Furthemore the study details the introduction of primary Schwann cells within the 
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graft for the study of cell-graft behaviour in vitro and peripheral nerve regeneration 
in vivo.   
1.1 Physiology of the nervous system 
The nervous system is one of the most highly organised systems within the human 
body, integrating various bodily processes and reactions of the organism to its 
environment. It is subdivided into the central nervous system (CNS) and peripheral 
nervous system (PNS), both differing in their physiology and function. The CNS 
is the larger system, comprising of the brain and spinal cord. The CNS conducts 
and interprets signals as well as providing stimuli to the PNS (Schmidt and Leach 
2003). The PNS comprises a vast network of spinal and cranial nerves that are 
linked to the brain and the spinal cord receptors. The function of the PNS is to help 
process changes in the internal and external environment through sensory receptors 
that informs the CNS of the stimuli and motor neurons running from the CNS to 
the muscles and glands (Noback 2005) .   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Schematic depiction of how the CNS and PNS work together to process changes in 
the environment through sensory and motor neurons. Adapted from Huang and Huang (2006) 
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1.2 Cellular components of the nervous system 
Cells of the nervous system can be divided into two broad categories; nerve cells 
(or neurons) and supporting cells, neuroglia or glia. Neurons are specialised for 
electrical signalling over long distances. Glial cells aid the function of neurons and 
include astrocytes, microglial  and oligodendrocytes in the CNS and Schwann cells 
in the PNS (Purves 2004). 
Neurons are the basic structural and functional elements of the nervous 
system, consisting of a cell body (soma) and its extensions (axons and dendrites). 
The cell body contains the nucleus and organelles of the cells, dendrites transmit 
electrical signals to the neuron cell body and the axon conducts impulses away. 
The axon usually ends in several small branches known as the axon terminals. 
Neurons are often connected in networks; however, they never come in contact 
with one another. The axon terminals of one neuron are separated from the 
dendrites of an adjacent neuron by a small gap known as a synapse. 
The electrical impulse moving through a neuron begins in the dendrites. 
From there, it passes through the cell body and travels along the axon. When the 
electrical impulse reaches the synapse at the end of the axon, it causes the release 
of specialised chemicals known as neurotransmitters. These neurotransmitters 
carry the signal across the synapse to the dendrites of the next neuron, starting the 
process again in the next cell. Neurons cannot divide by mitosis; however, they can 
regenerate a severed portion or sprout new processes under certain conditions. 
Neuroglia or glial cells are the most abundant cell types, outnumbering 
neurons by a ratio of 3 to 1 in the brain. They are in direct contact with neurons, 
often surrounding them, unlike neurons, glial cells have some capacity for cell 
division (Huang and Huang 2006). Roles of glial cells include maintaining the ionic 
gradient of nerve cells, modulating the rate of nerve cell propagation, modulating 
synaptic action by controlling the uptake of neurotransmitters, providing a scaffold 
for neural development and aiding (or impeding in some cases) recovery from 
neural injury. 
 
 
 
5 
 
1.2.1 Cellular components of the CNS 
In the CNS there are three types of glial cells; astrocytes, oligodendrocytes and 
microglial cells. Astrocytes, which are restricted to the brain and spinal cord, 
maintain an appropriate chemical environment for neuronal signalling. Microglial 
(immune) cells are primarily scavenger cells that remove cellular debris from sites 
of injury or normal cell turnover. In addition, these cells secrete cytokines that 
modulate local inflammation and influence cell survival or apoptosis.  
Oligodendrocytes lay down a lipid-rich sheath called myelin around specific axons. 
The myelin sheath acts as an electrical insulator, preventing short-circuiting 
between axons as well as increasing the propagation velocity of the nerve impulse, 
which is vital for those axons that extend long distances (up to 1 mm) (Schmidt and 
Leach 2003). The nodes of Ranvier are the only points where the axon is uncovered 
by myelin and ions of Na+ and K+ can be exchanged between it and the extracellular 
fluid. Depolarization of the axonal membrane at the nodes of Ranvier boosts the 
action potential that is transmitted along the axon and is the basis of jumping 
conduction.      
1.2.2 Cellular components of the PNS 
In the PNS, sheaths of Schwann cells surround all axons. Schwann cells enclose 
and separate unmyelinated nerve fibres from each other as well as producing 
myelin sheaths which wrap around large diameter axons of all motor neurons and 
some sensory neurons (Figure 1.2). 
 Myelinated axons are enclosed by many layers of compacted Schwann cell 
membranes, which form the myelin sheath, whereas unmyelinated axons retract 
into grooves in the Schwann cell cytoplasm (Maravilla and Bowen 1998). Each 
myelinating Schwann cell associates with a single axon and creates the myelin 
sheath necessary for salutatory nerve conduction. Non-myelinating Schwann cells 
are associated with small-diameter axons of C-fibres emanating from many sensory 
and all postganglionic sympathetic neurons. Each non-myelinating Schwann cell 
wraps around several sensory axons to form a Remak bundle, keeping individual 
axons separated by thin extensions of the Schwann cell body (Corfas, Velardez et 
al. 2004) . 
In the CNS, oligodendrocytes make multiple segments of myelin that wrap 
around many axons. In contrast, in the PNS each Schwann cell makes only one 
segment of myelin. This is a reason why peripheral myelin regenerates more 
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efficiently. On the outer surface of the Schwann cell layer is a continuous basement 
membrane, neurilemma. Unlike CNS glial cells, Schwann cells secrete collagen, 
laminin and fibronectin (extracellular adhesive proteins). These proteins are the 
main constituent of the basal and basement lamina that surrounds the cell 
membrane of axons.    
Schwann cells have many important functions in the peripheral nerve 
including aiding the conduction of nervous impulses along axons, nerve 
development and regeneration, trophic support for neurons, production of the nerve 
extracellular matrix (ECM), modulation of neuromuscular synaptic activity, and 
presentation of antigens to T-lymphocytes.  
 
 
 
 
 
 
 
Figure 1.2. Schematic representation of a Schwann cell. Peripheral motor neuron cell body 
and a cross section of the neuron.   
1.3 Anatomy of the nervous system: spinal cord and peripheral 
nerve 
1.3.1 Anatomy of the spinal cord 
The spinal cord is composed of dendrites, axons and cell bodies. The centre of the 
spinal cord is referred to as the grey matter containing neurons, glial cells and blood 
vessels. The grey matter is surrounded by white matter which helps protect and 
insulate the spinal cord. White matter consists of axons, oligodendrocytes, 
astrocytes and microglia. Axons project from the white matter in fascicles which 
exit the encasing bone of the spinal column, travel through the PNS-CNS transition 
zone and enter the PNS. The transition zone is a region where the glial cells in the 
CNS are separated from those in the PNS.  
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1.3.2 Anatomy of the peripheral nerve 
Peripheral nerves consist of motor and sensory axons bundled together by support 
tissue into an atomically defined trunk. Each peripheral nerve consists of axons, 
Schwann cells, myelin sheath and connective tissue (endoneurium, perineurium 
and epineurium). Connective tissue encases the nerves to ensure flexibility as well 
as protecting the nerves from stretch and compression forces during body 
movement (Figure 1.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Anatomical overview of the PNS. Figure reproduced from “Nerve Anatomy.” 
A.D.A.M. Anatomy (Maki 2009) 
The endoneurium is the innermost component of the peripheral nerve sheath with 
Schwann cells being the most predominant cell type.  The endoneurium also 
contains to a lesser extent fibroblasts, endothelial cells, macrophages and mast cells 
in addition to the collagen fibres and capillaries (Causey and Barton 1959). The 
perineurium consists of alternating concentrically arranged layers of flattened 
perineurial cells and collagen (Bunge, Wood et al. 1989); these layers are each 
enclosed by basal lamina and separated by spaces housing capillaries, collagen 
fibrils and elastic fibres (Thomas and Jones 1967).  
The perineurium enclose individual fascicles of nerve fibres and function 
as a diffusion barrier to the movement of ionic compounds and macromolecules 
between non-neural tissues and the endoneurium (Alovskaya, Alekseeva et al. 
2007). The epineurium, an outer sheath of loose connective tissue containing 
fibroblasts, collagen and fat, binds individual nerve fascicles into a nerve trunk.  
Peripheral nerves are vascularised by capillaries within the connective tissue of the 
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nerve trunk or by vessels that penetrate the nerve from surrounding arteries and 
veins (Schmidt and Leach 2003). 
1.3.3 Peripheral nerve extracellular matrix (ECM) 
The basal lamina and ECM are the non-cellular components of the nerve tissue that 
along with Schwann cells and axons comprise the endoneurium and form nerve 
fascicles. The basal lamina is a Schwann cell product consisting of continuous 
laminin tubes (~10μm diameter) embedded within the ECM (Figure 1.4). The basal 
lamina also contains fibronectin, collagen type IV and V, heparin sulphate 
proteoglycan, tenascin and entactin, all of which help promote axonal outgrowth 
(Weinstein 1999). 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Illustration and transmission electron microscopy (TEM) image of a cross-section 
of a peripheral nerve. The TEM image is of a rat sciatic nerve; Axons (A), Schwann cells (SC), 
blood vessels (BV) and an extracellular matrix (ECM) are held within the nerve by the 
epineurium (E). Schwann cells wrap around individual axons to form myelinated axons (MA). 
The ECM includes the epineurium, basal laminae (BL), and the interstitial endoneurium. 
Basal laminae surround myelinated axons, and the interstitial endoneurium provides 
structural support between the basal laminae. Reproduced from Hudson, Liu et al. (2004) 
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The ECM is a highly dynamic three dimensional network represented by 
the secreted products of resident cells (i.e. Schwann cells) such as proteins, 
glycoproteins and proteoglycans. The ECM provides structural support for tissues, 
cell layers and individual cells as well as fundamental cell processes such as cell 
growth, adhesion,  migration, proliferation, differentiation and gene expression 
(Gao, Wang et al. 2013) by sensing different environmental stimuli and providing 
specific inputs to the surrounding cells.  In addition, the ECM captures a wide range 
of cellular growth factors so changes in the physiological conditions and specific 
stimuli can trigger the local release and activation of those factors. In the PNS the 
three dimensional ultrastructure, surface topology and composition of the ECM 
provide precise guidance for axonal regeneration. In peripheral nerve tissue, the 
important ECM components include collagen types I, III, IV and V, laminin, 
fibronectin and chondroitin sulphate proteoglycans (CSPGs) (Gao, Wang et al. 
2013). 
Collagen is a structural protein and is the main ECM constituent found in 
all three connective tissue layers within the PNS. Collagen type I and III together 
constitute approximately 49% of total protein in the nerves (Bunge, Bunge et al. 
1989). The collagenous matrix surrounds and protects individual axons and their 
Schwann cell sheaths from trauma (Lundborg 2004). In the PNS, two classes of 
collagen molecules are expressed; fibril forming collagens (type I, III, and V) and 
basement membrane collagens (type IV) (Koopmans, Hasse et al. 2009). Collagen 
I, the most predominant collagen in the human body, is localised primarily in the 
epineurium whilst collagen III is located within the endoneurium and perineurium. 
Collagen V co-localises with both collagen I and III, however it is also present in 
the basal lamina, enveloping myelinating Schwann cells (Chernousov, Rothblum 
et al. 2006).  
Whilst the bulk of fibril forming collagen is synthesized by fibroblasts, 
Schwann cells and perineurial cells secrete the non-fibrillar type IV collagen of the 
basal lamina. Collagen IV is an important structural component of basement 
membranes, integrating ECM proteins such as laminin and perlican into a stable 
supramolecular aggregate (Hudson, Reeders et al. 1993), lining the outer aspect of 
endoneurial capillaries  as well as surrounding the processes of Schwann cells and 
perineurial cells (Alovskaya, Alekseeva et al. 2007).  
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Laminins are glycoproteins, existing within the endoneurium and 
perineurium of the peripheral nerve (Palm and Furcht 1983), forming a major 
structural element of the basement membrane, the basal lamina (Timpl 1996). They 
are produced by Schwann cells and are distributed along the cell surface in a 
continuous band. Evidence suggests that Schwann cells require the formation of an 
organised basal lamina to properly ensheath and myelinate axons (Obremski, 
Johnson et al. 1993).  Laminin plays many roles within the PNS including 
promoting neurite outgrowth and survival (Edgar, Timpl et al. 1984) such as 
laminin-2 (α2β1γ1) and laminin-8 (α2β1γ1), which are important for postnatal 
nerve development and are upregulated for axonal regeneration after injury 
(Wallquist, Patarroyo et al. 2002). Laminin also act as a ligand for cell surface 
receptors (e.g. integrins, heparin and α-dystroglycan), thereby initiating signals that 
influence cell behaviour and survival (Schwartz 2001) such as cell adhesion 
(Nomizu, Kuratomi et al. 1998), proliferation (Kubota, Tashiro et al. 1992), 
migration (Colucci, Giannelli et al. 1996) and differentiation (Rozzo, Ratti et al. 
1993). In addition laminin also   provides attachment points for  axons to extend 
and exert forces on the ECM (Laura, Leipzig et al. 2008). 
Fibronectin is a cell surface associated glycoprotein produced by Schwann 
cells, predominantly located in the perineurium. They contain different functional 
domains that directly bind onto various molecules such as fibrin, collagen and 
heparin (White and Muro 2011), as well as two domains that support cell adhesion. 
In the PNS neurons can extend neurites on the two domains (Humphries, Akiyama 
et al. 1988).  Fibronectin also plays a role in peripheral nerve repair as they promote 
Schwann cell growth (Baron-Van Evercooren, Kleinman et al. 1982).  
GAGs such as CSPGs are proteoglycans consisting of a protein core and a 
chondroitin sulphate side chain, which are produced by Schwann cells. In the PNS 
they exist mainly in the basal lamina and ECM surrounding collagen fibrils 
(Aquino, Margolis et al. 1984). These proteoglycans have been implicated in the 
regulation of axonal growth, however it has been found that CSPGs bind to and 
inhibit the neurite-promoting activity of laminin. It has been observed that after a 
nerve injury there are markedly upregulated levels of inhibitory CSPGs levels 
which accumulate in the endoneurial tissue surrounding the Schwann cell basal 
laminae (Zuo, Hernandez et al. 1998); consequently CSPGs play a negative role in 
nerve regeneration.  
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1.4 Nerve injury and regeneration 
When the CNS is injured the physiological response from the body is the slow 
infiltration of macrophages to the site of injury. A blood-spine barrier delays the 
removal of the inhibitory myelin by limiting macrophage entry to only the site of 
injury (Avellino, Hart et al. 1995). In addition, cell adhesion molecules in the distal 
end of the injured spinal cord are not readily upregulated, thereby limiting 
macrophage recruitment. Astrocytes also respond to the injury by proliferating and 
producing glial scars that inhibit regeneration (McKeon, Schreiber et al. 1991).  
The PNS is typically damaged by traumatic injury (i.e. stretch, crush, 
lacerations and ischemia), surgery or repetitive compression (e.g. carpel tunnel 
syndrome). A recent study revealed that 87% of PNS injuries were from trauma 
and 12% due to surgery. Over 81% of nerve injuries occurred in the upper 
extremities and 11% in the lower extremities with the balance in other locations 
(Pfister, Gordon et al. 2011). Injury to the PNS can range from severe, leading to 
major loss of function or intractable neuropathic pain, to mild, with some sensory 
and/or motor deficits affecting quality of life (Pfister, Gordon et al. 2011). In 
contrast to the CNS, the microenvironment surrounding an injury site in the PNS 
is often more permissive to axonal regeneration. Over relatively short distances 
(less than 5 mm), axons can spontaneously regenerate (Rangappa, Romero et al. 
2000). 
1.4.1 Peripheral nerve regeneration 
When a nerve is injured or transected, the transected fibres distal to the lesion are 
disconnected from the neuronal body. Immediately after, the proximal and distal 
nerve stumps retract, axoplasma (cytoplasm within the axon of a neuron) leaks out 
and breakdown of the cytoskeleton and dissolution of the cell membrane occurs. 
The proximal end of the nerve stump however experiences minimal damage. This 
process is known as chromatolysis and reflects the change from the production of 
neurotransmitters needed for synaptic activity to the production of materials needed 
for axonal growth and repair (Seckel 1990). At the distal end Schwann cells shed 
their myelin lipids and surround the axons. Macrophages are recruited to the site 
of lesion and contribute to the lysis and phagocytosis of myelin and axon debris 
and subsequent Schwann cell proliferation. Both cell types play a role in enhancing 
axonal regeneration and myelination by secreting cytokines and growth factors.  
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In the first few days’ post injury Wallerian degeneration takes place in the 
distal axonal stump. This is a process which serves to create a microenvironment 
distal to the injury site that favours axonal growth. This involves the degeneration 
of axons, myelin sheath detachment and degradation of the distal portion of the 
nerve by protease activity and the separation from the metabolic resources of the 
nerve cell bodies. During the degeneration the basal lamina which had formerly 
covered the myelinating Schwann cell-axon unit is spared. This leaves intact 
“endotubes” formed by the residual basal lamina and Schwann cells which still 
remain viable. These endotubes form channels into which the regenerated axons 
will grow (Weinstein 1999) 
Following debris clearance by activated macrophages, and a local 
inflammatory environment, Schwann cells within the distal stump are stimulated 
to proliferate within their basal lamina tubes forming the bands of Büngner. This 
proliferation carries on for approximately 2 weeks with the Schwann cells forming 
“rail tracks” which guide the regenerating axons to their target (Terenghi 1999). 
Regeneration begins at the proximal end and continues towards the distal stump 
with new axonal sprouts emanating from the nodes of Ranvier to restore function 
(Figure 1.5). In humans, axon regeneration occurs at a rate of 1 mm/day (Allodi, 
Udina et al. 2012).  
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Figure 1. 5. Degeneration and regeneration after peripheral nerve injury. P = proximal and 
D = distal.  Adapted from Allodi, Udna et al. (2012) and Chaudhry, Glass et al. (1992).  
The regenerative sprouting of the proximal axon requires elongation of the axon. 
This is mediated by the growth cone (Seckel 1990). A growth cone is a motile 
extension of the regenerating nerve fibre seeking its synaptic target. It advances 
through the tissue by releasing a protease which dissolves the matrix (Krystosek 
and Seeds 1981). 
Growth cones consist of mobile filopodia extruding from a flattened sheet 
of lamellipodia. This enables them to move and to explore the microenvironment 
of the regenerating axons. Actin influences this motility. The growth cone plays an 
essential role in axon guidance and responds to contact guidance clues afforded by 
adhesive molecules that are presented on a neighbouring cell surface such as 
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transmembrane cell adhesion molecules (CAMs) or those that are assembled into 
the ECM such as   laminin and fibronectin (Figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Growth cone of a regenerating axon. Adapted from Lowery and Van Vactor (2009) 
 
1.4.2 Classifications of nerve injury 
 
There are different classifications of nerve injury; neurapraxia, axonotmesis and 
neurotemesis are the three discrete types first described by Sir Herbert Seddon in 
1943 with the addition of two intermediate steps in 1954. Dellon and Mackinnon 
described a 6th degree nerve injury, one which combines several of these degrees 
of injuries per fascicle (Table 1.1) (Evans 2001). The classification of the 6th degree 
of nerve injury allows possible replacements of individual fascicles as opposed to 
the entire injured nerve. When surgical repair of the nerve is required, the goal is 
to guide regenerating sensory, motor, and autonomic axons to the distal, 
degenerating nerve segment to maximize the chance of target reinnervation.
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Table 1.1. Classification of peripheral nerve injuries; TEC = tissue engineered constructs. Adapted from Pfister, Gordon et al. 2011 
Degree of Injury Pathology Treatment TEC Prognosis 
I. Neurapraxia Axons not disrupted. Possible 
segmented demyelination 
 
None No Full recovery 
Days up to 3 months 
II. Axonotmesis Axon lost. Endoneurium, 
perineurium and epineurium 
intact 
 
None. Slow regeneration 
2–3 cm per month 
No Good, rate is slow 
III. Axon lost. Endoneurium 
disrupted. Perineurium and 
epineurium intact  
None. Surgery only if no recovery in 
2–3 months. 
Slow regeneration 
2–3 cm per 
month 
 
? Incomplete 
axonal loss and misdirection 
IV. 
 
 
 
 
 
Axon lost. Endoneurium and 
perineurium disrupted. 
Epineurium intact 
 
Surgery required to remove scar 
tissue. Autograft or 
conduit for gaps 
 
Yes Regeneration only after repair. 
Availability of graft material 
 
V.  Neurotmesis Complete disruption of nerve Surgical repair to proximate the two 
ends. Direct repair, autograft or 
conduit for gaps 
 
Yes Regeneration only after repair. 
Availability of graft 
material 
VI. Mixed injury  Surgical repair Yes  
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Each category has its own complications and clinical symptoms; however, 
evidence is in support that an increase in the degree of injury indicates an increase 
in severity and decrease in recovery. After axonotmesis the connective sheaths of 
the nerve are preserved and only the axons are injured so functional recovery is 
good. In contrast after neurotmesis (nerve transection) the endoneurial tubes lose 
their continuity, axons are misdirected and reinnervate incorrect target organs 
leading to poor functional outcomes. Witzel et al. (2005) estimated that only 10% 
of axons after a nerve transection and ‘‘best’’ surgical apposition reach target 
organs (Witzel, Rohde et al. 2005).  
Inappropriate targets can be reinnervated by axtomised nerves i.e. efferent 
motor axons may be misdirected to sensory end organs resulting in degradation or 
loss of function depending on the severity of the mismatch (Allodi, Udina et al. 
2012). As surgical repair techniques cannot be further refined there is a need for 
new and improved strategies to enhance specific axonal regeneration. 
1.4 Clinical need for peripheral nerve repair 
Several hundred thousand nerve injuries occur worldwide each year, with over 
300,000 cases reported annually in Europe (Mohanna, Young et al. 2003) and over 
360,000 (of the upper extremity) in the USA (Belkas, Shoichet et al. 2004); this 
has associated annual costs of $7 billion (American Paralysis Association, 1997). 
Currently, there is no effective treatment for damage to the CNS, and acute spinal 
cord injury has been resistant to treatment (Evans 2001). Compared to spinal cord 
injury, injuries of the peripheral nerves are more common and debilitating, 
affecting 2.8% of trauma patients. Nevertheless despite recent advancements 
peripheral nerve injury remains a critical clinical issue with over 50,000 procedures 
performed annually in the United States alone (Noble, Munro et al. 1998).  
The assumption has been that peripheral nerve injuries recover, given the 
observation of spontaneous axonal regeneration following injury. Whilst this 
capacity of regeneration is higher than that of the CNS, complete recovery is 
infrequent, misdirected or associated with debilitating neuropathic pain. Axon 
regeneration progresses at a slow rate. The rate of axon regeneration varies from 1-
2 mm/day in small nerves and 5 mm/day in large nerves (Recknor and 
Mallapragada 2006) and any defect size greater than 5-10 mm often results in poor 
functional recovery (Pfister, Gordon et al. 2011). Nerve transection is usually 
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associated with poor outgrowth, particularly when the distance between injury and 
target is long.  
Despite best efforts and modern surgical techniques functional restoration 
is often incomplete, with approximately 50% of surgical cases achieving normal to 
good restoration of function.The incidence of PNS injury is grossly underestimated 
due to the span of causes and the intervention from many clinical disciplines, 
including orthopaedic surgery, plastic surgery and neurosurgery however it 
presents a critical clinical issue (Pfister, Gordon et al. 2011). Therefore, there is 
need for biomedical research to develop novel strategies to improve outcomes 
following nerve damage 
1.5 Current clinical approaches for treating peripheral nerve 
injuries 
Current treatment for peripheral nerve injury consists of either direct end-to-end 
surgical suturing of the damaged nerve ends or the use of an autologous nerve graft.  
Suturing is limited to the repair of small defects or gaps in the nerve, for longer 
nerve gaps this approach is not desirable because any tension introduced into the 
nerve cable would inhibit nerve regeneration.  
For longer nerve gaps the current “gold standard” treatment is autologous 
grafting; using donor sensory nerve tissue (usually the sural nerve) which is 
harvested from another site in the body to replace the injured tissue. Limitations 
using this method include donor site morbidity and chronic pain. Sural nerves in 
general possess a typically small diameter so multiple sural nerve segments are 
placed side by side to match the width of the nerve being replaced (Dahlin 2008). 
This means that there is also the risk of lack of donor nerve tissue if the nerve injury 
is substantial. In addition, sural nerves also possess smaller fascicular patterns (i.e. 
the number and size of fascicles) which do not match the fascicular patterns of the 
nerve being grafted (Meek and Coert 2002) which can cause misdirection and 
misalignment, and is why the autologous clinical functional recovery rates is only 
80% (Schmidt and Leach 2003).   
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1.6 Nerve guides conduits (NGCs) and grafts to aid peripheral 
nerve regeneration  
It is commonly accepted that physical guidance of axons is a vital component of 
nerve repair and regeneration. In the 1960’s Millesi determined that nerve grafts 
reduced the tension on damaged nerves as well as enhancing functional recovery. 
Current research focuses on “entubulating” opposing nerve stumps of the severed 
nerve in an autograft tube known as a Nerve Guidance Conduit (NGC) (Kehoe, 
Zhang et al. 2011). These conduits can be used for defects of 20 mm - 25 mm and 
eliminates the need to graft. Advantages of NGCs over autografts is their unlimited 
supply, no donor-site morbidity, no restriction by fascicular sizes and they can 
provide the regenerating nerve fibres with the ability to seek their own path to their 
targets with a high degree of specificity through neurotropism (Shin, Friedrich et 
al. 2009).  
Once nerves are sutured into the ends of the conduit, protein-rich 
(axoplasmic) fluid, containing growth factors exudates from the stumps and are 
released into the NGC. Within days a fibrin matrix forms, providing support for 
the migration of Schwann cells, fibroblasts and macrophages (Figure 1.7).   
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Figure 1.7; Principle of nerve entubulisation and the sequence of events leading to the growth 
of a new nerve cable: Adapted from Heath and Rutkowski (1998); Belkas, Shoichett et al. 
(2004); Daly, Yao et al. (2012)  
 
 
 
 
 
 
 
 
I. 
 
 
 
II. 
 
 
 
III. 
 
 
 
IV. 
 
 
 
V. 
 
Chamber walls with a protein-rich fluid 
(containing neurotrophic factors) 
 
 
 
 
 
 
Generation of a fibrin-rich scaffold 
 
 
 
 
 
 
Cell migration (perineural, endothelial and 
Schwann cells) 
 
 
 
 
 
Axonal cables elongation 
Schwann cells switch to a myelinating 
phenotype and associated with 
regenerated axons forming mature 
myelinated axons. 
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The role of an NGC is to mechanically support and direct axonal sprouting between 
the injured nerve stumps by providing a guidance cue (via a tubular 3D structure).  
The NGC also needs to prevent fibrous tissue ingrowth into the injury site and 
retain the neurotrophic factors secreted by damaged nerve ends. The design criteria 
of an NGC should include: 
I. Biocompatibility so to not evoke an inflammatory response 
II. Biodegradability, however the NGC must retain a mechanically stable architecture 
during the regeneration process  
III. Flexibility, to prevent compression of regenerating axons and limit tissue 
inflammation  
IV. Semi-permeability to allow diffusion of oxygen and nutrients through pores.  Ideal 
pore size range between 5-30µm. Pore sizes less than 5µm inhibits cell and tissue 
proliferation whilst pore sizes exceeding 30µm increases infiltration of 
inflammatory cells into the conduit   
V. Meeting clinical requirements for further production, sterilization, long-term 
storage and surgical handling such as suturing. 
 
The Food and Drug Administration (FDA) and Conformit Europe (CE) have 
approved a relatively small number of guidance conduits for clinical repair of 
peripheral nerves. These NGC devices can be grouped into naturally derived or 
synthetic as well as resorbable and non-resorbable material (Table 1.2).   
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Table 1.2 Summary of commercially available nerve guides and wraps. Adapted from 
Waldram (2003); Bell and Haycock (2011)  
1.6.1 Naturally derived nerve guides 
There has been great focus on using purified natural ECM proteins and GAGs as 
natural scaffolds for nerve regeneration. ECM molecules such as collagen, laminin 
and fibronectin have shown to play a significant role in axonal development and 
repair in vivo. Furthermore proteoglycans and GAGs are known to modulate neural 
activity and neurite extension as well as providing stimulatory and inhibitory cues 
(Bovolenta and Fernaud-Espinosa 2000).   
Investigation using silicone tubes filled with ECM molecules have shown 
improved regeneration over a 10 mm rat sciatic nerve gap compared to controls 
(Chen, Hsieh et al. 2000). Other studies have shown that orientated fibres of 
collagen within gels can provide an ideal template for neurite extension as well as 
an ideal matrix for Schwann and neurite migration (Ceballos, Navarro et al. 1999).  
Additional naturally derived molecules currently under investigation 
include hyaluronic acid, fibrinogen, agarose, alginate, chitosan and self-assembling 
peptides. Tissue engineering techniques are being applied to modify these materials 
to make them applicable for nerve repair applications by applying chemical cross-
linking, magnetic fields or the addition of biomolecules (Schmidt and Leach 2003).   
 
Commercial Name Company Material 
 
Neuragen ®/NeuraWrap TM  Integra Type I collagen 
 
Neurolac ® Polyganics PDDL/CL 
 
Neurotube ® Synovis PGA 
 
Neuromatrix/NeuroflexTM 
Conduits and NeuroMend TM 
wrap  
 
Collagen 
matrix Inc 
Type I collagen 
Salubridge TM/SaluTunnel TM Salumedica Polyvinyl 
alcohol 
hydrogel 
 
Surgisis ®/Axoguard TM  AxoGen Inc Porcine small 
intestinal 
submucosa 
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1.6.1.1 Clinically available naturally derived resorbable devices  
Neuragen® and Neuromatrix/NeuroflexTM conduits are derived from collagen I. 
Collagen I, a major component of the ECM is a commonly used biomaterial as it 
can be easily isolated and purified and made to offer varying degrees of 
resorbability. Collagen has an established record of biocompatibility and has been 
shown to support and guide tissue regeneration in vivo. However, despite its 
abundance there is still an issue of batch-to-batch variations that can compromise 
reproducible performances. Furthermore undesirable immune responses may occur 
in some devices, therefore there is a requirement to use immunosuppressive drugs 
(Kehoe, Zhang et al. 2011). 
Neuragen® conduits degrade after 48 months and have been reported to 
have comparable efficacy to autologous grafts in defects up to 20 mm in clinical 
studies. In addition, pre-clinical studies showing efficacy in defects up to 40 mm. 
To this date no other FDA device has reported levels of efficacy up to this gap 
length in literature. However, the limitation is the time required for complete 
biodegradation to occur may lead to nerve compression. In contrast 
Neuromatrix/NeuroflexTM conduit resorbs in vivo over a period of 4-8 months. 
However these conduits have been designed to bridge nerve gap defects that do not 
exceed 2.5 cm (Kehoe, Zhang et al. 2011).  
 
 
Table 1.3. Summary of clinically approved naturally derived resorbable nerve conduits.  
Reproduced from Meek and Coert (2008)  
Available FDA/CE-approved naturally derived resorbable nerve conduits 
  
NeuraGen ® 
 
NeuroMatrix/NeuroFlex™ 
 
Composition 
 
Type I collagen 
 
Type I collagen 
Company Integra NeuroSciences 
Plainsboru, NJ, USA 
Collagen Matrix Inc 
Franklin Lakes, NJ, USA 
 
Maximum Length 
 
3 cm 
 
2.5 cm 
 
Diameter 
 
1.5-7 mm 
 
2-6 mm 
 
Clinical data 
(PubMed) 
 
Yes 
 
No 
 
Degradation Time 
 
4 years 
 
4-8 months 
 
Price (The 
Netherlands) 
 
€1200 
 
€600 
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1.6.2 Synthetic nerve guides 
Synthetic materials are ideal as their chemical and physical properties (degradation 
rate, porosity, mechanical strength) can be optimised for particular applications. 
Their limitation however lies in their biocompatibility in vivo as the body’s 
response can vary from one material to another. In some cases, the material may 
cause an inflammatory response or may be incompatible with cell adhesion or 
tissue repair, hindering the regeneration process. However, through tissue 
engineering there are various ways to modify the material to make it more 
biocompatible. 
  A number of different synthetic materials have been explored for use in 
aiding nerve regeneration including non-degradable polymers like silicone, 
biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA), poly (ε-
caprolactone (PCL), poly L-lactic acid (PLLA) (Subramanian, Krishnan et al. 
2009). Researchers have also shown that electrical charges play a significant role 
in stimulating cellular different for various tissue types. Piezoelectric material such 
as poly (vinylidene fluoride) (PVDF) and electrically conducting polymers 
(polypyrrole, polyaniline) are known to significantly enhance neurite extension. 
Further modification of these materials with biological stimuli i.e. hyaluronic acid 
may create interactive biomaterials for use as nerve guidance channels (Schmidt 
and Leach 2003).  
1.6.2.1 Clinically available synthetic resorbable devices  
Synthetic resorbable devices are deemed desirable as surface erosion permits the 
device to retain its structural stability for a longer time after implantation. A surface 
eroding polymeric device is also expected to provide better contact guidance cues 
for nerve regeneration.  
Neurotube®, a highly porous bioresorbable device made from polyglycolide 
acid (PGA), is a woven tubular device with a grooved surface. The grooved surface 
helps the resistance of occlusive forces of surrounding soft tissue. Neurotube® 
shows excellent degradability, good initial mechanical properties and is associated 
with high levels of cell viability. Amongst surgeons it is considered the preferential 
synthetic device due to its length (2 cm), price and wide availability of clinical data.  
In randomised clinical trials the device has been reported to have 
comparable efficacy to autologous treatment in defects up to 20mm. Moreover, 
pre-clinical data exists for this device showing efficacy in gap defects up to 30 mm. 
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However, limitations include its high rate of degradation and the device losing its 
initial strength (1-2 months in vivo).  Other disadvantages include the production 
of acidic degradation products (glycolate and pyruvate) as well as its low solubility.  
 Neurolac® is the only approved transparent device, a feature which helps 
aid the clinician during surgical insertion across the nerve gap defect. It is 
composed of the co-polymer poly (D, L-lactide-co-ɛ-caprolactone) (PCL) and is 
highly soluble in a wide range of organic solvents and its crystalline nature enables 
it to form at relatively low temperatures. The device is able to degrade at a steady 
rate without producing toxic degradation products.  
In clinical trials Neurolac® has been reported to have comparable efficacy 
to the autologous standard in defects up to 20 mm. Limitations of this device 
however include its high rigidity, with Meek et al 2008 noting frequent breakages 
of needles when suturing the device in place (Meek and Coert 2008). Rigidity can 
also lead to nerve stumps being torn out of the NGC lumen during the regeneration 
period due to the inflexibility over the joints during immobilisation. Other 
limitations associated with the device include severe foreign body reactions and 
swelling, fragmentation due to incomplete degradation as well as early collapse of 
the device leading to neuroma formation.                
 
Available FDA/CE-approved synthetic resorbable nerve conduits 
  
Neurotube ® 
 
Neurolac ® 
Composition Polyglycolic acid Poly (65/35(85/15L/D) lactide-
ε-caprolactone) 
Company Synovis Polyganics BV 
Maximum Length 4 cm 3 cm 
Diameter 2.3-8 mm 1.5-10 mm 
Clinical data (PubMed) Yes Yes 
Degradation Time 6-12 months 2-3 years 
Price (The Netherlands) ±Euro 340 ±Euro 700 up to 1800 
Table 1.4. Summary of clinically approved synthetic resorbable nerve conduits. Reproduced 
from Meek and Coert (2008)  
 
25 
 
1.6.2.2 Clinically available synthetic non-resorbable device 
Salubridge TM / SaluTunnel TM are non-resorbable nerve cuff hydrogels composed 
of a hydrophilic and non-degradable biomaterial called SalubriaTM. The SalubriaTM 
hydrogel mimics human tissue in terms of its softness and compliancy.  
SaluTunnelTM is identical in structure and composition to the SalubridgeTM apart 
from a longitudinal slit to facilitate ease of surgical placement; thereby this device 
is used in the management of peripheral nerve injuries in which there has been no 
substantial loss of nerve tissue. However, the non-resorbable nature of these 
devices can lead to issues relating to higher risks of infection and chronic 
inflammation as well as nerve compression and tension at the suture lines after 
nerve regeneration. 
 
Available FDA/CE-approved synthetic non-resorbable nerve 
conduits 
                                  
Salubridge TM /SaluTunnel TM 
Composition Salubria-polyvinyl alcohol (PVA) 
hydrogel 
Company Salumedica LLC, Atlanta, GA, USA 
Maximum Length 6.35 cm 
Degradation Time Non-biodegradable 
Table 1.5. Summary of clinically approved synthetic non-resorbable nerve conduits. 
Reproduced from Meek and Coert (2008)  
1.6.3 Motor outcomes after reconstruction of nerve defect using NGCs 
The majority of data reporting the clinical success of NGCs in promoting nerve 
regeneration has been with respect to sensory nerve recovery (Weber, Breidenbach 
et al. 2000, Taras and Jacoby 2008).  
There have been few case reports on motor nerve recovery (Ashley, 
Weatherly et al. 2006, Donoghoe, Rosson et al. 2007, Inada, Hosoi et al. 2007), 
however the focus was primarily on animals and the evaluation carried out using 
either compound muscle action potentials or walking track analysis to quantify 
motor recovery are known to have high variability and are  indirect (Shin, Friedrich 
et al. 2009).    
Clinically motor recovery is inferior to sensory recovery following repair 
(Gattuso, Glasby et al. 1989, Duteille, Petry et al. 2001).  Motor nerve 
reconstruction differs from the sensory reconstruction as there are time dependant 
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degradation and ultrastructural changes of the muscle as well as irreversible 
changes that occur at the motor end plate (Bain, Veltri et al. 2001, Shin, Friedrich 
et al. 2009).   
A study conducted by Shin et al 2009 used a rat sciatic nerve model to 
compare the efficacy of the three clinically synthetic bioabsorbable NGCs 
(Neurolac®, Neurotube® and NeuraGen®) in terms of motor nerve recovery. 
Maximum isometric tetanic force with optimisation of variables was used as the 
primary measure of motor outcomes. Results showed no significant difference 
between the Neurolac® conduit and autograft in all the assessments. Neurolac® did 
however outperform the other commercially available NGCs and Neurotube® 
repairs were significantly worse than other repairs in all assessments (Table 1.6).  
Nonetheless other studies with Neurotube® show a more positive outcome in 
human studies (Bain, Veltri et al. 2001, Navissano, Malan et al. 2005, Inada, Hosoi 
et al. 2007). This disparity may be attributed to a number of factors such high 
degradation rate and nerve lumen size mismatch. 
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Table 1.6 Summary of the effectiveness of commercially available NGCs in repairing motor nerve regeneration. Overall the autograft is the most effective 
in promoting motor nerve recovery followed by Neurolac®. Neurotube® is deemed the least effective for promoting motor nerve regeneration. 
Reproduced from Shin, Freidrich et al. 2009)   
 
 Autograft Neurolac ®  NeuraGen ® 
 
Neurotube ® 
 
Isometric tetanic force  
      Anterior isometric tetanic force recovery of tibialis              
anterior (%) 
      Recovery rate of tibialis anterior (%)  
 
 
37 ± 17  
 
100 (20/20) 
 
34 ± 13 
 
94 (17/18) 
 
23 ± 11 
 
100 (19/19) 
 
3 ± 5 
 
29 (4/17) 
Compound muscle action potentials 
      Recovery of tibialis anterior† (%) 
      Recovery rate of tibialis anterior (%) 
      Recovery of flexor digiti quinti brevis† (%)  
      Recovery rate of flexor digiti quinti brevis (%) 
 
51 ± 51 
100(15/15) 
10 ± 12 
53 (8/15) 
 
32 ± 16 
93 (14/15) 
10 ± 11 
73 (11/15) 
 
25 ± 14 
100 (15/15) 
3 ±4 
33 (5/15) 
 
3 ± 7 
15 (2/13) 
0 
0 (0/15) 
Weight (normalised to contralateral side) 
      Muscle weight of tibialis anterior† (%) 
      No. tested 
 
 
58 ±7 
20 
 
54 ± 10 
20 
 
49 ±9 
20 
 
19 ± 8 
19 
Histomorphometry (%) 
     Peroneal axon count 
     Peroneal nerve area (µm) 
     Peroneal nerve fibre area (µm) 
     Peroneal myelin thickness (µm) 
 
 
118 ± 24 
89 ± 17 
39 ±4 
87 ±9 
 
112 ± 23 
88 ± 20 
34 ±5 
84 ±8 
 
86 ± 15 
74 ± 13 
41 ± 19 
90 ±5 
 
47 ± 16 
58 ± 11 
35 ± 2 
76 ± 7 
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The study conducted by Shin et al. (2009) demonstrated the functional regenerative 
potential of NGCs in motor nerve repair and their limitations. In addition, it also 
highlights the necessity to consider both sensory and motor functions when 
creating NGCs or grafts for nerve repair.  
1.6.4 Clinical efficacy of autografts and NGCS in treating peripheral 
nerve repair 
Due to the lack of multicentres and prospective, randomised, controlled studies 
based around peripheral nerve repair research, surgeons have come to rely on 
experimental data from expert and institutional publications when determining 
expected outcomes or forming an evidenced based approach for treatment of 
peripheral nerve injuries.  For the “gold standard” autograft there is a wealth of 
single centre experimental data available. In a review by Frykman and Gramyk 
(1991), meaningful  functional recovery was reported in 80% of nerve autograft 
repairs in digital nerve gaps less than 50 mm, 63-81% meaningful motor funtion in 
mixed nerves of the forearm and 75-78% meaningful levels of sensory function 
(Frykman 1991). 
For autograft alternatives (NGCs) the largest published randomised 
controlled study was by Weber et al (2000). The study was a direct comparison of 
conduits with direct suture and autograft for sensory only digital nerve repairs. The 
NGC’s performed well in a gap of 4 mm or less with 100% meaningful recovery, 
however with gap lengths between 5-25 mm only 34% reported meaningful 
recovery (Weber, Breidenbach et al. 2000).  Table 1.7 summerises published 
studies which have been carried out on autograft and NGCs for peripheral nerve 
repair.   
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Table 1.7. Comparison of different types of nerve repair in reference to historical literature based on individual study parameters for acceptable 
recovery: M3-M5, S3-S4. Reproduced by Brooks, Weber et al. (2012) 
Study Number of Repairs Nerve injury type Test article Positive Outcomes 
Wangensteen and 
Kallianien (2009) 
64 Sensory, mixed and 
motor nerves 
Neuragen®  43% 
Kim and Kline (2001-
2006) 
52 Sensory and mixed 
nerves 
Direct Suture and autograft 67-86% 
Frykman and Gramyk 
(1991) 
91 Mixed nerves Direct Suture and autograft 75-78% 
Frykman and Gramyk 
(1991) 
384 Sensory nerves Autograft for digital nerve 
injury under 5cm 
80% 
Weber et al. (2000) 62 Sensory nerves Neurotube®  74% 
Weber et al. (2000) 74 Sensory nerves Direct repair and autograft 86% 
Kallio et al. (1993) 254 Sensory nerves Autograft and direct repair 70% 
Lohmeyer et al. (2009) 12 Sensory nerves NeuraGen® Type I Bovine 
Collagen Tube 
75% 
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1.6.5 Limitations of NGCs in promoting regeneration across critical gap 
length 
A study comparing autograft to conduit repair of digital nerve injuries concluded 
that conduits were limited to defects of up to 25 mm. It was also noted that the 
quality of recovery decreased  as the gap size increased and that a third of repairs 
for gaps between 5 and 25 mm had poor outcomes (Weber, Breidenbach et al. 
2000).   
Fibrin clot instability seems to a leading factor leading to the failure of 
NGCs to provide sufficient regeneration across larger gaps. A study by Lundborg 
et al. (1982) demonstrated loss of fibrin stability with an increasing distance 
between nerve ends within a silicone nerve tube (Lundborg, Dahlin et al. 1982). 
The failure to form a fibrin clot means that Schwann cells and axons would not 
have a scaffold to guide and support their migration across the conduit. Other 
factors which may also limit the NGCs are neurotrophic factors, Schwann cell 
invasion (Daly, Yao et al. 2012) and  absence of physical guidance such as the 
Schwann cell basal lamina and ECM (Spivey, Khaing et al. 2012). 
1.7 Importance of ECM and Schwann cell basal lamina in nerve 
regeneration 
During the last decade many trials have been undertaken with nerve tubes of 
different materials, growth factors as well as cells, all with the aim of increasing 
the speed of nerve regeneration and directing nerve fibres for target specificity.   
These grafts avoid the problem of availability, donor site morbidity and immune-
rejection however they have limited efficacy in nerve regeneration. A plausible 
explanation for this is the absence of physical guidance for the cells at a relevant 
scale (~50μm) such as the Schwann cell basal lamina and ECM (Spivey, Khaing et 
al. 2012). 
The nanostructure of basal laminae is primarily composed of collagen and 
laminin so it can be inferred that they present aligned, linear nano-scale features to 
cells. Laminin is known to promote neurite extension both in vitro and in vivo 
(Corey, Lin et al. 2007; Nguyen, Sanes et al. 2002; Smeal et al. 2005) 
 An in vitro studies of dorsal root ganglia exposed to aligned, nanofibrous 
surfaces show that axon extension is strongly influenced by the alignment of 
nanotopography to support this hypothesis (Corey, Lin et al. 2007).   
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An in vivo study using a murine model where the structure of the nerve 
tissue (including the basal laminae) was preserved during a crush-type axotomy 
showed the motor axons retracing their original pathways to re-establish 
neuromuscular junctions at the original sites with little variation (Nguyen, Sanes et 
al. 2002).  A study by Smeal et al. (2005) demonstrated that axon regeneration was 
more effective when presented with smaller diameter tube structures and that axons 
are sensitive to substrate curvature, demonstrating more directional extension when 
exposed to a smaller radius of curvature (Smeal, Rabbitt et al. 2005).  
It is therefore hypothesised that as a prerequisite for efficient axon 
extension, next generation NGC’s and grafts should incorporate cell-scale 
topography consisting of continuous, tube-like micron scale structure that are both 
linear and aligned over macroscopic distances.  
1.8 Tissue decellularisation  
Use of cadaveric or donor nerve tissues can provide an ECM that mimics the native 
nerve tissue as well as offering the potential for clinically relevant size/length and 
motor/sensory specificity (Moore, MacEwan et al. 2011). Such grafts contain an 
endoneurial microstructure which provides the same level of guidance and 
regenerative support as nerve autografts.   
Nevertheless, when used clinically these grafts possess risks from the 
immune response from the body due to the presence of foreign cells. Taking 
immunosuppressant’s will allow the host axons and Schwann cells to regenerate 
across the allograft scaffold; however side effects may result in opportunistic 
infections, neoplasia or tumour formation (Mackinnon, Doolabh et al. 2001).  
Alternatively, the immunogenic components from the graft can be removed 
through a process called decellularisation, producing a non-immunogenic acellular 
tissue graft. Decellularisation can remove DNA,  remove/mask antigenic epitopes, 
(Gilbert, Sellaro et al. 2006, Badylak and Gilbert 2008) and damage associated 
molecular pattern (DAMP) molecules (Rubartelli and Lotze 2007). Theoretically 
acellular grafts still retain the 3D structure and ECM components of the native 
tissue; however, such a graft may be used clinically without eliciting an adverse 
immune response. ECM components are generally conserved amongst species and 
are tolerated well by recipients in the absence of immunogenic cellular 
components.  
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1.8.1 Clinical relevance for the use of acellular scaffolds 
There is an increasing use of ECM derived from acellular tissue in tissue 
engineering and regenerative applications. Acellular scaffolds have been 
commonly used for the surgical reconstruction of a variety of tissues including 
tendons (Coons and Barber 2006), dermal (Brigido 2006) and gastrointestinal 
(Ueno, Pickett et al. 2004). Recent strategies have also included whole organ 
decellularisation such as the heart, liver and lung (Ott, Matthiesen et al. 2008, 
Petersen, Calle et al. 2010, Uygun, Soto-Gutierrez et al. 2010). Table 1.8 
summarises the current clinical acellular products, which are obtained from a 
variety of allogeneic or xenogeneic tissue sources.  
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Product Tissue source Application 
AlloDerm® (Lifecell Corp.) Human dermis Soft tissue 
AlloPatch HD™, FlexHD® 
(Musculoskeletal Transplant 
Foundation) 
Human dermis Tendon, breast 
NeoForm™ (Mentor Worldwide LLC) Human dermis Breast 
GraftJacket® (Wright Medical 
Technology Inc.) 
Human dermis Soft tissue, chronic 
wounds 
Strattice™ (Lifecell Corp.) Porcine dermis Soft tissue 
Zimmer Collagen Repair Patch™ 
(Zimmer Inc.) 
Porcine dermis Soft tissue 
TissueMend® (Stryker Corp.) Bovine dermis Soft tissue 
MatriStem®, Acell Vet (Acell Inc.) Porcine urinary bladder Soft tissue 
Oasis®, Surgisis® (Cook Biotech Inc.) Porcine small intestine Soft tissue 
Restore™ (DePuy Orthopaedics) Porcine small intestine Soft tissue 
FortaFlex® (Organogenesis Inc.) Porcine small intestine Soft tissue 
CorMatrix ECM™ (CorMatrix® 
Cardiovascular Inc.) 
Porcine small intestine Pericardium, cardiac 
tissue 
Meso BioMatrix™ (Kensey Nash Corp.) Porcine mesothelium Soft tissue 
IOPatch™ (IOP Inc.) Human pericardium Ophthalmology 
OrthAdapt®, Unite® (Synovis 
Orthopedic and Woundcare Inc.) 
Equine pericardium Soft tissue, chronic 
wounds 
CopiOs® (Zimmer Inc.) Bovine pericardium Dentistry 
Lyoplant® (B. Braun Melsungen AG) Bovine pericardium Dura mater 
Perimount® (Edwards Lifesciences 
LLC) 
Bovine pericardium Valve replacement 
Hancock® II, Mosaic®, Freestyle® 
(Medtronic Inc.) 
Porcine heart valve Valve replacement 
Prima™ Plus (Edwards Lifesciences 
LLC) 
Porcine heart valve Valve replacement 
Epic™, SJM Biocor® (St. Jude Medical 
Inc.) 
Porcine heart valve Valve replacement 
 
Table 1.8 Clinical products composed of acellular tissue. Reproduced from Crapo, Gilbert et 
al. (2011)            
 
 
 
 
 
 
                      
34 
 
1.8.2 Decellularisation methods 
The aim of any decellularisation process is to efficiently remove all cellular and 
nuclear material whilst minimising any adverse effect on the composition, 
biological activity and mechanical integrity of the remaining ECM. Nonetheless 
any process that requires the removal of cells is likely to alter the native three 
dimensional architecture of the ECM.  
Numerous methods exist for preparing acellular scaffolds (Table 1.9).  
Despite inherent differences all processing techniques aim to reduce the tissue 
immunogenicity and enhance the regenerative capacity through preservation of the 
native ECM.  
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Table 1.9 Summary of the decellularisation methods used and their effect on the ECM. Reproduced from Gilbert, Sellaro et al. (2006)   
Method Mode of action  Effect on ECM 
Physical: 
 Snap freezing 
 Mechanical force 
 Mechanical agitation 
 Electroporation 
Disrupt cell membrane, burst cells and 
tissue, cell lysis  
Disrupts and damage ECM 
Chemical: 
 Acids and alkalines 
 
 
 
 Ionic, non-ionic and 
zwitterionic detergents 
 
 
 
 Hypo and hypertonic 
solutions 
 
Solubilises cytoplasmic and nuclear 
cellular membranes.  
 
 
Disrupts lipid-lipid, lipid-protein and 
protein-protein interactions 
 
 
 
Cell lysis by osmotic shock, disrupts 
DNA-protein interactions 
 
 
Damages collagen and removes GAG’s, growth factors and cytoplasmic proteins.  
 
Disrupts tissue ultrastructure, removes GAG’s and cytoplasmic proteins and damages 
collagen. Effective cell removal 
 
Does not effectively remove the cellular remnants  
 
Enzymatic: 
 Trypsin 
 
 
 Dipases 
 
 
 
 Endo and exonucleases 
 
 
 
Cleaves peptide bonds on the carboxyl-
side (COOH) of Arg and Lys 
Cleaves specific peptides, mainly 
fibronectin and collagen IV 
 
Catalyse the hydrolysis of the interior 
and terminal bonds of ribonucleotide 
and deoxyribonucleotide chains 
 
Prolonged exposure can disrupt ECM structure; remove laminin, fibronectin collagen IV, 
elastin and GAGs. 
 
 
Difficult to remove from tissue and can invoke an immune response. 
 
 
Chelating agents: 
 EDTA, EGTA 
Bind divalent metallic ions, thereby 
disrupting cell adhesion to ECM 
 
No isolated exposure, typically used with enzymatic methods (e.g. trypsin) 
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1.8.3 Decellularisation solutions and agents 
1.8.3.1 Detergents 
1.8.3.1.1 Ionic detergents 
Ionic detergents solubilise both cytoplasmic and nuclear cellular membranes; 
however they also denature proteins by disrupting protein-protein interactions 
(Seddon, Curnow et al. 2004). Common ionic detergents include sodium dodecyl 
sulphate (SDS) (Wilshaw, Rooney et al. 2011, Wakimura, Wang et al. 2015), 
sodium deoxycholate (Wang, Itoh et al. 2015) and Triton X-200 (Hudson, Liu et 
al. 2004).  
SDS is efficient in removing cellular components from tissue as well as 
nuclear remnants and cytoplasmic proteins (Woods and Gratzer 2005). Drawbacks 
of SDS include potential disruption to the native tissue structure, decrease GAG 
content and disruption of collagen integrity (Gilbert, Sellaro et al. 2006). However, 
SDS does not appear to solubilise or remove collagen from the tissue. Sodium 
deoxycholate is also effective in removing cell remnants; however it tends to cause 
greater disruption to the tissue and has to be used in conjunction with other 
zwitterionic detergents or Triton X 200 (Hudson, Liu et al. 2004).  Residual 
chemicals from the ECM must be flushed away after decellularisation especially if 
using detergents that penetrate into dense tissue such as SDS. Residual detergent 
within the tissue may cause cytotoxicity, inhibiting the beneficial properties of an 
acellular scaffold    
1.8.3.1.2 Non-ionic detergents 
Non-ionic detergents have been extensively used due to their mild effects upon 
tissue structure. These detergents disrupt the lipid-lipid and lipid-protein 
interactions whilst leaving protein-protein interactions intact so that the proteins 
within the tissue can be left in a functional confirmation (Seddon, Curnow et al. 
2004). 
Triton X-100 is the most commonly studied non-ionic detergent for the 
decellularisation protocol. The use of this detergent on different tissue types 
however has shown mixed results in terms of the removal of nuclear material (Dahl, 
Koh et al. 2003, Grauss, Hazekamp et al. 2005). In regards to the ECM components 
there has been a complete loss of GAGs as well as a decrease in laminin and 
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fibronectin content (Grauss, Hazekamp et al. 2005). The efficacy of Triton X-100 
is dependent upon the tissue being decellularised as well as the other methods with 
which it is combined in a given decellularisation protocol.   
1.8.3.1.3 Zwitterionic detergents 
These detergents exhibit the properties of both non-ionic and ionic detergents and 
include 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 
sulfobetaine-10 (SB-10) and -16 (SB-16). CHAPs treated artery tissue showed 
retention of collagen and elastin but decreased the mechanical integrity of the tissue 
(Dahl, Koh et al. 2003). SB-10 and SB-16 in conjunction with Triton X-200 have 
shown to have a less detrimental effect on the ECM of peripheral nerve tissue 
(Hudson, Liu et al. 2004). 
1.8.3.2 Hypotonic and hypertonic treatments 
Hypertonic solutions dissociate DNA from proteins whilst hypotonic solutions are 
used to lyse the cells within tissues through osmotic shock with minimal changes 
in matrix molecules and architecture. For a maximum osmotic effect, it is common 
for the tissue to be immersed alternatively in hyper and hypotonic solutions. This 
treatment however does not remove the cellular remnants from the tissue therefore 
additional enzymatic or chemical treatments are necessary for the removal of the 
cellular debris (Crapo, Gilbert et al. 2011). 
1.8.3.3 Chelating agents 
Chelating agents such as EDTA and EGTA form a ring-shaped molecular complex 
that binds and isolates a central metal ion. Divalent cations such as Ca2+ and Mg2+ 
are needed for cell attachment to collagen and fibronectin at the Arg-Gly-Asp 
receptor(Klebe 1974, Gailit and Ruoslahti 1988). By binding the divalent cations 
present at the cell adhesions to the ECM the chelating agents facilitate in the 
removal of the cellular material from the tissue.  
1.8.3.4 Enzymatic methods 
These methods include the use of protein digestion, calcium chelating agents and 
nucleases (Bader, Schilling et al. 1998, Gamba, Conconi et al. 2002, McFetridge, 
Daniel et al. 2004). Trypsin is a commonly used proteolytic enzyme in 
decellularisation. This enzyme cleaves the peptide bonds on the carbon side of 
arginine and lysine if the next residue is not proline (Voet, Voet et al. 1999).  
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Nucleases such as endonucleases catalyse the hydrolysis of the interior bonds of 
deoxyribonucleotide or ribonucleotide chains whereas exonucleases catalyse the 
hydrolysis of the terminal bonds which ultimately leads to the degradation of RNA 
and DNA (Freyman 2008).   
The effectiveness of enzymatic treatment for the removal of cellular 
material from the ECM has been studied in a variety of tissues with varied results 
(Schenke-Layland, Vasilevski et al. 2003, Grauss, Hazekamp et al. 2005). 
Prolonged treatment with trypsin/EDTA can cause disruption of the ECM structure 
but does not affect the overall amount of collagen in the tissue. Trypsin/EDTA has 
however been shown to substantially reduce the laminin and fibronectin content of 
the ECM (Schenke-Layland, Vasilevski et al. 2003). Prolonged exposure with 
trypsin/EDTA can also decrease the elastin and GAG content (chondroitin 
sulphates, keratin sulphates and dermatan sulphates) over time.  A loss of these 
components can result in the decrease in tensile strength of up to 50% (Schenke-
Layland, Vasilevski et al. 2003, Grauss, Hazekamp et al. 2005).     
1.8.3.5 Protease inhibitors 
During the decellularisation process, proteases can be released from the disrupted 
cells, which in turn can damage the native ECM ultrastructure. Protease inhibitors 
such as aprotinin are therefore added to solutions. Buffered solutions of pH 7-8 as 
well as temperature control and time of exposure to the lysis solutions can also 
limit protease activity (Gilbert, Sellaro et al. 2006).    
1.8.3.6 Antibiotics 
The presence of bacteria can contaminate tissues which have been subjected to 
prolonged chemical decellularisation methods. Antibiotics such as penicillin, 
streptomycin or amphotericin have been included in many decellularisation 
protocols (Costa, Dohmen et al. 2004, Hilbert, Yanagida et al. 2004, Woods and 
Gratzer 2005). However antibiotic residues may remain in the tissue material after 
the decellularisation protocol which may increase the complexity of regulatory 
approval. 
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1.9 Sterilisation of acellular tissue 
Following the completion of the decellularisation process the tissues must be 
sterilised prior to in vitro cell seeding or in vivo studies. Sterilisation of biological 
scaffolds is vital to eliminate endotoxins and viral and bacterial DNA that may be 
present. Sterilisation methods have included incubation in acids or solvents, 
ethylene oxide exposure, gamma irradiation and electron beam irradiation (Hodde 
and Hiles 2002).   
Ethylene oxide, gamma irradiation and electron beam irradiation are known 
to alter ECM ultrastructure and mechanical properties of the tissue (Freytes, Stoner 
et al. 2008, Gouk, Lim et al. 2008, Sun and Leung 2008). Irradiation has been 
shown to causes ECM degradation due to the denaturation of structural proteins 
such as collagen (Sun and Leung 2008). Gamma irradiation causes lipids to become 
cytotoxic as well as accelerating enzymatic degradation of ECM (Moreau, Gallois 
et al. 2000, Gouk, Lim et al. 2008). Supercritical carbon dioxide has been recently 
investigated and demonstrated  effective reduction of bacterial and viral loads 
within porcine dermal ECM with minimal effect on the mechanical properties (Qiu, 
Leamy et al. 2009).  
Acid and alkaline treatments solubilise the cytoplasmic component of the 
cells as well as removing nucleic acids such as RNA and DNA through hydrolytic 
degradation. Bases such as calcium hydroxide, sodium sulphide and sodium 
hydroxide are harsh chemicals that can eliminate growth factors from the matrix 
and decrease ECM mechanical properties by cleaving collagen fibrils and 
disrupting collagen crosslinking (Gilbert, Sellaro et al. 2006). 
Acids such as peracetic (PAA), sulphuric and hydrochloric can effectively 
disrupt cell membranes and intracellular organelles. PAA is an oxidising agent and 
an effective chemical sterilant (Pruss, Kao et al. 1999, Hodde and Hiles 2002). 
PAA also doubles up as a decellularisation agent with the removal of residual 
nucleic acid (Badylak, Tullius et al. 1995) as well as being an excellent agent for 
inhibiting viruses (Hodde and Hiles 2002).  
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1.10 Immune response to biological scaffolds 
The immune response to acellular scaffolds involves both the innate and adaptive 
immune system. They determine the eventual clinical outcome of the scaffolds. 
The innate (non-specific) system consists of cells and proteins that are always 
present and ready to fight microbes at the site of infection. The main components 
of the innate immune system include the physical epithelial barriers, phagocytic 
leukocytes, dendritic cells, natural killer (NK) cell (granular lymphocyte), and 
circulating plasma proteins. 
The adaptive (specific) system is activated against pathogens that have 
evaded the innate immune defence system. There are two types of adaptive immune 
responses; humoral immunity, mediated by antibodies produced by B lymphocytes, 
and cell-mediated immunity, mediated by T lymphocytes (Chaplin 2010). 
1.10.1 Constructive remodelling versus pro-inflammatory response to 
biological scaffolds  
The host cellular response and remodelling outcomes differ amongst the tissue 
engineered  scaffold and is affected by variables such as the processing steps 
involved in creating the scaffold, intended clinical application, tissue source from 
which the ECM is harvested and  the tissues in vivo degradability (Badylak, Freytes 
et al. 2009). 
1.10.1.1 Th1 versus Th2 lymphocyte response  
The T helper (Th) cells have distinct phenotypic polarisation profiles known as Th1 
and Th2. Polarisation is a process when cells express different functional programs 
in response to signals from the microenvironment  (Mantovani, Sozzani et al. 
2002). Th1 lymphocytes produce cytokines such as interleukin (IL)-2, interferon 
(IFN)-γ, and tumour necrosis factor (TNF)-β. This leads to macrophage activation, 
stimulation of complement fixing Ab isotypes and differentiation of CD8+ cells to 
a cytotoxic phenotype  (Abbas, Murphy et al. 1996). Activation of this pathway is 
associated with transplant rejection  (Strom, Roy-Chaudhury et al. 1996).  
Th2 lymphocytes produce IL-4, IL-5, IL-6, and IL-10, cytokines that do not 
activate macrophages and that lead to production of non-complement fixing Ab 
isotypes. Activation of the Th2 pathway is associated with transplant acceptance 
(Chen and Field 1995, Piccotti, Chan et al. 1997). 
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1.10.1.2 M1 versus M2 macrophage response  
Similarly, to the Th1/Th2 lymphocytes there is also a distinct phenotypic 
polarisation profile for the mononuclear macrophages. M1 are macrophages which 
possess a pro-inflammatory, cytotoxic phenotype. They are characterised as cells 
that promote pathogen killing and are associated with classic signs of 
inflammation. M2 are anti-inflammatory macrophages. These cells promote 
immunoregulation, tissue repair and tissue remodelling (Mosser 2003, Mantovani, 
Sica et al. 2005).  
These mononuclear macrophages are morphologically similar however 
they can be distinguished by their cell surface markers and their cytokine and gene 
expression profiles (Mantovani, Sica et al. 2004, Stout, Jiang et al. 2005). In rats 
M1 macrophages are characterized by CD68+ and CD80+ cell surface markers. 
These cells also produce large amounts of nitric oxide and other reactive oxygen 
intermediates as well and copious amounts of pro-inflammatory cytokines such as 
IL-12 and TNFα. Conversely, M2 macrophages express CD163 surface markers in 
rats. These cells produce high levels of IL-10 and TGF-β expression, produce large 
amounts of arginase, inhibit release of proinflammatory cytokines, scavenge 
debris, promote angiogenesis, and recruit cells involved in constructive tissue 
remodelling.  
1.10.2 Degradation of biological scaffolds  
ECM derived scaffolds which have not been cross-linked rapidly degrade after 
implantation. Studies using small intestinal submucosa for tendon repair (Gilbert, 
Stewart-Akers et al. 2007) and urinary bladder repair (Record, Hillegonds et al. 
2001) reported approximately 60% of the mass was degraded and resorbed within 
4 weeks of implantation and completely degraded by 3 months.   
The duration of the ECM scaffold in vivo in relation to the host immune 
response is unknown however recent studies suggest that degradation of the 
scaffold is shown to induce constructive host remodelling response. During 
degradation low molecular weight peptides are formed. In vitro analysis have 
shown that  these peptides have a chemoattractant potential for several cell types, 
including multipotential progenitor cells (Li, Li et al. 2004) . In addition  in vivo  
studies have shown the recruitment of bone-marrow derived cells to the 
degradation site where they participate in the long term remodelling of the ECM 
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(Badylak, Park et al. 2001).  Therefore, degradation may actually be a requisite 
needed to pave the way for the remodelling events that follow.  
1.11 Acellular  nerve grafts 
A number of methods have been documented for the preparation of acellular nerve 
grafts from donor nerve tissue. The most commonly utilised method for 
decellularisation of nerve tissue involves physical (Hiles 1972, Gulati 1988, Evans, 
Mackinnon et al. 1998, Ide, Tohyama et al. 1998), chemical (Sondell, Lundborg et 
al. 1998, Hudson, Liu et al. 2004) or enzymatic treatments (Wang, Itoh et al. 2015). 
1.11.1  Avance® Nerve Graft 
AxoGen Inc is the only medical device company that offers comercially available 
acellular allografts for peripheral nerve regeneration.  Avance® Nerve Graft,  an 
allograft with lengths ranging between 15-70 mm utilises the decellularised ECM 
from donated human peripheral nerve tissue. The tissue undergoes a combination 
of treatments including chemical decellularisation (detergent processing) to 
selectively remove cellular components and debris, and gamma-irradiation for 
sterilization. In addition these allografts also undergo pre-Wallerian degeneration, 
an enzymatic digestion of chondroitin sulfate proteoglycan (CSPG). CSPG is a 
known inhibitor of axonal growth, through acute enzymatic treatment using 
chondroitinase the quantity of CSPG can be effectively reduced and therby 
increases axonal regeneration (Muir 2010). The whole processing technique 
renders the tissue non-immunogenic whilst preserving the inherent and relevant 
structural characteristics of the tissue.  
1.11.2 Clinical studies on Avance® Nerve Graft  
A comparison study between Avance® Grafts and NeuraGen® was carried out in a 
rat sciatic model. The study saw regeneration of 20 times more myelinated axons 
in the Avance® Graft.  In addition in both 14 and 28 mm defects, the Avance® Graft 
contained significantly more nerve fibres at all-time points (Whitlock, Tuffaha et 
al. 2009). In a subsequent study examining nerve fibre density  Avance® graft was 
found to have more evenly distributed nerve fibres across the cross section of the 
nerve when compared to NeuraGen® (Johnson, Newton et al. 2011) .  
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Early clinical studies carried about at the Mayo Clinic have demonstrated 
that the Avance® Graft (mean length of 2.23 cm) has the ability to repair segmental 
nerve defects ranging from 0.5 - 3cm within the hand and fingers (Figure 1.8).  
 
 
 
   
 
 
 
 
 
Figure 1.8 AxoGen® Nerve Graft being used to repair segmental nerve defects.  A bilateral 
digital nerve injury being repaired (A); nerve graft at 8 weeks following implantation (B).  
Reproduced from Karabekmez, Duymaz et al. (2009). 
 
Eight digital and two dorsal sensory nerves were repaired with a follow-up 
time of 9 months (Table 1.10). There were no reported cases of infection or 
rejection and the grafts may provide an option for segmental nerve gaps beyond 2 
cm (Karabekmez, Duymaz et al. 2009). 
A B 
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Table 1.10. Summary of ten nerve reconstructions with defect length and follow up values. Reproduced by Karabekmez, Duymaz et al. (2009)
No. Injured nerve Etiology Length (mm) Diameter (mm) Follow-up (mm) 
1 Digital nerve Laceration 0.5 2 5.5 
2 Dorsal sensory branch of the ulna Neuroma 
excision 
3 1 8.5 
3 Dorsal sensory branch of the ulna Neuroma 
excision 
3 2 8.5 
4 Ring finger radial digital nerve Laceration 1 2 12 
5 Ring finger ulnar digital nerve Laceration 3 2 12 
6 Long finger radial digital nerve Laceration 3 2 9 
7 Digital nerve Laceration 3 2 5 
8 Digital nerve Laceration 3 2 5 
9 Thumb radial digital nerve Laceration 1 2 12 
10 Thumb ulnar digital nerve Laceration 1 2 12 
AVG   2.15 1.90 8.95 
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Between 2007-2012 a comprehensive clinical study was carried out from a 
multicentre, evaluating the efficacy outcomes for Avance® Grafts in sensory, 
mixed and motor nerve injuries with a mean graft length of 27±14 (5-50) mm. A 
total of 108 subjects were involved in the study with 132 nerve repairs, termed the 
Utilisation Population (UP). Subjects that provided sufficient follow up 
assessments to evaluate functional outcomes were placed into the Outcome 
Population (OP). With both the UP and OP studies there were no reported implant 
complications, tissue rejections or any adverse events related to the use of the graft. 
The majority of repairs were digital nerves in the hand (60%) followed by 
upper extremity nerves (32%), head/neck region (5%) and lower extremities (3%) 
(Table 1.11). Although not all the repairs in the UP reported sufficient follow up 
for outcomes analysis the demographic between the subject, injury and repair found 
the OP to be comparable to the UP. Table 1.12 shows on average 89.5% of all 
subjects with different nerve injuries reported a positve response to the treatment 
using the Avance® Graft whilst 87.3% achieved meaningful recovery.  
No obvious conclusion could be drawn in regards to the relationship 
between  the nerve type, gap length  patient age and outcomes. This may have been 
attributed to the number of  subjects in each group, distribution of variables across 
the group, or the surgeon’s approach. This study has certain limitations such as  
increased risk of heterogeniety in the datasets; variability between subjects and 
injuries and multiple sources of data. Observational studies were also limited in the 
fact that they couldn’t be conducted in a prospective, randomised fashion.   
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                       Table 1.11. Summary of the nerves treated in the Utilisation Population and Outcome Population.  
                       Reproduced by Brooks, Weber et al. (2012)    
  
 
 
 
 
 
 
  
 
                  
 
 
                     Table 1.12. Summary of the demographic characteristics of subjects in the Outcome Population.  
                     Reproduced by Brooks, Weber et al. (2012)  
 
                                     
Nerve Utilisation population Outcomes population 
Digital 73 48 
Median 22 11 
Ulnar 15 6 
Radial 4 2 
Peroneal 5 2 
Musculocutaneous 1 1 
Anterior interosseous 1 0 
Facial 3 3 
Tibial 2 0 
Sciatic 1 0 
Spinal Accessory 2 1 
Posterior Interosseous 1 0 
Axillary nerve 1 1 
Ulnar nerve motor branch 1 1 
Total Repairs 132 76 
Nerve Type Number Gap (mm) Response Rate Meaningful 
Recovery 
Sensory 49 19±8 91.8% 88.6% 
Mixed 18 29±12 83.3% 77.0% 
Motor 9 29±13 88.8% 85.7% 
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A direct comparison of the clinical results obtained with acellular graft 
repairs versus those achieved with NGCs is not possible based on the current 
literature. Currently only positive results on the clinical use of Avance ® Grafts 
have been published whilst there have been mixed results for the commercially 
available NGCs. This may skewer the impressions as to which treatment is best for 
promoting nerve regeneration. It is important to note that the experimental studies 
to date have only investigated small-diameter, small gap defects and future studies 
still need to be undertaken to compare acellular grafts to autograft and NGCs. A 
major factor that limits such studies is the identification of a low-cost acellular 
nerve graft that is both comparable to commercially available acellular nerve grafts, 
and beneficial for laboratory use.   
1.11.3 Use of xenogeneic acellular nerve grafts  
In recent years’ focus has shifted in the use of xenogeneic ECM as scaffolds or 
grafts due to ease of harvesting and availability. The use of xenogeneic material 
has been used in a variety of biomedical applications such as heart valves (Booth, 
Korossis et al. 2002) and tissue patches such as and Matristem® for ulcer repairs 
(Badylak and Gilbert 2008). 
When used clinically, xenografts do possess some risks due to α-Gal 
epitopes found in some unmodified xenogeneic tissue, which can trigger an 
immune response. To remove the potential threat of α-Gal epitopes, tissues can be 
crosslinked i.e. with glutaraldehyde or enzymatically treated with α-galactosidase 
(Badylak and Gilbert 2008). This enzymatic treatment has been shown to 
effectively remove the α-Gal epitope from both porcine cartilage and ACL tissues 
(Stone, Ayala et al. 1998, Stone, Abdel-Motal et al. 2007, Stone, Walgenbach et al. 
2007). Table 1.13 shows the clinically available xenogeneic products, some of 
which have been crosslinked to remove the α-Gal epitope. 
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Table 1.13. Source tissue and processing methods for commercially available devices produced from extracellular matrix scaffold material. 
Reproduced from Badylak and Gilbert (2008) 
  
 Species/Tissue origin Crosslinking 
Oasis™, Surgisis™ Cook Biotech, Inc.) Porcine small intestinal submucosa n/a 
Restore™ (DePuy Orthopaedics) Porcine small intestinal submucosa n/a 
CuffPatch™ (Organogenesis, Inc) Porcine small intestinal submucosa Carbodiimide 
Acell Vet (Acell, Inc.) Porcine urinary bladder basement membrane 
and mucosa 
n/a 
Zimmer Collagen Repair Patch™ (Zimmer, Inc.) Porcine dermis  Isocyanate 
TissueMend® (Stryker) Bovine dermis Proprietary 
Mosaic®, Freestyle® (Medtronic, Inc.) Porcine heart valve Glutaraldehyde 
OrthAdapt™ (Pegasus, Inc.) Equine Pericardium Proprietary 
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Acellular xenogeneic nerve tissue from rat, rabbit and pigs has been widely used 
for peripheral nerve studies. Several studies have demonstrated that xenogeneic 
nerve tissue possess an ECM and basement membrane that serve as physical 
guidance cues for axonal growth (Gutmann and Sanders 1943, Osawa, Tohyama et 
al. 1990, Hudson, Liu et al. 2004, Whitlock, Tuffaha et al. 2009, Zhang, Luo et al. 
2010).   
1.11.4 Limitations of acellular nerve grafts  
The Avance® nerve graft has shown to be superior over the comercially available 
NGCs in promoting nerve regeneration. Nonetheless, like with the autografts and 
comercially available NGCs, the acellular graft does have limitations. The Avance® 
Nerve Graft uses human nerve donor tissue, which is fraught with complications in 
terms of gaining approval and cost as they need to be kept frozen until implantation, 
which can create additional overhead costs.   
Clinical studies have shown Avance® to be an effective nerve substitute, 
however the graft only supports nerve regeneration over limited distances (up to 60 
mm) (Saheb-Al-Zamani, Yan et al. 2013). In addition, when compared to native 
nerve autografts the Avance® graft still only possessed reduced regenerative 
capacities. It was demonstrated that the number of fibres supported by the Avance® 
graft was only 30% of that supported by autografts (Whitlock, Tuffaha et al. 2009).  
The limited regeneration in acellular grafts is due to the grafts dependency 
on in situ Schwan cells to support axonal regeneration (Moore, MacEwan et al. 
2011).  It has been proposed that populating longer acellular nerve grafts places a 
greater proliferative demand on in situ Schwan cells, which may cause them to 
senesce (Saheb-Al-Zamani, Yan et al. 2013). Although the acellular graft length 
seems to be limited by the Schwann cell migration problem, the critical gap size is 
not yet known. There are reports of acellular grafts up to 70 mm in length currently 
being utilised for clinical nerve reconstruction but in the absence of supporting data 
(Moore, MacEwan et al. 2011).    
To improve axon regeneration and extend the workable length of the 
acellular graft focus has shifted to repopulating the graft with support cells. With 
this come many new challenges such as identifying the cell type, isolating and 
proliferating this cell, and seeding the cells into the acellular material.  
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1.12 Importance of cellular therapies for nerve regeneration 
The similarities between the developing and regenerating nerve such as axon 
outgrowth and myelination may seem that regeneration recapitulates development. 
During development axons serve as a template to guide Schwann cell migration, 
establishing a Schwann cell-axon unit, a characteristic of a mature myelinated 
nerve. Conversely in the regenerating nerve, axons migrate into an environment 
where Schwann cells are already in situ. Furthermore the molecular events in the 
Schwann cell vary in the developing verses the regenerating nerve (Weinstein 
1999). Schwann cells therefore play a crucial role in supporting axonal growth and 
migration following PNS injury.  
Several investigations have highlighted the close relationship between 
Schwann cells and axon as a “regenerating unit” (Morris, Hudson et al. 1972, 
Brushart 2011).  A study conducted by Enver and Hall (1994) used mitomycin C 
to block Schwann cell proliferation in the proximal and distal stumps in rats with 
inserted muscle basal lamina grafts. It was discovered that in the absence of cell 
migration axonal outgrowth was delayed until the Schwann cell population 
recovered from the anti-mitotic drug (Enver and Hall 1994). In another study by it 
was revealed that axons enter acellular grafts only when associated with co-
migratory Schwann cells (Feneley, Fawcett et al. 1991).  
1.12.1 Role of Schwann cells in nerve regeneration 
The exact underlying mechanism through which Schwann cells and damaged axons 
communicate is poorly understood. It has been suggested that interactions between 
neurotransmitters and their upregulated receptors may be involved. Inhibition of 
the neurotransmitter acetylcholine to its receptor saw a decrease in axonal 
regeneration (Vrbova, Mehra et al. 2009). Another study states that the Toll-like 
receptors, expressed by Schwann cells act as mediators between the Schwann cells 
and degenerating axons to stimulate Schwann and immune cells to clear myelin 
and start the repair process (Goethals, Ydens et al. 2010). 
Following PNS injury Schwann cells become activated, undergoing a 
phenotypic change from myelinating to growth supportive to help lead regenerating 
axons towards the distal nerve stump. This phenotype switch is associated with the 
up-regulation of several growth associated genes including neurotrophic factors 
(P75 NTR, GFAP, GAP-43 and netrin-1), cell adhesion molecules and receptors 
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including IL-1, N-cadherin, gamma integrins and neural cell adhesion molecule 
(N-CAM) (Rodrigues, Rodrigues et al. 2012).  These molecules help support 
axonal migration and recruit further cells such as macrophages, mast cells and 
activated endothelial cells into the injury site (Hall 2005, Walsh and Midha 2009). 
Activated Schwann cells also provide a supportive environment by producing 
collagen and laminin which yields Schwann cell proliferation (4-17 times the 
original number seen in normal nerve) (Daly, Yao et al. 2012) and form 
longitudinally orientated strands (bands of Büngner) that guide regrowing axons 
(Bunge 1994). 
If the axonal contact is not re-established or the gap length increases 
Schwann cell migration, proliferation and alignment decreases and the growth 
supportive environment cannot be maintained due to the cells losing their ability to 
express regeneration-assisting genes. As the capacity of the denervated distal nerve 
to support axonal regeneration is dependent on proliferating Schwann cells this 
translates to poor reinnervation outcomes (Walsh and Midha 2009). In an attempt 
to aid the regenerative cellular response to injury and to help stimulate nerve 
regeneration across long peripheral nerve defects cellular based therapies are 
considered essential for nerve repair.   
1.12.2 Use of cellular therapy in nerve tissue engineering applications 
Schwann cells have been used in synthetic and natural based NGC’s as well as in 
acellular nerve tissue to improve functional recovery, regeneration and 
remyelination of injured peripheral nerves.   
1.12.2.1 Current cellular therapy for NGCs 
Several different methods have been implemented to introduce cells into the 
conduit. These include injection, suspension within an intraluminal hydrogel, 
distributed along intraluminal guidance structures or released from the luminal 
wall. Hydrogels (alginate/fibronectin, gelatin, collagen and Matrigel) are 
commonly used as supporting substrates to deliver Schwan cells into the lumen of 
NGCs. Schwann cells have been successfully implanted in a number of studies with 
varying effects on nerve regeneration and functional recovery (Table 1.14).   
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Table 1.14 Use of Schwann cells to help stimulate nerve regeneration in nerve guide conduits. Reproduced from Jiang, Lim et al. (2010); Daly, Yao et 
al. (2012) and Rodrigues, Rodrigues et al. (2012) 
Cellular 
Components 
Conduit 
Material 
Animal 
model 
Gap 
length 
Major findings Reference 
Schwann cells (syngeneic) PLGA coated with 
biomembranes 
Rat sciatic nerve  2 cm Increased nerve regeneration (Cheng and Chen 2002) 
Schwann cells (syngeneic, 
heterologous) 
PAN/PVC copolymer Rat sciatic nerve 8 mm Successful nerve regeneration conditional to 
number of cells implanted 
(Guenard, Kleitman et al. 1992) 
Schwann cells (syngeneic) Collagen (type I/III) Rat sciatic nerve 20 mm Axonal regeneration (Stang, Fansa et al. 2005) 
Transduced Schwann cells 
(syngeneic) 
PHB Rat sciatic nerve 10 mm Increased regeneration process and 
enhanced axonal regeneration rate 
(Mosahebi, Woodward et al. 2001) 
Schwann cells (autologous) Silicone Rat sciatic nerve 10 mm Regeneration of nerve fibres (Nilsson, Dahlin et al. 2005) 
Schwann cells (allogeneic) 
plus FK-506 
Collagen Mouse sciatic nerve 0.6 cm Successful regeneration and functional 
recovery 
(Udina, Rodriguez et al. 2004) 
Schwann cells 
(allogeneic) 
Bioactive poly (L-
lactic 
acid) 
Rat sciatic nerve 1.2 cm Increased nerve regeneration (Evans, Brandt et al. 2002) 
Schwann cells L-lactide /d ε-
caprolactone 
Rat sciatic nerve 1.2 cm Axonal regeneration (Koshimune, Takamatsu et al. 2003) 
Schwann cells (syngeneic) Reinforced collagen Rat sciatic nerve 1.8 cm Successful nerve regeneration conditional to 
number of cells implanted 
(Ansselin, Fink et al. 1997) 
Schwann cells and 
ultrasound 
Hollow PLGA/silicone 
NGC 
Rat sciatic nerve 10 mm Significant increase in nerve regeneration (Chang, Hsu et al. 2005) 
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1.12.2.2 Current cellular therapy for acellular nerve grafts 
The current studies which use acellular grafts in conjunction with cellular therapy 
to promote regeneration are summarised in Table 1.15. Several studies reported 
significant regeneration as well as structurally and functional repair with the 
inclusion of cells (Nishiura, Brandt et al. 2004, Hess, Brenner et al. 2007, Hu, Zhu 
et al. 2007, Zhang, Luo et al. 2010).   
However other studies reported little effect of adding Schwann cells to 
acellular graft material (Frerichs, Fansa et al. 2002, Fansa and Keilhoff 2004, Fox, 
Schwetye et al. 2005). A reason for this could be that in situ Schwann cells 
migrating from the host stumps are able to cross short distances and provide 
sufficient regeneration despite the addition of exogenous cells. When Schwann 
cells migrate over long distances, such as in the case of large gap models (>20 mm 
– ‘critical gap’), nerve regeneration fails. This suggests that cell supplementation 
of acellular grafts may be of greatest clinical use for large gaps, rather than those 
with adequate host Schwann cell migration (Nadim, Anderson et al. 1990).   
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Table 1.15. Studies conducted using cellular therapy in acellular grafts to help stimulate nerve regeneration  
Cellular component Acellular graft Model Gap length Findings Reference 
Autologous Schwann 
cells 
Macaca 
fascicularis ulnar 
nerve  
Macaca fascicularis 
primate ulnar nerve 
60 mm Significant regeneration 
across injury gap 
(Hess, Brenner et al. 2007) 
Autologous non-
hematopoietic MSCs 
Rhesus monkey 
sciatic nerve 
branches 
Rhesus monkey ulnar 
nerve 
40 mm Structural and functionally repair after 6 months.  (Hu, Zhu et al. 2007) 
ADSCs Porcine nerve graft Rat sciatic nerve 10 mm Basal lamina of graft interacted with cells to form 
longitudinal cell alignment that resemble bands of 
Bünger  
(Zhang, Luo et al. 2010) 
Skin-derived 
precursor cells pre-
differentiated 
towards a Schwann 
cell phenotype (SKP-
SCs) 
Rat sciatic nerve 
graft 
Rat sciatic nerve 12 mm Nerve graft supported axonal elongation to the same 
extent as autograft, as well as providing axon 
regeneration, myelination and electrophysiological 
recovery.  
 
(Walsh, Biernaskie et al. 2009) 
Schwann cells Rat tendon nerve 
graft 
Rat sciatic nerve 10 and 15 
mm 
Myelination was significantly increased in 10mm 
defects. No difference was seen in the 15 mm defect  
(Arino, Brandt et al. 2008) 
Isogenic Schwann 
cells  
Rat muscle graft Rat sciatic nerve 20 mm  Systematic and organized regeneration including 
proper orientation of regenerated fibers. 
(Fansa and Keilhoff 2004) 
Autologous Schwann 
cells 
Rat tibial nerve 
grafts 
Rat sciatic nerve 15 mm Regeneration without evidence of rejection but the 
addition of cultured Schwann cells showed no 
additional benefit for nerve regeneration 
(Fox, Schwetye et al. 2005) 
Isogenic Schwann 
cells  
Predegenerated 
acellular and 
acellular rat sciatic 
nerve grafts 
Rat sciatic nerve 20 mm Predegenerated acellular nerve grafts showed superior 
results in axon density and histological appearance 
compared to acellular graft. Inclusion of cells did not 
show any significant improvement 
(Frerichs, Fansa et al. 2002) 
Adult Schwann cells 
from predegenerated 
rat sciatic nerves 
Tendon autografts 
excised from rat 
tail. Freeze–
thawed muscle 
graft 
Rat sciatic nerve 10 mm Addition of cells to the two graft models improved 
regeneration by increasing the rate of axonal 
outgrowth when compared with grafts without added 
cells. 
(Nishiura, Brandt et al. 2004) 
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1.12.3 Introduction of cells into acellular grafts 
The current approaches in repopulating acellular nerve grafts involve injection of 
cells using a syringe into the ends of the graft in vitro. The reseeded grafts are then 
transplanted into an in vivo animal mode and harvested at a later time point for 
histological analysis (Brenner et al 2005; Fox et al 2005; Hess et al 2007). These 
animal models are useful in revealing aspects of PNS development as well as nerve 
regeneration after injury.  
When working with acellular tissue it is important to establish a suitable 
approach to seeding cells into the graft. Previous methods using Schwann cells in 
acellular grafts have found mixed results. These inconsistencies may be attributed 
to the different cell seeding methods that have been implemented (Brenner et al 
2005; Fox et al 2005; Hess et al 2007). A study by Jesuraj, Santosa et al. (2011) 
established a systematic approach to seeding Schwann cells in cold preserved 
acellular grafts (Figure 1.9). It was discovered that a sub-epineurial injection with 
a 27-gauge needle at a cell concentration of 1x106/ 5µL  resulted in the highest 
viability of cells with the least damage to the epineurium (Jesuraj, Santosa et al. 
2011) 
 
Figure 1.9. In vitro set up model for Schwann cell injection into acellular graft. The proximal 
(P) end of the graft was sutured to a sterile syringe bent to form a hook and secured under the 
microscope (A). Using a HamiltonTM syringe, Schwann cells were injected longitudinally under the 
epineurium of the distal stump (B and C). Figure reproduced from Jesuraj, Santosa et al. (2011)  
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To determine whether the injection was successful Jesuraj et al. (2011) also 
developed a method to track seeded Schwann cells prior to graft implantation to 
decrease the probability of experimental error such as low Schwann cell numbers 
due to injection error. The use of Qtracker® dye allowed the qualitative assessment 
of Schwann cell injection into the graft by fluorescence microscopy (Figure 1.10).   
 
Figure 1.10.  Sagittal sections of acellular grafts post injection. Grafts injected with 1x105 (day 
0 (A), day 1 (B), day 3 (C)) and 1x106 (day 0 (D), day 1 (E), day 3 (F)) cells were frozen and 
sectioned for stereological counts. The presence of cells was confirmed with co-staining of DAPI 
(blue) and Qtracker® in the sections. Scale bar at 1.5mm.  Figure reproduced from Jesuraj, Santosa 
et al. (2011)   
1.13 In vitro acellular nerve model   
Acellular grafts have been used in vivo and have shown to outperform the 
commercially available NGCs in terms of nerve regeneration. In vivo studies with 
reseeded acellular grafts have shown that they promote regeneration over longer 
distances. However, understanding the molecular, biochemical, and biological 
changes that occur in vivo during reinnervation is difficult, due to the inherent 
complexity of the regeneration process.  These include the influence of Schwann 
cells, the impact of local inflammation, and the humoral response (Gingras, 
Bergeron et al. 2003).  
In vitro models have value in a number of areas including developmental 
biology, disease studies and the design of devices and scaffolds for peripheral nerve 
repair (Daud, Pawar et al. 2012). Current studies involve the use of collagen gels 
and sponges which have shown to support axon ingrowth and Schwann cell 
proliferation (Allodi, Guzmán-Lenis et al. 2011) as well as myelination (Gingras, 
Beaulieu et al. 2008). A study by Daud, Pawar et al. (2012) developed a 3D in vitro 
peripheral nerve model using aligned electrospun polycaprolactone fibre scaffolds 
showed aligned neurite formation with dorsal root ganglion explants and co-
localisation of Schwann cells with the neuritis (Daud, Pawar et al. 2012).  
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A 3D acellular nerve graft model can prove beneficial in understanding how 
cells interact, migrate and proliferate within the nerve matrix. The acellular nerve 
model can also be used as a basis for the study of perfused flow within the tissue 
for the introduction of Schwann cells. A study by Sun, Norton et al. (2007) for 
evaluating nerve guide conduits seeded with Schwannoma cells found that a 
continuous flow increased total cell number by 2.5-fold verses static culture (Sun, 
Norton et al. 2008). 
1.14 Conclusion 
In conclusion, the PNS plays a vital role in everyday life, helping process changes 
in the environment through sensory and motor receptors. When injured peripheral 
nerves have the capacity to spontaneously regenerate, however this is limited to 
relatively short distances of less than 5mm. For larger nerve gaps, autografts are 
considered the “gold standard” treatment; however, limitations include donor site 
morbidity and the need for multiple surgeries.   
Scientists have taken advantage of the PNS’s ability to spontaneously 
regenerate and developed a small number of clinically approved natural and 
synthetic nerve guides to treat larger nerve injuries. These devices help guide axons 
between the injured nerve stumps by providing a guidance cue; however, 
drawbacks include batch variation, degradation rates and breakdown products. The 
efficacy of these nerve guides are also not comparable to autograft and are limited 
to treating injuries up to 20 mm.  
Current investigations into peripheral nerve repair have found a link 
between the role of cells and surface topography in the regeneration process. 
Peripheral nerve cells need an environment that can provide them with physical 
guidance such as the basal lamina and ECM. These non-cellular components 
provide precise guidance for axonal regeneration as well as cues that influence cell 
migration, proliferation and differentiation. Research has now turned to developing 
techniques in which cell scale topography can be incorporated into nerve guides.  
Decellularisation is a processing method in which native nerve tissue can be used 
to produce a non-immunogenic acellular nerve graft whilst retaining its non-
cellular components. Despite their inherent native nerve architecture acellular 
nerve grafts are still not comparable to the autologous graft in terms of the 
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regenerative distance. This is thought to be due to the exclusion of support cells 
such as Schwann cells within the graft.      
Schwann cells play a vital role in peripheral nerve regeneration and are 
important in synthesising several components of the ECM including laminin, 
collagen and proteoglycans. In vivo studies using acellular nerve grafts have shown 
that cell seeded scaffolds promoted better nerve regeneration compared to controls 
(unseeded scaffolds), however they are only effective when treating long nerve gap 
injuries (>20 mm).  
Less is known however known on the migratory pattern and proliferation 
of cells when seeded into the acellular graft. It would therefore be of value to 
develop an in vitro 3D model using the acellular nerve as a scaffold for the 
introduction of primary Schwann cells. Primary cells are the best representation of 
cells found in vivo, maintaining many of the important markers and functions. 
Therefore, the data obtained from  these in vitro models are more likely to predict 
the phenomena occurring in vivo during nerve regeneration than any other  cell 
line-based models (Geuna, Raimondo et al. 2015).  
The migration and survival of these cells within the scaffold are dependent 
on the maintenance of nutrient diffusion throughout the scaffold (Sun, Norton et 
al. 2005).  In situ peripheral nerve cells receive constant nutrients from blood 
vessels which are located within the epineurium. Therefore, for primary Schwann 
cells growing on scaffolds it is likely that continuous perfusion with medium will 
better support metabolic activity and proliferation (Sun, Norton et al. 2008).  
Based on the literature it is hypothesised that an acellular nerve graft can 
serve as a superior alternative to the current commercially available nerve guides 
due to its intact surface topography and natural ECM components. It is further 
postulated that acellular grafts could match the “gold standard” autograft with the 
addition of cell therapy to treat nerve gap injuries beyond 20 mm.  Nonetheless   
further research is still required into creating a low cost, reproducible nerve graft 
which can also support the growth of Schwann cells for the study of nerve 
regeneration over long distances.    
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1.15 Aims and Objectives  
Aims: 
The aims of this study were to develop an acellular, biocompatible porcine 
peripheral nerve graft. The acellular graft would then be used as a basis for the 
study of perfused flow within the tissue for the introduction of primary Schwann 
cells, as the delivery of such cell types is reported to improve nerve cell 
development. Subsequently the acellular and recellularised grafts would be 
implanted in a rat sciatic nerve model to assess axonal regeneration across the 
grafts.  
 
Objectives: 
 To develop and optimise a process for the decellularisation of porcine peripheral 
nerves 
 
 To assess the effects of the decellularisation process on the nerves 
histioarchitecture and the total amount of DNA left within the tissue 
 
 To assess the biomechanical properties and the presence of specific matrix proteins 
within the graft 
 
 To determine the in vitro biocompatibility of the acellular graft 
 
 To define conditions for the introduction of primary Schwann cells into the 
acellular nerve graft 
 
 To develop a bioreactor for the study of perfusion within the graft  
 
 To analyse axonal regeneration within graft post implantation 
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Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Equipment 
The equipment and suppliers used in this study are listed in Table 2.1 
Equipment  Model Supplier 
Automatic pipettes Gilson P10-P1000 Anachem Ltd. 
Balances GR200/GX2000 Jencons PLC 
Bench top centrifuge 5415R Eppendorf 
Bose tensile testing 
machine 
- Electroforce test 
instruments 
Callipers - Fisher Scientific 
Centrifuge machine Harrier 15/80 SANYO Biomedical 
Europe BV 
Class II laminar flow 
cabinet 
Heraeus 85 Kendro 
CO2 Incubator MCO-20AIC SANYO  
 
Biomedical Europe BV 
Confocal microscope LSM510 META Carl Zeiss Ltd. 
Cryostat CM1850 Leica 
Digital camera Image pro Plus v 5.1 Media Cybernetics 
Freezer (-20°C) Electrolux 3000  Jencons Plc 
Freezer (-80°C) R 404-A VWR 
Freeze-dryer - Cole-Parmer 
Fridge Electrolux ER8817C  Jencons Plc 
Fume cupboard/fume 
hood 
- Whiteley 
Histology water bath MH8515  Barnstead Electrothermal 
Hot plate E18.1 hotplate Raymond A lamb 
Microliter syringes  10 µL cemented needles Cole Parmer 
Micro plate 
spectrophotometer 
Multiskan spectrum Thermo Scientific 
Microscope (upright) BX51 Olympus, UK 
Microtome RM2125 RTR  Leica Microsystems 
Microwave (800 watt) KM19W, 800w  PROLINE 
Mounted needle  agar scientific 
Nanodrop 
spectrophotometer 
ND-100 Labtech Int 
Orbital shaker Grant PSU-10i Scientific Laboratory 
Supplies 
Oven OMT225 SANYO  
 
Biomedical Europe BV 
pH meter Jenway 3010  VWR International 
Phase contrast 
microscope 
CK40 Olympus 
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Pipette boy Acu  Intergra Biosciences 
Plate reader Multiskan Spectrum 1500  Thermo 
Plate shaker IKA KS130 basic  Jencons Plc 
Masterflex ® L/SPump  Cole Parmer 
Tissue embedder EG1150 Leica Biosystems 
Tissue Processor TP11020  Leica Microsystems 
Vortexer TopMix FB15024  Fisher Scientific 
Water bath Grant Jencons Plc 
  Table 2.1 Equipment used throughout the study 
2.1.2 General consumables 
The general consumables and suppliers used in this study are listed in Table 2.2 
Item Model/Size Supplier 
Bijouxs 5 mL Scientific Laboratory 
Supplies 
Surflo Straight I.V. 
Cannula (Yellow)  
24 g x 0.75 x 50 Terumo 
Centrifuge tubes  50 mL Thermo Fisher Scientific 
Laboratory 
Falcon cell strainer  40 µm Becton Dickenson 
Filter paper Whatman® Grades 1-5 Whatman International Ltd 
Flat-bottomed 96 
well plate 
- Scientific Laboratory 
Supplies 
Forceps - R.A. Lamb 
Glass coverslips - Scientific Laboratory 
Supplies 
Haemocytometer - Labtech 
Histology cassettes CMB-160-030R  
 
Thermo Fisher Scientific 
Ltd 
ImmEdge 
Hydrophobic 
Barrier Pen  
H-000 Vector Laboratories 
Magnetic stirrer Stuart SB161 Scientific Laboratory 
Supplies 
Microtome blades SD3050835 Fisher scientific 
Parafilm M - Sigma-Aldrich 
Petri dishes  35 mm IWAKI 
Pharmed tubes BPT NSF-51 Cole Parmer 
Pipette tips (non-
filtered) 
10 µL, 20 µL, 200 µL, 1000 
µL, 5000 µL  
Star Labs 
Plastic syringes - Scientific Laboratory 
Supplies 
Plates (24 wells)  Corning Incorporated 
Scalpel blade Size 22 Fisher Scientific 
Sterile containers 60 mL, 150 mL, 250 mL Scientific Laboratory 
Supplies 
Sterile syringe filter  0.2 µm  
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Stripette ™ 
(disposable pipettes)  
5 mL, 10 mL, 25 mL Sigma-Aldrich 
Superfrost plus 
microscope slide 
- Scientific Laboratory 
Supplies 
Sutures Ethicon3-0, 4-0 and 10-0 
Prolene 
Ethicon (Johnson&Johnson 
Ltd) 
Syringe needles  Thermo Fisher Scientific 
Tissue culture flasks  25 and 75 cm2 Thermo Fisher Scientific Ltd 
Universals 25 mL Scientific Laboratory 
Supplies 
  Table 2.2 General consumables used throughout the study 
2.1.3 Chemicals and reagents 
The chemicals/reagents and suppliers used in this study are listed in Table 2.3 
Chemical/Reagent Supplier 
1,9 dimethylene blue Sigma-Aldrich 
Acetate Sigma-Aldrich 
Acetone European Bios 
Acetic acid Thermo Fisher Scientific Ltd 
Alcian blue Atom scientific 
Amphotericin B Sigma-Aldrich 
Aprotinin (10, 000 KIU.mL-1) Nordic Pharma 
Aqueous periodic acid solution, 0.1% Sigma 
Benzonase Nuclease Novagen 
Bovine pituitary extract Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
Calcium chloride Sigma-Aldrich 
Chloramine T Sigma-Aldrich 
Chloroform Genta Medical 
Chondroitin sulphate B Sigma-Aldrich 
Citric acid (monohydrate) VWR International 
Collagenase I Sigma-Aldrich 
Collagen gel (rat tail) Sigma-Aldrich 
Cyanoacrylate contact adhesive Sigma-Aldrich 
DAPI stain (4’,6-diamidino-2-phenylindole 
dihydrochloride) 
Sigma-Aldrich 
Diastase Sigma-Aldrich 
Di-sodium hydrogen orthophosphate VWR International 
DMSO Sigma-Aldrich 
DPX mountant Thermo Fisher Scientific Ltd 
Dulbecco’s modified Eagle’s media Biosera 
Dulbecco’s PBS tablets Oxoid 
Eosin Y VWR International 
Ethanol Thermo Fisher Scientific Ltd 
Ethylenediaminetetraacetic acid (EDTA) Thermo Fisher Scientific Ltd 
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Ferric ammonium sulphate (iron alum) BDH 
Fibronectin Sigma-Aldrich 
FITC conjugated secondary anti-rabbit 
antibody 
Sigma-Aldrich 
Foetal Calf Serum Biosera 
Formalin solution, neutral buffered, 10% Sigma-Aldrich 
Formic acid Sigma-Aldrich 
Forskolin Sigma-Aldrich 
Gentamycin sulphate Merck Millipore 
Giemsa Solution VWR International 
Gills no 3 Haematoxylin Sigma 
Glacial acetic acid VWR International 
Gold (III) chloride Sigma  
Harris Haematoxylin Thermo Fisher Scientific Ltd 
Hexane ProLab Scientific 
Hydrochloric acid VWR International 
Hydrogen peroxide (30% v/v) Sigma-Aldrich 
Industrial methylated spirit  Biostain Ready Reagents 
Isopropyl Alcohol GPR 
Laminin solution (1mg mL-1) Sigma-Aldrich 
Leica cryofact disinfectant Ecolab 
L-glutamine Invitrogen 
Liquid nitrogen BOC 
Magnesium chloride hexahydrate Thermo Fisher Scientific Ltd 
MEM- D-valine labtech 
Methanol Sigma-Aldrich 
Miller’s stain Raymond A Lamb 
MTT reagent Sigma-Aldrich 
Neutral buffered formalin (10% w/v) Genta Medical 
N2 supplement  Invitrogen 
OCT embedding matrix R.A. Lamb 
Oil Red O solution Sigma 
Oxalic acid VWR International 
Papain  Sigma-Aldrich 
Paraffin wax Thermo Fisher Ltd 
Paraformaldehyde solution Sigma-Aldrich 
p-dimethylaminobenzaldehyde Sigma-Aldrich 
Phosphate buffered Saline (PBS) tablets Oxoid 
Penicillin- Streptomycin Sigma-Aldrich 
Peracetic acid Sigma-Aldrich 
Perchloric acid (60%) BDH 
Picric acid Sigma-Aldrich 
Potassium permanganate Thermo Fisher Ltd 
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Poly-L-lysine (0.01% (wt/vol), mol.wt. 70,000-
150,000) 
Sigma-Aldrich 
Polymyxin B Merck Millipore 
Porcine trypsin Sigma-Aldrich 
Propan-1-ol VWR International 
Rabbit anti-GFAP delta antibody (ab28926) abcam 
Rabbit anti-p75 NGF receptor antibody 
(ab38335) 
abcam 
Rabbit anti-S100 antibody-astrocyte marker 
(ab868) 
abcam 
Schiff’s reagent Sigma-Aldrich 
Silver nitrate  Sigma 
Sirius red VWR International 
Sodium acetate Thermo Fisher Ltd 
Sodium azide 1% solution G Biosciences 
Sodium chloride Thermo Fisher Ltd 
Sodium di-hydrogen orthophosphate VWR International 
Sodium dodecyl sulphate Invitrogen Life Technologies 
Sodium formate Sigma-Aldrich 
Sodium hydroxide Thermo Fisher Ltd 
Sodium phosphate dibasic (Na2HPO4) 
(anhydrous) 
Sigma-Aldrich 
Sodium phosphate monobasic (NaH2PO4) 
(anhydrous) 
Sigma-Aldrich 
Sodium thiosulphate pentahydrate VWR International 
Trans-4-hydroxy-L-proline Sigma-Aldrich 
Trypsin-EDTA solution Sigma-Aldrich 
Triton X-100 BDH 
Trizma base Sigma-Aldrich 
Tween -20 BDH 
Vancomycin hydrochloride VWR International 
Weigert’s haematoxylin 
Solution A 
Solution B 
Atom Scientific 
Xylene Biostain Ready Reagents 
Table 2.3 Chemicals and reagents used throughout the study 
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2.1.4 Kits 
The kits used in this study are listed in Table 2.4 
Kit Catalogue 
Number 
Supplier 
Cell Tracker TM 
Red CMTPX 
Dye     
C34552 Life Technologies 
DNeasy® Blood 
& Tissue Kit 
69504 QIAgen 
Table 2.4. Kits used throughout the study 
2.1.5 Cells 
The cells used in this study are listed in Table 2.5 
Cells Species Supplier 
Primary Schwann cell Rodent Isolated using a selective D-valine 
protocol (Kaewkhaw, Scutt et al. 
2012) 
Dermal Fibroblast Human; isolated from donor skin of 
abdominoplasty or breast reduction 
Donated from patients of the 
Royal Hallamshire Hospital, 
Sheffield; in accordance with local 
ethically approved NHS 
guidelines and under HTA 
Research Tissue Bank license 
number 12179 regulations 
RN22 Schwann cell Rodent European Collection of Cell 
Cultures (ECACC, batch number 
93011414) 
 Table 2.5 Cells lines used throughout the study 
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2.1.6 Animal tissue 
There were no ethical issues in the procurement of the animal tissue throughout 
this study  
2.1.6.1 Porcine legs 
Porcine legs, from large white Yorkshire pigs (24 - 26 weeks old) were obtained 
from a local abattoir (John Penny & Sons, Leeds, United Kingdom) within 24 hours 
of slaughter. The legs were stored at 4°C until required for dissection  
2.1.6.2 Rat sciatic nerve 
Male Wistar rats (10-12 weeks old) were killed on the day by a Schedule 1 method 
(cervical dislocation) according to the regulation of the Animals (Scientific 
Procedures) Act 1986. 
2.1.7 General chemical stock solutions 
 
2.1.7.1 Phosphate buffered saline (PBS) 
Five PBS tablets were dissolved in 500 mL of distilled water and the pH adjusted 
to pH 7.4-7.6. The solution was sterilised by autoclaving and stored at room 
temperature until needed.  
2.1.7.2 Sodium hydroxide solution (6M) 
Dissolve 120 g of sodium hydroxide into 500 mL of distilled water. Store at room 
temperature for up to three months 
2.1.8 General cell work reagents/solutions 
2.1.8.1 Collagenase solution 
Make a 0.05 % (w/v) collagenase solution by dissolving 5mg collagenase powder 
in 10 mL serum-free Dulbecco’s Modified Eagles Medium (DMEM). Make fresh 
on the day of the experiment and filter-sterilize using a 0.2 µm syringe filter. 
2.1.8.2 Forskolin stock solution 
Dissolve 10 mg of forskolin in 1 mL of DMSO to prepare a 25 mM stock solution. 
Store the aliquots at -20 °C for up to one month. 
67 
 
2.1.8.3 Cell culture medium for fibroblasts and RN22 
The standard cell culture medium used for fibroblast and RN22 cells was 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10 % (v/v) FCS, 100 
U/mL penicillin/ 100 µg. mL-1 streptomycin, 0.25 µg. mL-1 amphotericin and 2 mM 
L-glutamine. The culture medium was stored at 4 °C for up a month. 
2.1.8.4 Cell culture medium for purification and expansion of primary 
Schwann cells 
The initial cell culture medium used for Schwann cell purification and expansion 
was Minimum Essential Medium (MEM) –d-valine containing 10 % (v/v) FCS, 2 
mM glutamine, 1 % (v/v) N2 Supplement, 20 µg/mL (w/v) bovine pituitary extract, 
5 µM forskolin, 100 U. mL−1 penicillin 100 µg. mL−1 streptomycin and 0.25 µg. 
mL-1 amphotericin B. The culture medium was stored at 4 °C for up a month.  
Once purity of Schwann cells was determined by immunolabelling cells with 
S100β marker, bovine pituitary extract and N2 supplemented could be omitted 
from the media, however for high Schwann cell purity and number forskolin needs 
to be present.     
2.2 Methods 
2.2.1 Histology techniques 
2.2.2.1 Cryo-embedding 
Tissue samples (porcine) were dropped in liquid nitrogen to snap freeze. The frozen 
samples were then orientated in the correct position in plastic moulds and 
embedded with OCT embedding mix. Samples were then transferred to a -80 °C 
freezer to set.  
2.2.2.1.2 Tissue sectioning of cryo- embedded samples 
The cryo-embedded tissue samples were sectioned using a Cryostat. The frozen 
tissues embedded in OCT were removed from the plastic mould and placed on the 
Peltier Chuck inside the cryostat in the required orientation. The tissue was 
sectioned at 10 µm. The tissue sections were collected onto Superfrost Plus® slides. 
These slides were electrostatically charged to prevent the sections from floating off 
the slides during staining. The slides were then put on a drying rack and left to dry 
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overnight at room temperature. The prepared slides were stored at -20 °C until 
further use.   
2.2.2.2 Paraffin embedding 
Tissue samples were immersed in 3.7 % (v/v) formaldehyde for 24 hours. In the 
case of porcine tissue, 1 cm segments were cut from either end of the nerve whilst 
for rat sciatic nerve 30 mm segments were cut from either end of the nerve. The 
samples were them placed in plastic cassettes were then dehydrated in an 
automated tissue processor. The tissue processor sequentially immersed the tissue 
samples in: two consecutive one hour immersions in 70 % (v/v) industrial 
methylated spirit IMS followed by a 1.5 hours’ immersion in 80, 85, 90, 95 % (v/v) 
IMS respectively. This was followed by two consecutive 1.5 hour immersions in 
100 % (v/v) IMS, two 1.5 hour immersions in xylene and lastly two consecutive 
two hour immersions in paraffin wax. The cassettes were transferred to an 
embedding station containing hot wax at 60 °C. Samples were removed from the 
cassette and orientated in metal wax block moulds using forceps and then fully 
covered in wax. The wax blocks were then left to cool and solidify on ice (one - 
two hours), once set the blocks were removed from the metal moulds and the excess 
wax around the edges was trimmed.  
2.2.2.2.1 Tissue sectioning of paraffin embedded samples 
Paraffin embedded tissue samples were sectioned using a microtome. For porcine 
tissue the thickness of the tissue sectioned ranged from 6-10 µm. For rat tissue the 
thickness of the tissue sectioned ranged from 4-6 µm. The tissue sections were 
transferred to a water bath set at 37 °C and collected onto Superfrost Plus® slides. 
These slides were electrostatically charged to prevent the sections from floating off 
the slides during staining. The slides were then put on a drying rack and left to dry 
overnight at room temperature. The prepared slides were stored at room 
temperature until further use.  
2.2.2.2.2 Dewaxing, rehydration and dehydration of paraffin embedded 
samples 
Slides containing the tissue sections were dewaxed by two consecutive immersions 
in in xylene, ten minutes each time. The slides were then submerged three times in 
100 % (v/v) IMS for three, two and one minutes respectively. The samples were 
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them placed in 70 % (v/v) IMS for one minute before being rinsed in slow running 
tap water for three minutes.    
2.2.2.2.3 Dehydration and clearing of paraffin embedded samples 
Following staining the tissue sections the slides were then dehydrated and cleared 
by placing them back in 70 % (v/v) IMS for five seconds and then sequentially 
immersing them thrice in 100 % (v/v) IMS for one, two and three minutes 
respectively. Finally, the slides were submerged in xylene twice, for ten minutes 
each time. Each slide was then mounted using DPX mountant and a coverslip and 
left to dry overnight in a fume cupboard 
2.2.3 Histological staining methods 
2.2.3.1 Haematoxylin and eosin (H & E) staining 
H & E staining is used to visualise tissue histioarchitecture of tissue, evaluating the 
connective tissue and spatial distribution of cell nuclei. 
Reagents: 
1. Harris haematoxylin 
2. Eosin Y 
3. IMS 
4. Xylene 
5. DPX mountant 
 
Method: 
Prior to staining the tissue sections were dewaxed and rehydrated. Each section was 
immersed in Harris haematoxylin solution for one minute and rinsed under tap 
water for blueing for three minutes. Slides were then stained with eosin Y for three 
minutes before dehydrating and clearing. Each slide was then mounted using DPX 
mountant and a coverslip and left to dry overnight in a fume cupboard before being 
viewed under an upright microscope. Images were captured using a digital camera.  
2.2.3.2 Nuclei labelling using 4’,6-diamidino-2-phenylindole (DAPI) 
DAPI is a stain which binds A-T rich regions of the DNA double helix and can be 
therefore used to visualise cell nuclei. 
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Reagents: 
1. 300 nM DAPI solution 
To make DAPI working solution dissolve 10 µL aliquot of DAPI into 10 mL PBS 
and store away from light. Make on the day of the experiment  
2. PBS, pH 7.4 
pH adjusted using 6 M hydrochloric acid or 6 M sodium hydroxide drop wise  
Method: 
Prior to staining tissue samples were dewaxed and rehydrated. Samples were 
incubated with 300 nM DAPI for twenty minutes in the dark, and then washed with 
PBS three times for five minutes each time in the dark. Nuclei were imaged using 
an upright fluorescent microscope and a DAPI filter (λex = 300 nm / λem = 510 nm).  
2.2.3.3 Alcian Blue Periodic Acid Schiff’s stain (ABPAS) 
ABPAS is used to localise GAGs in the tissue 
Reagents: 
1. 1 % (w/v) Alcian blue solution, pH 2.5 
2. 0.1 % (w/v) periodic acid solution 
3. Schiff’s reagent 
4. Gills number 3 haematoxylin 
5. IMS 
6. Xylene 
7. DPX mountant 
 
Method: 
Prior to staining tissue samples were dewaxed and rehydrated.  Samples were 
immersed in 1 % (w/v) Alcian blue solution (pH 2.5) for one minute and rinsed 
with tap water. The slides were then immersed in 0.1 % (w/v) periodic acid solution 
for five minutes and rinsed three times with distilled water. The slides were then 
immersed in Schiff’s reagent for 15 minutes and rinsed with tap water for five 
minutes; cell nuclei were stained with Gills number 3 haematoxylin for 90 seconds. 
Samples were blued using tap water, dehydrated, cleared and mounted using DPX 
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mountant before being viewed using an upright microscope under Kohler 
illumination. 
2.2.3.4 Picro Sirius red and Millers elastic stain 
Picro Sirius red and Millers elastic stain are used to visualise collagen and elastin 
in the tissue respectively. 
Reagents: 
1. 5 % (w/v) potassium permanganate solution 
Add 15 g of potassium permanganate to 300 mL of distilled water and dissolve 
using a magnetic stirrer. Store the solution for up to six months at room 
temperature. Filter before use 
 
2. 1 % (w/v) oxalic acid 
Add 1 g oxalic acid to 100 mL of distilled water and dissolve using a magnetic 
stirrer. Use immediately. 
 
3. Weigert’s iron haematoxylin 
Mix equal volumes of solution A and solution B. Store mixed solutions at 4 ºC for 
one month. 
 
4. 0.1 % (w/v) Picro-Sirius Red  
Weigh out 0.1 g Sirius red powder in fume cupboard and dissolve into 100 mL of 
aqueous picric acid solution using a magnetic stirrer. Store at room temperature for 
up to six months and filter before use.   
5. Millers’ stain 
6. IMS 
7. Xylene 
8. DPX mountant 
 
Method: 
Prior to staining tissue samples were dewaxed and rehydrated, the same slide was 
used to stain for both the collagen and elastin. Samples were immersed in 5 % (w/v) 
potassium permanganate for five minutes and then rinsed with distilled water, and 
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then submerged into 1 % (w/v) oxalic acid for two minutes, rinsed with water for 
a further four minutes and submerged in 95 % (v/v) IMS and 70 % (v/v) IMS for 
one minute respectively. Samples were then stained for one hour with Millers’ stain 
and rinsed with 95 % (v/v) ethanol, 70 % (v/v) ethanol and distilled water 
respectively. Samples were subsequently stained with Weigert’s iron haematoxylin 
for ten minutes and rinsed with distilled water for thirty seconds for blueing. 
Samples were then stained with 0.1 % (w/v) Picro-Sirius Red for one hour, rinsed 
with distilled water and blot dried. Sections were dehydrated, cleared and mounted 
using DPX mountant before being viewed under Kohler and polarised illumination. 
2.2.3.5 Reticulin stain 
The reticulin stain is used to stain reticular fibres (collagen III) within formalin 
fixed, paraffin embedded tissue. Potassium permanganate sensitises the reticular 
fibres, allowing silver to be deposited. The silver solution readily precipitates, 
therefore formalin is used as a reducing agent to allow silver to be deposited in the 
form of a metal. Excess silver is subsequently removed using the hypo solution. 
Fibres stain neutral black with high intensity 
Reagents: 
1. 1 % (w/v) potassium permanganate 
Add 1 g of potassium permanganate to 100 mL of deionised water and dissolve 
using a magnetic stirrer. Store the solution for up to six months at room temperature 
 
2. 10 % (w/v) aqueous silver nitrate 
Add 10 mg of silver nitrate to 10 mL deionised water and stir using a magnetic 
stirrer and bar. 
 
3. 3 % (w/v) sodium hydroxide solution 
Add 0.15 g sodium hydroxide to 5 mL deionised water and stir using a magnetic 
stirrer and bar  
 
4. Ammoniacal silver solution 
Add ammonia drop by drop to 5 mL 10 % (w/v) aqueous silver nitrate solution 
until precipitate that forms has just dissolved. Add 5 mL of aqueous silver nitrate 
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solution to 5 mL of 3 % (w/v) sodium hydroxide. Add ammonia drop by drop until 
the resulting precipitate is completely dissolved and the solution retains a trace of 
opalescence and then make up to 50 mL with distilled water.  
 
5. 1 % (w/v) oxalic acid 
Add 1 g oxalic acid to 100 mL of distilled water and dissolve using a magnetic 
stirrer. Use immediately. 
 
6. 2.5 % (w/v) aqueous iron alum 
Add 2.5 g ferric ammonium sulphate (iron alum) to 100 mL distilled water and stir 
using a magnetic stirrer and bar 
 
7. 0.2 % (w/v) gold chloride 
Add 0.2 g gold chloride to 100 mL distilled water and mix thoroughly by inversion 
 
8. Hypo solution (5 % sodium thiosulphate) 
Add 5 g sodium thiosulphate to 100 mL distilled water and stir using a magnetic 
stirrer and bar 
 
9. 10 % (w/v) aqueous formalin 
10. IMS 
11. Xylene 
12. DPX mountant 
 
Method: 
Prior to staining tissue samples were dewaxed and rehydrated and then oxidised in 
1 % acidified potassium permanganate for three minutes. Samples were then rinsed 
with tap water before bleaching them in 1 % oxalic acid for one minute. The 
samples were then rinsed with tap water before immersing them in 2.5 % iron alum 
for ten minutes. The slides were then rinsed twice in distilled water and then placed 
in ammoniacal silver solution for a further two minutes. Samples were rinsed twice 
in distilled water and then reduced in 10 % aqueous formalin for a further two 
minutes. Samples were then rinsed under running tap water before being immersed 
in 0.2 % gold chloride for two minutes. Samples were rinsed again with tap water 
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before being immersed in hypo solution for three minutes and then briefly rinsed 
again with tap water. Sections were dehydrated, cleared and mounted using DPX 
mountant before being viewed under Kohler illumination. 
2.2.3.6 Oil Red O staining 
Cryosectioned native and decellularised nerve samples were stained for lipid and 
fat using Oil Red O solution. Presence of lipid within tissue was detected by 
presence of a bright reddish-orange colour.   
Reagents: 
1. 0.5 % (w/v) Oil Red O stock solution 
Dissolve 0.5 g of Oil Red O into 100 mL isopropanol.  
2. Oil red O working solution 
Dilute 30 mL of Oil Red O stock solution with 20 mL distilled water. Allow to 
stand for ten minutes and filter using a 0.2 μm syringe filter into a Coplin jar. 
Solution should be prepared on the day of use. 
 
3. Harris haematoxylin 
4.  IMS 
5. DPX mountant 
 
Method:  
Prior to staining tissue slides were fixed in 3.7 % formaldehyde for 5 minutes at 
room temperature. The tissue slides were immersed in Oil Red O working solution 
for ten minutes and rinsed in distilled water before being immersed in haematoxylin 
for ten seconds finally being rinsed again with distilled water. Each slide was then 
mounted using DPX mountant and a coverslip and left to dry overnight in a fume 
cupboard before being viewed under an upright microscope. 
2.2.4 Immunolabelling using FITC-conjugated antibodies 
2.2.4.1 Tissue fixation 
Tissues were fixed in 3.7 % (v/v) formaldehyde for 24 hours, placed into the 
automated tissue processor and wax embedded as described in Section 2.2.2.1.
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Table 2.5 Antibodies and working dilutions used for labelling tissue samples 
Antigen Supplier Isotype Clone Initial 
concentration 
Working dilution 
Rabbit anti-laminin antibody 
L9393 
Sigma 
Aldrich 
 Polyclonal 0.5 mg. mL-1 1°Ab 1:50 
2°Ab 1:100 
Rabbit anti-fibronectin 
antibody  
F3648 
Sigma 
Aldrich 
 Polyclonal  1°Ab 1:400 
2°Ab 1:100 
Anti-S100 -astrocyte marker 
ab868 
abcam ® IgG Rabbit 
Polyclonal 
 1°Ab 1:200  
2°Ab 1:400 
Anti-GFAP delta primary 
antibody ab28926 
abcam ® IgG Rabbit 
Polyclonal 
 1°Ab 1:200  
2°Ab 1:400 
FITC-conjugated secondary anti-
rabbit antibody 
Vector Labs     
Anti- PGP 9.5 antibody 
Z511601-2 
Dako  Rabbit 
Polyclonal 
 1°Ab 1:200  
2°Ab 1:100 
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Antigen Supplier Isotype Clone Initial 
concentration 
Working 
dilution 
Anti-S100 -
astrocyte marker 
ab868 
abcam ® IgG Rabbit 
Polyclonal 
 1°Ab 1:250 
2°Ab 1:200 
Anti-GFAP delta 
primary antibody 
ab28926 
abcam ® IgG Rabbit 
Polyclonal 
 1°Ab 1:250 
2°Ab 1:200 
Anti-p75 NGF 
receptor antibody 
abcam ® IgG Rabbit 
Polyclonal 
0.3 mg. mL-1 1°Ab 1:50 
2°Ab1:100 
FITC-conjugated 
secondary anti-
rabbit antibody 
Vector Labs     
Table 2.6 Antibodies and working dilutions used for labelling cells 
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Reagents: 
1. 0.1 % (v/v) Triton X-100 
Add 10 µL Triton x-100 to 9.99 mL PBS and mix using vortex 
 
2. 1 % (w/v) BSA solution 
Dissolve 0.1 g bovine serum albumin into 10 mL PBS and pass the solution through 
a 0.2 µm filter 
 
3. 7.5 % (w/v) BSA solution 
Dissolve 3.75 g bovine serum albumin into 5 mL PBS and pass the solution through 
a 0.2 µm filter 
 
Method: 
Prior to staining tissue samples were dewaxed and rehydrated. Tissue sections were 
circled with a hydrophobic marker and gently permeabilised with 0.1 % (v/v) 
Triton X-100 diluted in PBS for 20 minutes. Samples were then incubated with 
7.5 % (w/v) bovine serum albumin diluted in PBS at room temperature for sixty 
minutes, followed by washing once with 1 % (w/v) BSA in PBS. Tissue samples 
were incubated with primary antibody (diluted to appropriate concentration with 
1% BSA) at 4 °C overnight in a humidified chamber. The following day the 
samples are washed three times with PBS, five minutes each time and then 
incubated with secondary FITC conjugated antibody at room temperature in the 
dark for one hour. Each section is then washed three times with PBS for five 
minutes and counterstained with 300 nM DAPI in PBS and incubated for twenty 
minutes in the dark at room temperature. Sections are then washed three times with 
PBS for five minutes and then immersed in PBS. Images are captured using long 
focal distance (3.5 mm) ‘water dipping’ objective lenses (10 9/0.3 and 20 9/0.5; 
Zeiss Achroplan) and a Zeiss LSM510 META upright/inverted confocal 
microscope (xenon arc lamp to excite FITC (λex = 495 nm / λem = 515 nm). Nuclei 
were visualised using λex = 300 nm / λem = 510 nm.  
78 
 
2.2.5 Cell culture 
2.2.5.1 Cell culture techniques 
Human dermal fibroblast and RN22 cells used in this study were cultured in 
standard DMEM cell culture medium (Section 2.1.7.3). The primary rat Schwann 
cells were cultured in MEM-d-valine (Section 2.1.7.4). All medium changes were 
performed aseptically in a Class II cabinet. All medium and reagents added to the 
cells were warmed to 37 °C before use. Cells were cultured at 37 °C in 5 % CO2 
(v/v). 
2.2.5.2 Resurrection and maintenance of cells 
Cells were removed from liquid nitrogen storage, and thawed in a 37 °C water bath. 
A T75 cell culture flask with 10 mL cell culture medium was prepared. When the 
cells were defrosted, 1 mL of the defrosted cell stock was slowly added into the 
T75 flask. The flask was incubated at 37 °C in 5 % CO2 (v/v) overnight to allow 
the cells to attach to the flask. The medium was changed every two days until the 
cells became confluent and ready to be passaged. 
2.2.5.3 Cell viability using Trypan blue 
Trypan blue dye is used to detect dead cells as the dye permeates into dead cells 
due to the loss of their membrane potential whilst live cells appear transparent. To 
perform the viability test, 20 μL of cell suspension was mixed with 20 μL of Trypan 
blue dye in a bijoux tube. 20 μL of this mixture was added to a haemocytometer. 
Viable cells were counted in n of the nine grids (n = the number of grids which 
allowed the viable cell count to fall between 100 and 300). The total number of 
viable cells per mL in the cell suspension was calculated as follows: 
 
Number of cells/mL=  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
𝑛
 ×104× Dilution factor 
 
n was the number of grids used to count the cells 
 
Dilution factor was the correction required due to the dilution of the cell suspension 
with Trypan blue dye (in this case, Dilution factor = 2) 
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2.2.5.4 Cell passaging 
The culture medium was aspirated from each cell culture flask, and the cell layer 
was washed in PBS for two minutes. Trypsin/EDTA (5 mL) was added to each T75 
culture flask, and the flasks were incubated in 5 % CO2 (v/v) at 37 °C for 3 minutes. 
Following incubation, the cells were detached by gently tapping the flasks. The 
trypsin/EDTA was neutralised by adding 10 mL of culture medium to each flask. 
The cell suspension was transferred into a universal tube and centrifuged for five 
minutes at 1000 g. Following centrifugation, the supernatant was carefully 
removed and the cell pellet was resuspended in 5 mL of cell culture medium. A 
viable cell count (Section 2.2.5.3) was performed and cells were seeded into fresh 
flasks at the appropriate density. The cell culture medium was changed every other 
day until the cells became confluent and ready to be passaged again. 
2.2.5.5 Cell storage 
Cells were isolated from the flasks (Section 2.2.6.4), and diluted to 1x106/mL with 
cryopreservation medium (DMEM containing 20 % (v/v) FBS, 10 % (v/v) filter 
sterilised Dimethyl sulfoxide (DMSO). The addition of DMSO prevented the 
formation of ice crystals during freezing, but it is toxic to the cells. In order to avoid 
the toxic effects, the cells were frozen immediately after the addition of DMSO. 
The cell suspension was aliquoted into 1 mL cryovials, and placed into a cryo 
freezing pot which contained isopropanol and placed into a -80 °C freezer 
overnight. The following day all vials were transferred to liquid nitrogen for long-
term storage. 
2.2.6 Uniaxial tensile testing 
The biomechanical properties of native and acellular porcine peripheral nerves 
(peroneal and tibial nerves) were compared using uniaxial tensile testing to failure 
in order to determine any significant effects of the decellularisation procedure on 
the mechanical properties of the tissue. The length of the nerve was kept to 
approximately 10 mm and the thickness of the tissue was measured using callipers. 
Three measurements were taken for each specimen at different positions along its 
length, and the average thickness was recorded. 
Hydrated samples of freshly dissected porcine peripheral nerves and 
acellular nerves were clamped, using a standard clamping system into a BOSE 
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tensiometer, using a 450 N load cell.  A single pull to failure test was carried out at 
a speed of 0.1 mm. s-1 with a gauge length of 8 mm. The specimen was clamped in 
the holder with two grip blocks and the load cell recorded the strength produced by 
the sample (Figure 2.1). The first failure point or plateau was used to calculate the 
ultimate tensile strength (UTS) and the displacement at this point was recorded as 
strain at ultimate tensile strength. The initial linear gradient was used to calculate 
the Young’s modulus (or elastic modulus). A typical stress-strain curve of 
peripheral nerve is illustrated in Figure 2.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Tensile testing of tissue sample. The sample is placed between two grip fixtures which 
clamp the sample. Weight is then applied to the sample gripped at one end whilst the other is fixed. 
The weight or load keeps increasing at a controlled rate whilst at the same time measuring the 
change in length of the sample.  (A) BOSE Electroforce test instrument. (B) Grips stretching sample. 
 
 
 
 
 
 
 
 
A 
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Figure 2.2. Typical stress-strain curve for peripheral nerves. The transition between the toe 
region and the linear region corresponds with the strain in situ. The slope of the stress-strain curve 
is called the modulus of elasticity and represents the stiffness of the nerve. If the slope is steep, then 
the nerve has more stiffness and is less compliant to elongation. If the slope is shallow, then the 
nerve has less stiffness and is more compliant to elongation. Once the nerve has reached the ultimate 
strain, the structural integrity of the nerve is overcome and the deformation is termed “plastic”. 
Reproduced from Topp and Boyd (2006)  
 
The tensile testing machine operating programme, WinTest® 2002 software 
(EnduraTEC) was used to analyse the data for each test run. Using the recorded 
load/displacement data, the stress was calculated for each data point according to: 
 
𝜎 =
𝐹
𝐴
 
 
 
Where 𝜎 represents the stress in MPa, F the force in Newtons (N) and A the cross 
sectional area of the nerve in mm2. The cross sectional area was calculated as A = 
nerve width × specimen thickness.  
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The strain was calculated according to: 
 
𝜀 =
∆𝑙
𝑙
 
 
 
where 𝜀 represents strain, ∆𝑙 the extension of the nerve in mm and 𝑙 the gauge 
length (8 mm)  
 
The analysis of the results was carried out per treatment group (at least three 
replicates from three different porcine legs). The stress-strain curves for the 
specimens of each group were averaged over the number of samples in each test 
group using the Origin software program (Version 8.5, Microbal). In addition, the 
tensile strength, strain and YM for each nerve obtained from BOSE machine were 
averaged over the number of specimens in the group.  
2.2.7 Statistical analysis 
In this study, all numerical data was analysed using GraphPad Prism and are shown 
as mean values ± 95 % confidence limits. Statistical significance was assessed 
using a Student’s t-test and one-way ANOVA was applied for the comparison of 
data from more than two groups using Tukey’s procedure. P-values of <0.05 were 
considered significant.    
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Chapter 3.  Characterisation of Porcine Peripheral Nerves 
in the Lower Limb for Tissue Engineering Applications 
3.1 Introduction 
The peripheral nervous system (PNS) is comprised of nerves, enclosed bundles of 
long fibres or axons and neurons, which connect the central nervous system to the 
rest of the body (Saladin 2011). The primary function of the PNS is to allow for 
movement, sensation and changes in behaviour to be undertaken in response to 
external or internal stimuli.  Peripheral nerves in the lower limb are composed of 
sensory, motor and sympathetic fibres. The sciatic nerve, situated in the posterior 
compartment of the leg, is the largest nerve beginning in the lower back and runs 
down towards the lower limb. Its function consists of providing motor innervation 
to the muscles of the posterior aspect of the thigh and those of the leg and foot, and 
sensory innervation to the skin of the lateral aspect of the leg and almost all of the 
foot (Williams PL 1995). The sciatic nerve divides into two terminal branches - the 
tibial and common peroneal nerve, with the tibial nerve being the larger of the 
branches. The tibial nerve provides motor innervation to the muscles of the 
posterior compartment of the leg and sensory innervation to the posterior aspect of 
the leg, via its contribution to the sural nerve and the sole of the foot. The peroneal 
nerve provides motor innervation to the muscles of the lateral compartment of the 
leg, which innervates the foot, and sensory innervation to the distal section and 
dorsum of the foot (McCrory, Bell et al. 2002). The sural nerve, formed by the 
junction of the medial sural cutaneous nerve with the peroneal branch, is a small 
superficial sensory nerve providing innervation to the posterior calf, lateral ankle, 
heel and foot (Riedl and Frey 2013). 
When considering injuries to peripheral nerves it is reported that several 
hundred thousand such injuries occur each year in Europe (300,000 cases annually) 
(Mohanna, Young et al. 2003)]. Peripheral nerve injuries are more common than 
spinal cord injuries, and over 50,000 surgical procedures are performed annually 
in the United States to repair damaged peripheral nerves (Noble, Munro et al. 
1998). Current treatment is comprised of either direct end-to-end surgical suturing 
of the damaged nerve ends or the use of an autologous nerve graft.  Suturing is 
limited to a few millimetres for the repair of small defects or gaps. For longer nerve 
gaps (>20 mm), the current ‘gold standard’ treatment is autologous grafting; using 
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a sensory nerve such as the sural nerve to replace the injured tissue. There are 
limitations to using this method, most notably donor site morbidity, chronic pain, 
and a lack of suitable donor nerve tissue. Due to a relatively small diameter, 
multiple sural nerve segments may be placed side by side to match the width of the 
nerve being replaced (Dahlin 2008). In addition, sural nerves also possess smaller 
fascicular patterns (i.e. the number and size of fascicles), which may not match the 
fascicular patterns of the nerve being grafted (Meek and Coert 2002). Considering 
these limitations there are clinical requirements for better approaches to aid nerve 
regeneration (Schmidt and Leach 2003).  
Tissue and organ decellularisation has been proposed as a method to create 
scaffolds for regenerative medicine applications.  The process of decellularisation 
aims to remove all of the native cells from a given tissue without adversely 
affecting its biochemical and mechanical properties. A resulting decellularised 
graft should retain a native ECM, which does not elicit an immune response, and 
may provide a native microenvironment containing cell adhesive and growth 
supporting properties.  It is hypothesised that such a graft will support axon 
regrowth for the repair of small gap nerve defects (Whitlock, Tuffaha et al. 2009) 
Human donor nerves have been used in nerve repair. Avance® Nerve Graft, 
a commercial available decellularised human nerve allograft is reported to better 
support nerve regeneration compared with commercially available NGCs 
(Whitlock, Tuffaha et al. 2009). However, the supply of human nerve tissue for 
decellularisation and use as a graft material is extremely limited in the United 
Kingdom and therefore research has focused on use of xenogeneic tissue due to 
ease of harvesting and availability. For small gap repair, xenogeneic nerve tissue 
from rat, rabbit and pigs have been evaluated (Gutmann and Sanders 1943; Osawa, 
Tohyama et al. 1990; Hudson, Liu et al. 2004; Whitlock, Tuffaha et al. 2009; 
Zhang, Luo et al. 2010). Rat sciatic nerve has been extensively characterised and 
evaluated for use as a nerve graft due to its ease of harvest and availability (Osawa, 
Tohyama et al. 1990; Hudson, Liu et al. 2004; Whitlock, Tuffaha et al. 2009; Wang, 
Zhang et al. 2014). However, rat sciatic nerves have limitations on the size of nerve 
that can be obtained. In contrast, it is hypothesised that porcine nerves are 
anatomically similar to human nerves. Other pig tissues and organs closely 
approximate their human counterparts; cross-linked porcine heart valves for 
example have been widely used clinically. Moreover, porcine nerves have been 
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considered suitable for trauma studies of the facial nerve (Barrs, Trahan et al. 
1991). In addition, porcine nerve tissue may have the potential to be used for longer 
and more specific nerve gap injuries due to their size, length, motor and sensory 
similarities to human nerves (Moore, MacEwan et al. 2011). 
  To the best of our knowledge there have been very few studies evaluating 
the potential of porcine peripheral nerves as grafts to repair short and long gap 
defects. However, in order to use porcine nerves clinically an understanding of the 
anatomy and physiology of porcine peripheral nerves is required, and this is 
currently absent from the literature.  
3.2 Aims and objectives 
Aims: 
The aim of the study was to evaluate the anatomical organisation, structure and 
characteristics of the major peripheral nerves in the porcine hind leg. 
 
Objectives: 
 Dissect and identify the porcine nerves in the lower limb 
 Evaluate the histioarchitecture (connective tissue and fascicular pattern) of each 
nerve by haematoxylin and eosin staining   
 Assess the suitability of porcine peripheral nerves and rat sciatic nerves for tissue 
engineering applications 
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3.3 Methods 
3.3.1 Dissection of porcine peripheral nerves in the lower limb  
Large white Yorkshire pigs (24 - 26 weeks old) were obtained from a local abattoir 
(John Penny & Sons, Leeds, United Kingdom) within 24 hours of slaughter. The 
sciatic, tibial, common peroneal and sural nerves were isolated and dissected, with 
initial reference to the anatomy of human nervous system anatomy of the lower 
leg. The sciatic nerve was dissected from the posterior compartment of the leg. The 
sciatic nerve divided into two terminal branches; the tibial and common peroneal 
nerve. The tibial nerve was observed to travel in the posterior section of the leg and 
the peroneal nerve in the lateral section. The sural nerve was dissected by a 
longitudinal incision made from the popliteal fossa along the posterior midline and 
towards the posterior-inferior aspect of the lateral malleolus (Figure 3.1). Excess 
fat and connective tissue was removed from the nerve samples and tissues washed 
three times in PBS containing 0.1 % (w/v) EDTA to remove excess blood. Tissues 
were then stored at -80 C on PBS moistened filter paper for future use. All nerves 
were 150 - 300 mm in length and varied in diameter, with the peroneal nerve 
ranging from 2 - 3 mm and the tibial nerve ranging from 2 - 4 mm. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Peripheral nerves dissected from the posterior section of the porcine hind limb. 
The sciatic nerve divides into the tibial and common peroneal nerves. Both the tibial and peroneal 
nerves run caudal to the stifle joint with the tibial running into the muscle. Two cutaneous branches, 
the medial and lateral branch off from the tibial and peroneal nerve respectively to form the sural 
nerve. Scale bar at 10 mm.  
 
Sural nerve 
Tibial nerve 
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Sciatic nerve 
10 mm 
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3.3.2 Dissection of rat sciatic nerve 
Male Wistar rats (10-12 weeks old) were killed by a Schedule 1 method (cervical   
dislocation). The rat skin was cut a around the abdominal region and skin above 
the gluteus maximus muscle was removed. The rat was then positioned ventral side 
down and a the sciatic nerve was bilaterally dissected by seperating the muscle 
tissue from the upper dorsal thigh, cutting the nerve just above this position at one 
end and immediatley above the knee at the other end to obtain a length of 
approxiamtley 1.5 cm The sciatic nerve was dissected    
3.4 Results 
3.4.1 Identification of porcine peripheral nerves 
Porcine peripheral nerves were dissected from the posterior section of the porcine 
hind limb. The sciatic divided into two branches of the tibial and common peroneal 
nerve.  
Both the tibial and peroneal nerve run caudal to the stifle joint with the tibial 
running into the muscle. Two cutaneous branches, the medial and lateral branch off 
from the tibial and peroneal nerve respectively to form the sural nerve (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Peripheral nerves dissected from the posterior section of the porcine hind limb. 
The sciatic nerve divides into the tibial and common peroneal nerves. Two cutaneous branches, the 
medial and lateral nerves branch off from the tibial and peroneal nerves respectively to form the 
sural nerve. Scale bar at 10 mm. 
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3.4.2 Histological evaluation of native porcine peripheral and rat sciatic 
nerve 
Peripheral nerves were embedded and sectioned transverly and longitudinally to 
reveal their histoarchitecture. Haematoxylin and eosin stained transverse and 
longitudinal sections revealed the nerve fasicles which contained a a large portion 
of cells embedded within the endoneurial connective tissue seen in blue. Each 
fasicle was surrounded by a perineurium layer, which also consisted of surrounding 
cells. The epineurium is the surrounding connective tissue (Figure 3.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
Figure 3.3 Histoarchitecture of transverse and longitudinal porcine peripheral nerve sections 
stained with haemotoxylin and eosin.  Peripheral nerve in transverse orientation reveal circular 
fasicles (A&C). Peripheral nerve in longitudinal orientation reveal long fasicles (B&D). The 
surrounding connective tissue is stained pink and cell nuclei are stained blue. Scale bars at 500 µm, 
200 µm and 100 µm.  
By haemotoxylin and eosin, the porcine nerves showed variation in the funiculi 
pattern within each nerve segment as they branch.  The sciatic nerve showed to 
possess slightly larger nerve fasicles than the rest of its branches, however it was 
found to possess a similar hstoarchitecture to its branches (pereoneal and tibial 
nerve) in displaying closely packed nerve fascicles within the epineneurium. In 
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contrast, the sural nerve and the cutaneous branches were found to contain a much 
smaller number of fasicles which are also smaller in size and sparsely distributed 
when compared to the sciatic nerve and its branches (Figures 3.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Histoarchitecture of transverse porcine peripheral nerve sections using 
haemotoxylin and eosin stain.  The sciatic nerve (A) and its branches (pereoneal and tibial nerve) 
(B) have numerous nerve fascicles packed closely together within the epineneurium. The sural nerve 
(C) and the cutaneous branches (D) have much smaller and sparsely distributed nerve fascicles 
within the epineurium. Scale bar at 500 µm.   
The rat sciatic nerve had larger but a fewer number of fasicles in comparison to the 
porcine nerves.  Nevertheless, similar to the porcine sciatic nerve and its branches 
(peroneal and tibial), the fasicles found in the rat scaitic nerve were closely packed 
together with little epineurium space (Figure 3.5).   
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Figure 3.5 Histoarchitecture of rat sciatic  nerve.  Transverse (A & C) and longitudinal (B&D) 
orientation using haemotoxylin and eosin stain. Transverse sections revealed the rat sciatic nerve 
fascicles contained an endoneurium and perineurium. Longitudinal sections revealed cells (blue) 
aligning amongst collagen fibrils. Majority of the cells are located within the perineurium and the 
endoneurium Scale bars A and  B at 200 µm; Scale bars C and D at 100 µm.  
3.4.3 Quantification of fasicle size and area 
The histology data of both porcine and rat nerve were quantified and analysed using 
Image J by using transverse images to measure the fasicle area. Data showed the 
porcine sciatic nerve to have an average of 11 fasicles with an average area of 150 
± 34.18mm2, whilst its branches had on average 20 fasicles with an average area of 
94.08 ± 12.28 mm2.  The sural cutaneous branch had an average of six fasicles with 
an average area of 68.97 ± 35.69 mm2 and the sural nerve had an average seven 
fasicles, with an average area of 47.93 ± 6.510 mm2. In terms of fasicle area size 
the porcine sciatic nerve was significantly larger than the sural nerve. The rat sciatic 
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nerve had an average of three fasicles with an average area of 157.3 mm2 . This 
area was similar to the porcine sciatic nerve (Table 3.1).   
 
Nerve Average number of 
fascicles 
Area of fascicles 
(mm2) 
Porcine sciatic 11 150.45 ± 34.18 
Porcine sciatic 
branches 
20 94.08 ± 12.28  
Porcine sural 
cutaneous branch 
6 68.97 ± 35.69 
Porcine sural 7 47.93 ± 6.510 
Rat sciatic 3 157.3 ± 80.16 
 
Table 3.1 The average number and area of fascicles present in porcine and rat peripheral 
nerves.  Porcine and rat  sciatic nerve have the largest fasicle area. The sural nerve has the smallest 
fasicle area, which is significantlly smaller than the sciatic nerves (p<0.05). Porcine sciatic nerve 
have  on average 11 fasicles with an average area of 150 ± 34.18mm2 (n = 3); sciatic branches 
(pereoneal/tibial nerve) have on average 20 fasicles with an average area of 94.08 ± 12.28 mm2 (n 
= 3) ; sural cutaneous branch has an average of  six fasicles with an average area of 68.97 ± 35.69 
mm2 (n =3); sural branch has an average of seven fasicles with an average area of 47.93 ± 6.510 
mm2 (n =3) and rat sciatic nerve has an average of  three with an average area of 157.3 mm2 (n = 
3). Data was analysed using the unpaired Student’s t-test and is presented as the mean ± 95 % C.I  
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3.5 Discussion  
In this study the identification and characterisation of porcine peripheral nerves 
located in the lower limb is reported. The rat sciatic nerve was also included in the 
study as a control. 
 The general nerve branching observed in the porcine peripheral nerves is 
consistent with similar findings in the peripheral nerve anatomy of humans as well 
as other mammals such as rat (Sunderland and Ray 1948; Schmalbruch 1986). In 
addition, the length and dimensions of the porcine nerves were found to be 
comparable to that of human nerves (Gustafson, Grinberg et al. 2012).  The 
fasicular pattern observed in the porcine nerves was similar to that reported for 
human studies (Sunderland 1990; Chentanez, Cha-oumphol et al. 2006; Ugrenovic, 
Jovanovic et al. 2013; Ugrenović 2014). When mapping the branches from the 
sciatic nerve, the fascicular patterns within the individual nerves have previously 
been shown to differ in respect to the arrangement, size and number. Sunderland et 
al. (1948) reported no constant or characteristic pattern in regards to the number 
and size of the funiculi, which varied greatly from nerve-to-nerve and individual-
to-individual at any given level (Sunderland and Ray 1948). Interestingly, a study 
by Ugrenović et al. (2014) showed a significant difference in the average number 
of fascicles between the tibial and common peroneal nerve. The common peroneal 
nerve had a significantly lower number of fascicles; however there was no 
significant difference in the average value of fascicular area or diameter between 
the two nerves (Ugrenović 2014). 
The internal nerve structure has substantial relevance in terms of the clinical 
outcome of nerve lesions, as well as the surgical repair of nerve injuries. In direct 
nerve repair the surgeon aligns the fascicles by matching similar looking ones in 
the stumps to prevent misalignment in addition to using epineurial blood vessels 
(Stewart 2003). Similarly in nerve grafting, attention to the fascicular pattern is 
thought to be of importance in achieving good functional recovery (Stewart 2003). 
In turn, an appropriately matched nerve graft would lead to a more accurate 
technical repair, minimal sutures and potentially less scarring.   
A study conducted by Burks et al. (2014) highlighted the challenge of 
insufficient donor nerve graft with a specific focus on human sciatic nerve 
transection requiring autologous sural nerve graft. The authors reported that a 
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considerable degree of variability existed in the diameter of the fascicles and cross 
sectional area of the sural nerve harvested, in comparison with the sciatic nerve. 
The study also reiterated the fact that small sensory nerves such as the sural nerve 
do not provide sufficient material for grafting and that allogeneic intercostal nerves 
(common peroneal or tibial) are preferred (Burks, Levi et al. 2014). This approach 
was reported by (Mackinnon, Doolabh et al. 2001)  where the tibial nerve was 
reconstructed with allograft tissue  . 
 The sciatic nerve in both porcine and rat possess larger fascicles in 
comparison to its branches. It was initially demonstrated by Sunderland et al. 
(1961) that there are more fascicles and larger cross-sectional area of extrafasicular 
connective tissue present in regions when the nerve passed a joint, such as the 
sciatic nerve. This led to the later suggestion that this was a protective feature by 
which vulnerable areas of nerves resisted mechanical injury (Sunderland and 
Bradley 1961). A study by (Phillips, Smit et al. 2004) also concluded that sciatic 
nerves exhibited greater strain in the joint region, however it was further concluded 
that this was a result of the complex tissue architecture rather than fascicle number 
(Mason and Phillips 2011).  
 
3.6 Conclusion 
In summary, this study details the anatomy of porcine peripheral nerves in the 
lower limb. The results demonstrate that porcine nerves are more comparable to 
human nerves than rat in terms of anatomical structure and size. In addition, the 
study also highlights anatomical differences of the nerve as it branches. It is 
therefore suggested that the similarities between porcine and human nerve may 
allow for the clinical use of porcine nerves as grafts following nerve injury. 
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Chapter 4. Optimisation of Methods for the Decellularisation 
of Porcine Peripheral Nerves 
 
4.1 Introduction 
Xenogeneic tissues such as porcine can be used as nerve grafts as they provide an 
ECM which mimics the native nerve tissue as described in Chapter 3. They contain 
an endoneurial microstructure which can provide the same level of guidance and 
regenerative support as nerve autografts.  In addition, these nerves can also offer 
the potential for size/length and motor/sensory specificity (Moore, MacEwan et al. 
2011).  
However when used clinically these grafts possess risks from the immune 
response from the body due to the presence of foreign cells (Janeway, Travers et 
al. 1999; Mackinnon, Doolabh et al. 2001; Badylak 2014). Alternatively, the 
immunogenic components from the graft can be removed through a processing 
condition called decellularisation, producing a non-immunogenic acellular tissue 
graft. Acellular grafts still retain the 3D structure and ECM components of the 
native tissue; however, it can be used clinically without eliciting an immune 
response. The rationale behind decellularisation are that ECM components are 
generally conserved amongst species and are tolerated well by recipients (Ratner, 
Hoffman et al. 2004; Badylak, Freytes et al. 2009).  
Xenogeneic nerve grafts such as rat (Hudson, Liu et al. 2004; Kim, Yoo et 
al. 2004; Yu, Peng et al. 2009; Gao, Zheng et al. 2014); porcine (Zhang, Luo et al. 
2010); Macaca fascicularis (Hess, Brenner et al. 2007); Rhesus monkey (Hu, Zhu 
et al. 2007) have been used extensively in tissue engineering applications.  It has 
been reported that decellularised nerve allografts are capable of returning adequate 
sensation in nerve defects ranging from 0.5 to 3 cm without infection or rejection 
(Moore, MacEwan et al. 2011). In another study, Hudson et al 2004 showed the 
ability of macrophages to migrate within a decellularised tissue and produce 
growth factors to promote axonal regeneration (Hudson, Zawko et al. 2004). 
The aim of any decellularisation protocol is to remove all immunogenic 
cellular and nuclear material whilst preserving the biochemical and biomechanical 
properties of the ECM. However, any process that removes cells will ultimately 
alter the native three dimensional architecture of the ECM.     
95 
 
A number of methods have been documented for the preparation of 
acellular nerve grafts from donor nerve tissue. The most commonly utilised method 
for decellularisation of nerve tissue involves physical (Hiles 1972; Gulati 1988; 
Evans, Mackinnon et al. 1998; Ide, Tohyama et al. 1998), chemical (Sondell, 
Lundborg et al. 1998; Hudson, Liu et al. 2004) or enzymatic treatments (Wang, 
Itoh et al. 2015) .  
Physical methods used to facilitate decellularisation of nerve tissues include 
cold preservation (Evans, Mackinnon et al. 1998) thermal (Gulati 1988; Ide, 
Tohyama et al. 1998)  and radiation (Hiles 1972). Prolonged cold preservation of 
donor nerve tissue resulted in the preservation of native Schwann cell basal laminae 
and nerve ECM. The drawbacks however were the long processing times 
(approximately seven weeks) as well as poor mechanical properties of the 
decellularised graft (Evans, Mackinnon et al. 1998).  
Thermal decellularisation subjects the nerve tissue to repeated freeze-thaw 
cycles, rendering the graft non-immunogenic by lysing cells (Zalewski and Gulati 
1982; Gulati and Cole 1994). The process however fails to remove the cell 
remnants and fractures the basal laminae that surround myelinated and 
unmyelinated axons. In vivo studies have shown that cellular remnants left behind 
from this process lead to cellular invasion in the form of Schwann cells and 
macrophages invading the basal lamina to clear away the debris and thereby 
delaying the regenerative process and further damaging the basal lamina (Pollard 
and Fitzpatrick 1973; Osawa, Tohyama et al. 1990; Danielsen, Kerns et al. 1995). 
Radiation has also been used as a decellularisation technique for nerve 
tissue. Studies have shown that this process does not damage the tissue morphology 
(Marmor 1964). Nevertheless similar to thermal decellularisation, cellular debris 
still remains inside the basal laminae causing cellular invasion post implantation 
(Hudson, Liu et al. 2004).  
Physical decellularisation treatments have the ability to detach cells from 
the nerves ECM. However, their inabilities to remove cellular debris from the tissue 
and the destructive effects of freeze-thawing on the nerve ultrastructure makes 
these processes insufficient. Therefore, to achieve complete and effective 
decellularisation physical treatments are usually combined with a chemical 
treatment, which includes the presence of detergents and hyper/hypotonic 
solutions. Commonly, physical treatments are applied at the beginning of the 
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decellularisation process to disrupt the cell membrane and lyse the cells and are 
then followed by the chemical treatments.   
Detergents are the predominant chemical treatments used in the 
decellularisation of nerves (Sondell, Lundborg et al. 1998; Hudson, Liu et al. 2004; 
Wakimura, Wang et al. 2015). Ionic, non-ionic, and zwitterionic detergents have 
been shown to be effective in the removal of cellular material by solubilising both 
cytoplasmic and nuclear cellular membranes.  However, these detergents can also 
denature proteins in the ECM by disrupting protein-protein interactions (Seddon, 
Curnow et al. 2004; Gilbert, Sellaro et al. 2006). Common ionic detergents that 
have been used for nerve tissue include sodium dodecyl sulphate (SDS) 
(Wakimura, Wang et al. 2015), sodium deoxycholate (Wang, Itoh et al. 2015) and 
Triton X-200 (Hudson, Liu et al. 2004). 
A study by Wang et al (2015) used TritonX-100 on its own and as a 
combination with sodium deoxycholate to decellularise rat sciatic nerve. The 
results  showed that in both  treatments  there were  nerve fibre breakage as well as 
traces of myelin sheath and cells still present within the tissue (Wang, Itoh et al. 
2015). In another study by Wakimura et al (2015) a combination of 1% SDS and 
Triton X-100 was used to decellularise rabbit median nerves. Results demonstrated 
an intact structure with the elimination of cells. Further in vivo analysis showed 
limited ED1-positive macrophage invasion in addition to abundant axons and 
Schwann cells penetrating through the implanted nerves (Wakimura, Wang et al. 
2015). 
Compared to other detergents SDS is the most  effective detergent for 
removal of cellular material ,  nuclear remnants,  and cytoplasmic proteins (Booth, 
Korossis et al. 2002; Grauss, Hazekamp et al. 2005; Wilcox, Korossis et al. 2005; 
Wilshaw, Kearney et al. 2006). A drawback of SDS does however include 
disruption to the native tissue structure and collagen structure (Gilbert, Sellaro et 
al. 2006). However studies have found that a low concentration of SDS (0.1 %; 
w/v) can eliminate cells whilst preserving the native structure of the tissue (Booth, 
Korossis et al. 2002; Wilcox, Korossis et al. 2005), as well as maintaining the 
tissues mechanical strength (Korossis, Booth et al. 2002).  
Non-ionic detergents such as Triton X-100 have been extensively used due 
to their mild effects upon tissue structure. Using a combination of Triton X-100 
and sodium deoxycholate Sondell et al. (1998) produced an acellular graft that was 
97 
 
shown to support nerve regeneration. Post implantation analysis revealed 
regenerating axons within the basal lamina tubes and migration of host Schwann 
cells, which reoccupied the empty basal lamina tubes without excessive signs of 
inflammation (Sondell, Lundborg et al. 1998) . The grafts however were still not 
able to match the regeneration rates observed with the autograft, even with the 
incorporation of Schwann cells (Frerichs, Fansa et al. 2002). It was  hypothesised 
that the inadequate preservation of the basal lamina  in the acellular graft was a 
contributing factor to this failure (Hudson, Zawko et al. 2004). Studies using Triton 
X-100 have reported a decrease in laminin and fibronectin content (Grauss, 
Hazekamp et al. 2005) which would attributed to damage of the basal lamina. 
A milder chemical decellularisation technique developed by Hudson et al 
(2004) used zwitterionic detergents in conjunction with Triton X-200; 
sulfobetaine-10 (SB-10) and Triton X-200/sulfobetaine-16 (SB-16). This process 
demonstrated superior preservation of native ECM and equivalent levels of 
decellularisation compared with the Sondell chemical processing technique 
(Hudson, Liu et al. 2004).  In vivo analysis of the acellular nerve graft developed 
by Hudson showed no sign of rejection on the basis of the level of immune cells (T 
cells and macrophages) in the graft. There was no increase in CD8+ cells (cell 
surface markers on cytotoxic T cells) when compared with isografts, however there 
was a slightly higher invasion of macrophages within the acellular graft.  A possible 
cause is that the open basal lamina tubes and the absence of myelin permitted a 
greater number of macrophages to invade and remain inside the grafts (Hudson, 
Zawko et al. 2004). Regeneration capacities of the acellular graft showed that the 
axon density at the midpoints of the acellular graft was indistinguishable from that 
in isografts and statistically higher than in the thermally decellularised model 
described by Gulati et al. (1988) and the chemically decellularised model described 
by Sondell et al. (1998).  
The decellularisation process developed by Hudson et al (2004) is now 
licensed by AxoGen® Inc. which produces Avance®, a clinically approved nerve 
graft for PNS injury repair.  The Avance® nerve graft has shown to be superior over 
the comercially available NGCs in promoting nerve regeneration (Karabekmez, 
Duymaz et al. 2009; Whitlock, Tuffaha et al. 2009; Mackinnon 2011). This is most 
likely attributed to the retention of the nerves ECM and basal lamina which are 
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known to play important in promoting and guiding axonal growth (Faweett and 
Keynes 1990; Ide, Osawa et al. 1990; Martini 1994; Hudson, Liu et al. 2004).  
Alongside detergents enzymatic treatments are commonly used in the 
decellularisation process. These include the use of calcium chelating agents and 
nucleases. Nucleases such as endonucleases catalyse the hydrolysis of the interior 
bonds of deoxyribonucleotide or ribonucleotide chains whereas exonucleases 
catalyse the hydrolysis of the terminal bonds which ultimately leads to the 
degradation of RNA and DNA (Crapo, Gilbert et al. 2011). The effectiveness of 
enzymatic treatment for the removal of cellular material from the ECM has been 
studied in a variety of tissues with varied results. Chelating agents such as EDTA 
and EGTA form a ring-shaped molecular complex that binds and isolates a central 
metal ion. Divalent cations such as Ca2+ and Mg2+ are needed for cell attachment 
to collagen and fibronectin at the Arg-Gly-Asp receptor. By binding the divalent 
cations present at the cell adhesions to the ECM the chelating agents facilitate in 
the removal of the cellular material from the tissue.  
Hypotonic and hypertonic solutions are commonly used in the 
decellularisation process. Hypotonic solutions are used to lyse the cells within 
tissues through osmotic shock with minimal changes in matrix molecules and 
architecture (Xu, Chan et al. 2007). Hypertonic solutions dissociate DNA from 
proteins (Cox and Emili 2006). For a maximum osmotic effect, it is common for 
the tissue to be immersed alternatively in hyper and hypotonic solutions. This 
treatment however does not remove the cellular remnants from the tissue therefore 
additional enzymatic or chemical treatments are necessary for the removal of the 
cellular debris (Crapo, Gilbert et al. 2011). 
During the decellularisation process proteases are released from lysed cells 
which can cause damage to the native ECM ultrastructure. Protease inhibitors such 
as Aprotinin are therefore added to solutions. Buffered solutions of pH 7 - 8 as well 
as temperature control and time of exposure to the lysis solutions can also limit 
protease activity.  
Following the completion of the decellularisation process the tissues must 
be sterilised prior to in vitro cell seeding or in vivo studies. Sterilisation of 
biological scaffolds is vital to eliminate endotoxins and viral and bacterial DNA 
that may be present. Sterilisation methods have included incubation in acids or 
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solvents, ethylene oxide exposure, gamma irradiation and electron beam irradiation 
(Hodde and Hiles 2002).   
Acid and alkaline treatments solubilise the cytoplasmic component of the 
cells as well as removing nucleic acids such as RNA and DNA through hydrolytic 
degradation (Gilbert, Sellaro et al. 2006). Acids such as peracetic (PAA), sulphuric 
and hydrochloric can effectively disrupt cell membranes and intracellular 
organelles. PAA is an oxidising agent and an effective chemical sterilant (Pruss, 
Kao et al. 1999; Hodde and Hiles 2002). PAA also doubles up as a decellularisation 
agent with the removal of residual nucleic acid (Badylak, Tullius et al. 1995) as 
well as being an excellent agent for inhibiting viruses (Hodde and Hiles 2002). 
PAA has minimal effect on the ECM composition and structure as seen with the 
preservation of several collagen types in a variety of porcine tissue such as small 
intestinal submucosa (SIS) and the urinary bladder (Hodde, Janis et al. 2007; 
Gilbert, Wognum et al. 2008). PAA treatment retains many of the native GAGs 
(hyaluronic acid, heparin, heparin sulphate, chondroitin sulphate A and dermatin 
sulphate) (Hodde, Badylak et al. 1996) as well as numerous growth factors 
including transforming growth factor-β, fibroblast growth factor and vascular 
endothelial growth factor (Voytik‐Harbin, Brightman et al. 1997; Hodde, Record 
et al. 2001) 
Peracetic acid has been associated with oxidative damage to collagen due 
to their reactivity with oxygen-free radicals. The presence of these compounds have 
been associated with crosslinks which can affect the mechanical properties of the 
sterilised ECM (Monboisse and Borel 1992; Brown, Merritt et al. 2002). The 
microstructure of the collagen fibres have also been reported to be dissimilar after 
the PAA treatment (Brown, Lindberg et al. 2006).  However a study by Hodde et 
al (2002) found that endothelial cells were still able to adhere to PAA treated  
porcine small intestinal submucosa (SIS) and urinary bladder matrix (UBM) which 
suggests that amino acid sequences responsible for cell adhesion remained 
unaltered by the PAA (Hodde, Record et al. 2002).  In addition a study by Freytes 
et al (2004) showed no significant difference between PAA treated and untreated 
porcine SIS, UBM and urinary bladder submucosa (UBS) (Freytes, Badylak et al. 
2004).   
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The efficacy of a given decellularisation protocol varies depending on the 
tissue, composition and density. In the case of denser tissues such as peripheral 
nerves access for the decellularisation solutions may be more difficult. It is 
therefore common to immerse the tissues in the solutions whilst being subjected to 
agitation. Immersion and agitation methods of tissue decellularisation have been 
well documented in a variety of tissues including heart valves (Meyer, Chiu et al. 
2006), tendons(Cartmell and Dunn 2000) and peripheral nerves (Hudson, Liu et al. 
2004; Karabekmez, Duymaz et al. 2009). The duration of this method is dependent 
on tissue thickness and density as well as the detergent used and the intensity of 
agitation.  
It is important to highlight that for each tissue studied, it is necessary to 
optimise a decellularisation and sterilisation protocol to achieve optimal cell 
removal without significantly damaging the ECM. Each variable will affect the 
composition and ultrastructure of the ECM which in turn will influence the host 
tissues response to the tissue following implantation (Gilbert, Sellaro et al. 2006).  
The removal of DNA is a vital indicator in determining the efficacy of the 
decellularisation method.  It is possible to quantitatively assess cell components 
such as double-stranded DNA (dsDNA), single stranded DNA (ssDNA), RNA, 
mitochondria or membrane associated molecules. Currently there is no value for 
the level of residual cellular material permitted within an acellular scaffold or what 
amount of residual material will elicit an immune response, this is almost certainly 
dependent on the tissue being decellularised. No decellularisation technique can 
remove 100 % of cell material, even with the most rigorous processing methods 
(Badylak 2014).  Most commercially available biological scaffolds contain trace 
amounts of remnant DNA, nonetheless the clinical efficacy of these devices have 
been largely positive (Table 4.1). 
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Table 4.1 Summary of clinically approved products produced from xenogeneic tissue. 
Reproduced from Badylack (Badylak 2014) 
Based on findings from in vivo studies in which constructive remodelling has been 
observed with no adverse host or cell responses, a minimum criteria has been 
developed to describe a decellularised scaffold (Crapo, Gilbert et al. 2011).  
 < 50 ng dsDNA per mg ECM dry weight 
 < 200 bp DNA fragment length  
 Lack of visible nuclear material in tissue sections stained with 4, 6-diamidino-2-
phenylindole (DAPI) or haematoxylin and eosin 
 
This Chapter therefore describes the development of a method for the 
decellularisation of porcine peripheral nerves, based on a previously developed 
method for arterial matrices (Wilshaw, Rooney et al. 2012). To create the most 
effective acellular nerve tissue the decellularisation process developed in the 
present study included a combination of physical, chemical and enzymatic 
methods.  
Freeze-thawing is carried out as the initial physical decellularisation step to 
detach cells from the ECM. Subsequently chemical and enzymatic treatments such 
as SDS, EDTA, hypotonic and hypertonic buffers are added to efficiently remove 
the cells from the tissue. A low concentration of SDS is chosen to remove cellular 
material and cytoplasmic proteins whilst preserving the native structure.  In 
addition, a nuclease treatment is also added to remove DNA and RNA from the 
tissue as well as a final sterilisation step using PAA. 
 
Source Tissue Source 
species 
                Products 
Dermis Porcine Strattice TM(Lifecell), XenMatrix TM 
(Bard Davol) 
Dermis Bovine TissueMend ® (Stryker), Veritas ® 
(Synovis) 
Pericardium Equine OrtAdapt ® (Synovis) 
Pericardium Bovine CopiOs ® (Zimmer Inc), Perimount ® 
(Edwards Lifesciences) 
Small intestine Porcine Surgisis ® (Cook Biotech), Restore ® 
(DePuy Orthapaedics), FortaFlex® 
(Integra LifeSciences) 
Urinary bladder Porcine MatriStem® (ACell) 
102 
 
4.2 Aims and Objectives 
Aims: 
The aim of the study presented in this Chapter was to optimise a process for the 
decellularisation of porcine peripheral nerves. 
 
Objectives: 
 To develop a decellularisation method for porcine peripheral nerves that is able to 
remove the cells and cellular remnants whilst preserving the histioarchitecture and 
the biomechanical integrity of the ECM. 
 To determine which type of peripheral nerve to use as a scaffold 
 To characterise the decellularised porcine peripheral nerves histologically 
 To assess the efficacy of the decellularisation process by quantifying the amount 
of DNA left in the nerve  
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4.3 Methods 
4.3.1 Decellularisation solutions 
4.3.1.1 Disinfection solution 
This solution was prepared fresh before use and consisted of 100 mL PBS 
containing 10 µg/mL vancomycin hydrochloride, 100 µg/mL gentamicin sulphate 
and 50 μg/mL polymyxin B. The volume was made up to 500 mL with PBS. 
4.3.1.2 EDTA solution (200 mM) 
EDTA (74.4 g) was dissolved in 1 L distilled water and the pH of the solution was 
adjusted to 7.2 - 7.4 by adding either 6 M hydrochloric acid or sodium hydroxide 
pellets. The solution was stored at room temperature for up to one month. Aprotinin 
(1 mL, 10,000 KIU/mL) was added to the solution just before use. 
4.3.1.3 PBS EDTA solution (2.7 Mm; 0.1% w/v) containing 10 KIU/mL 
aprotinin 
EDTA (1 g) was added to 1 L PBS and the pH of the solution was adjusted to 7.2 
- 7.4 by adding either 6 M hydrochloric acid or sodium hydroxide pellets. The 
solution was stored at room temperature for up to one month. Aprotinin (1 mL, 
10,000 KIU/mL) was added to the solution immediately before use. 
4.3.1.4 Hypotonic buffer (10 mM Tris, 2.7 mM EDTA, 10 KIU/mL aprotinin) 
Trizma base (1.21 g) and EDTA (1 g) was dissolved in 900 mL distilled water and 
the pH of the solution was adjusted to 8 - 8.2 by adding either 6 M hydrochloric 
acid or sodium hydroxide pellets. The solution was made up to 1 L with distilled 
water and autoclaved. The solution was stored at room temperature for up to one 
month. Aprotinin (1 mL, 10,000 KIU/mL) was added to the solution immediately 
before use. 
4.3.1.5 Hypertonic buffer (50 mM Tris buffer, 1.5 M sodium chloride) 
Trizma base (6.06 g) and sodium chloride (87.66 g) was dissolved in 900 mL 
distilled water and the pH of the solution was adjusted to 7.5 - 7.7 by adding either 
6M hydrochloric acid or sodium hydroxide pellets. The solution was made up to 1 
L with distilled water and autoclaved. The solution was stored at room temperature 
for up to one month. 
104 
 
4.3.1.6 SDS hypotonic buffer (0.1 % w/v SDS, 10 mM Tris, 0.1 % w/v EDTA, 
10 KIU/mL aprotinin) 
SDS (1 g) was added to 10 mL distilled water to make a 10 % (w/v) stock solution 
and filter sterilised.  The 10 % (w/v) SDS stock solution was added to 990 mL 
sterile hypotonic buffer. The unused hypotonic SDS buffer was stored for up to one 
week at 4 °C if it was opened aseptically. Aprotinin (1 mL, 10,000 KIU/mL) was 
added to the solution just before use 
4.3.1.7 Nuclease treatment solution (50 mM Tris buffer, 1 mM MgCl2.6H2O, 1 
U/mL Benzonase) 
Trizma base (6.1 g) and magnesium chloride (0.203 g) was dissolved in 100 mL 
distilled water and the pH of the solution was adjusted to 7.5 - 7.7 by adding either 
6M hydrochloric acid or sodium hydroxide pellets. The solution was made up to 1 
L with distilled water and autoclaved. On the day of use 4 µL of Benzonase (250 
U/µL) was added to the solution under sterile conditions. The nuclease solution 
must be used within ten minutes of preparation.  
4.3.1.8 Peracetic solution (0.1 % v/v) 
PAA (40 %, 2.5 mL) was added to 500 mL of PBS. The pH was adjusted to 7.2 - 
7.5 by adding 6 M NaOH dropwise. The solution was made fresh just prior to use. 
4.3.2 Histology 
4.3.2.1 Evaluating the decellularisation process 
Tissue samples from three decellularised nerves from different animals were fixed 
with 3.7 % (v/v) formaldehyde and paraffin embedded as described in Section 2. 
Histological evaluation was performed as described in Section 2.2.4 Paraffin 
embedded tissue sections of 6 μm were all positioned transversely to study the 
effects of decellularisation.  Haematoxylin and eosin was used to study the tissue 
architecture and cell distribution. H&E samples were viewed using an upright 
microscope. Nuclei were imaged using an upright fluorescent microscope using a 
DAPI filter (λex = 300 nm / λem = 550 nm)  
4.3.2.2 Evaluating the lipid content of native and acellular tissue 
Tissue samples from native and acellular nerves were cryo embedded as described 
in Section 2.2.3.1. Cryo embedded tissue sections of 10 μm were positioned 
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longitudinally to study the lipid content. Slides were stained with Oil Red O and 
haematoxylin as described in Section 2.2.4.   Oil Red O and haematoxylin were 
used to study the lipid content and cell distribution. Samples were viewed using an 
upright microscope. 
4.3.3 DNA quantification 
DNA quantification was used to determine the total remaining DNA in porcine 
peripheral nerves following decellularisation by comparing the DNA levels in 
decellularised and fresh tissue. This was for determining the efficacy of the 
decellurisation process.  
4.3.3.1 DNA extraction 
DNA was extracted from fresh and decellularised porcine nerves using the QIAgen 
DNeasy blood and tissue kit. DNA was extracted from tissues from three fresh and 
three decellularised porcine nerves. For each nerve triplicate samples were taken 
for DNA extraction. 
Samples of the fresh and decellurised porcine nerves were lyophilized to a 
constant weight prior to DNA quantification assay. Each sample consisting of 100 
mg tissue were macerated with a scalpel blade and placed in a sterile 1.5 mL 
microcentrifuge tube. The samples were then freeze-dried; the mass of each sample 
was recorded daily until a consistent weight was achieved (approximately 25 mg). 
DNA extraction was carried out using the DNeasy blood and tissue kit 
(QIAgen). Buffer ATL (360 µL) and proteinase K (40 µL), both from the QIAgen 
kit, were mixed with the macerated freeze dried tissue by vortexing and incubating 
at 56 °C for three hours or until the tissue was completely digested. Pulse vortexing 
(5 to 10 seconds) was performed every 30 minutes to disperse the sample. Each 
sample was vortexed for 15 seconds at the end of the incubation. Buffer AL (400 
μL) from the QIAgen kit was added to the sample, and mixed thoroughly 
immediately by vortexing and 400 μL of ethanol (100 %; v/v) was added, and 
mixed thoroughly immediately by vortexing. 
Each sample was transferred to a separate DNeasy Mini spin column placed 
in a 2 mL collection tube, and centrifuged at 6,000 × g for one minute. The flow-
through was discarded together with the collection tube. The DNeasy Mini spin 
column was placed in a fresh 2 mL collection tube, and Buffer AW1 (500 μL) was 
added to the column. The DNeasy membrane at the bottom of the DNeasy Mini 
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spin column was dried by centrifuging at 15,000 × g for three minutes. The flow-
through was discarded together with the collection tube. The DNeasy Mini spin 
column was placed in a clean 1.5 mL microcentrifuge tube, and Buffer AE (200 
μL) was added directly to the centre of the DNeasy membrane. After incubation 
for one minute, the 1.5 mL microcentrifuge tube was centrifuged for one minute at 
6,000 × g to elute. The extracted DNA was in Buffer AE in the flow-through. The 
DNeasy Mini spin column was discarded. The extracted DNA was subjected to 
quantification immediately or stored at – 20 °C until needed. 
4.3.3.2 DNA quantification by spectrophometry 
The concentration of extracted DNA was determined spectrophometrically using a 
Nanodrop spectrophotometer. Buffer AE (2 μL) was used as a blank. Extracted 
DNA sample (2 μL) was loaded onto the Nanodrop, and the absorbance was 
determined at 260 nm. Three readings were taken for each sample, and the mean 
was considered as the absorbance of the sample. The DNA concentration (ng/μL) 
in the sample was directly displayed in the Nanodrop software. This concentration 
was used to calculate the DNA weight/tissue weight (μg/mg) according to: 
 
DNA weight/tissue weight (μg/mg) = 
𝑐×200
25×1000
 
 
where C represents the DNA concentration in the Buffer AE (ng/μL). The volume 
of the Buffer AE containing extracted DNA was 200 μL. The total weight for each 
tissue sample was 25 mg. The mean ± 95 % C.I. of the DNA weight/tissue weight 
(μg/mg) for each region of fresh (n = 3) or decellularised (n = 3) tissue was 
calculated. 
4.3.4 Dissection and storage of porcine peripheral nerves 
Yorkshire pigs (24 - 26 weeks old) were obtained from a local abattoir (John Penny 
& Sons, Leeds, United Kingdom) within 24 hours of slaughter. The peripheral 
nerves dissected from the porcine leg included the femoral, sciatic, tibial, common 
peroneal and sural nerve. Femoral nerves (10 - 15 mm diameter) were dissected 
from the anterior compartment of the thigh. Sciatic nerve (10 - 15 mm diameter) 
was dissected from the posterior compartment of the leg. The sciatic nerve divides 
into two terminal branches; the tibial (3 - 6 mm diameter) and common peroneal 
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nerve (2 - 4 mm diameter). The tibial nerve travels in the posterior leg and the 
peroneal nerve travels in the lateral compartment of the leg. The sural nerve (1 - 
1.5 mm diameter) was dissected by a longitudinal incision made from the popliteal 
fossa along the posterior midline and towards the posterior-inferior aspect of the 
lateral malleolus. As much excess fat and connective tissue was removed from the 
samples and the tissues were washed thrice at room temperature, 30 minutes each 
time in PBS containing 0.1 % (w/v) EDTA and Aprotinin 10 KIU/mL to remove 
excess blood. Tissues were then cut into individual 5 cm segments, positioned 
longitudinally to avoid any kinks and stored at - 80 °C on PBS moistened filter 
paper for future use.  
4.4 Decellularisation of peripheral nerves  
Prior to the decellularisation process the peripheral nerves were subjected to a 
freeze-thaw cycle and individually placed in 200 mL sterile containers containing 
200 mL disinfection solution and incubated for an hour at 37 °C under agitation 
(containers were placed horizontally) at 120 rpm.  Each nerve was subjected to 200 
mL of the solutions indicated below. Figure 4.1 summarises the standard 
decellularisation process. The number of SDS and nuclease cycles along with 
incubation temperature and agitation speeds was subject to change. 
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Figure 4.1 Overview of the key stages involved in the decellularisation process. The process 
involves a combination of physical, chemical and enzymatic treatment for efficient cell removal.    
For some stages the exact temperature and agitation speed are not specified due to subject to change   
 
1. Freeze thaw tissue for 30 minutes at 37°C  
2. Wash samples in disinfection solution for 30 minutes at 37°C  under fast 
agitation 
3. Wash samples in EDTA  solution for 24 hours at 4 °C under fast agitation 
4. Wash samples in hypotonic buffer  solution for 24 hours under fast agitation 
5. Wash samples in hypotonic SDS buffer  solution for 24 hours under fast 
agitation 
6. Wash samples in PBS-EDTA solution for 48 hours at 4°C
7.Wash samples with nuclease treatment at 35°C for 3 hours under slow agitation 
of 50 RPM
8. Wash samples three times in PBS solution for 30 minutes each times  under fast 
agitation
9. Wash samples in hypertonic buffer  solution for 24 hours under fast agitation 
10. Wash samples in PBS solution for 48 hours at 4°C under  fast agitation
11. Sterilise samples with peracetic acid for three hours at room temperature
Physical 
 
 
 
 
 
 
Chemical 
 
 
 
 
 
 
Enzymatic 
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4.4.1 Decellularisation of femoral nerves  
Three decellularisation runs were carried out on femoral nerves (n = 3); all agitation 
was carried out at 120 rpm, apart from the nuclease step which was carried out at 
50 rpm. The temperatures of the solutions changed within each run apart from the 
nuclease step which remained at 37 °C.  In the first decellularisation run all steps 
were carried out at 37 °C unless otherwise stated and the nerves were subjected to 
two SDS cycles.  
After freeze thaw and disinfection, each femoral nerve was washed in 200 
mM EDTA solution for 24 hours at 4 °C. The nerves were then subjected to three 
cycles of hypotonic buffer in the presence of Aprotinin for 24 hours with one of 
the buffers containing 0.1 % (w/v) SDS. The nerves were then washed with PBS 
and 0.1 % (w/v) EDTA containing Aprotinin for 48 - 56 hours at 4 °C.  The nerves 
were subjected to one cycles of hypotonic buffer containing 0.1 % (w/v) SDS for 
24 hours and were then washed three times in PBS for 30 minutes each time before 
being further washed in PBS overnight. The following day the nerves were 
incubated in two nuclease cycles for three hours at 50 rpm agitation for each cycle. 
Each nerve was then washed three times in PBS at for 30 minutes each time before 
being further washed in PBS overnight. The nerves were then washed in hypertonic 
buffer at and incubated for 24 hours with agitation. The nerves were washed three 
times in PBS, 30 minutes each time at before being sterilised with 0.1 % (v/v) 
peracetic acid in PBS for three hours at room temperature (20 – 25 °C) with 
agitation. Nerves were then washed a further three times in sterile PBS for 30 
minutes each with agitation and stored in the fridge at 4 °C till needed.  
 The same procedure was used for the second and third decellurisation 
methods however in the second run all steps were carried out at 42 °C and the 
nerves were subjected to three SDS cycles. In the third run all steps were carried 
out at 45 °C and the nerves were subjected to two SDS cycles. Table 4.2 
summarises the decellularisation runs carried out on the femoral nerves.   
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Table 4.2 Summary of the decellularision runs carried out on the femoral nerves 
4.4.1.1 Results of the decellularised femoral nerves  
Characterisation of the femoral nerves decellularised using the methods 
summarised in Table 4.2 was undertaken by analysing their tissue structure by 
staining them with haematoxylin & eosin. Presence of cell nuclei within the tissue 
was detected with DAPI labelling. Decellularisation of femoral nerves using 
method 1 revealed the presence of cell nuclei within the endoneurium (Figure 4.2 
D). Haematoxylin & eosin staining revealed an intact histioarchitecture when 
compared to native controls (Figures 4.2 A and B). Figure 4.2 B shows the presence 
of the nerve fascicles with an intact endoneurium and surrounding perineurium. 
There is a however a loss of surrounding epineurial connective tissue in the 
decellularised nerve.   
 
 
 
 
 
 
 
 
 
 
 
 
Method Nerve 
type 
SDS 
cycles 
Incubation 
temp (°C) 
Agitation 
speed (rpm) 
Nuclease 
Cycles 
1 Femoral  
2 37 120 2 
2 Femoral  3 42 120 2 
3 Femoral  2 45 120 2 
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Figure 4.2. Decellularisation of porcine femoral nerve at 37°C. Haemotoxylin and eosin (A and 
B) and DAPI staining (C and D) of native and acellular femoral nerves . H&E of acellular femoral 
nerve revealed retention of nerve fasicles along with the connective  tissue  stained in pink and cell 
nuclei in blue, there was some noticable loss of connective tissue surrounding the the epineurium 
and within the endoneurium as indicated by the arrows  (B). DAPI staining of native nerve shows 
presence of cells predominatly around the perineurium and within the endoneurium, with some cells 
present in the epineurium (C). DAPI staining revealed presence of cells in endoneurium seen in 
blue (D). Scale bar at  500 µm. Nuclei were imaged using an upright fluorescent microscope using 
a DAPI filter (λex = 300 nm / λem = 550 nm)  
 
Decellularisation of femoral nerves using method 2 saw no presence of cell 
nuclei following DAPI labelling (Figure 4.3 B).  However, this process resulted in 
the degradation of the tissue architecture, and its connective tissues. The 
endoneurium is not as compact and the fascicles have lost parts of the perineurium 
layer.  There is also a notable loss of surrounding epineurial connective tissue 
(Figure 4.3 A).  
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Figure 4.3. Decellularisation of porcine femoral nerve using increased SDS cycles.  
Haemotoxylin and eosin staining showed disruption of collagen fibrils within the endoneurium and 
loss of surrounding perineurium around the fascicles. There was a notable loss of surrounding 
epineurial tissues in the acellular femoral nerve (A); DAPI labelling showed no evidence of cell 
nuclei which is usually seen in blue. The structure of the nerve tissue is seen in green (B). Scale bar 
at 500 µm. Nuclei were imaged using an upright fluorescent microscope using a DAPI filter (λex = 
300 nm / λem = 550 nm). Structure of tissue in green is the natural autofluorescence of the tissue 
when imaged under a fluorescent microscope 
Decellularisation of femoral nerves using method 3 saw the complete destruction 
of the nerve architecture revealed by haematoxylin and eosin staining as a result of 
the increased temperature (Figure 4.4). Further analysis of the tissue was not 
possible due to the quality of the tissue.  
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Figure 4.4. Decellularisation of porcine femoral nerve using increased temperature. 
Haematoxylin and eosin labelling of figure B and C show a complete loss of the nerves connective 
tissue when compared to the native nerves structure (A). Scale bars at 500 µm and 200 µm 
4.5 Removal of fat from femoral nerve 
It was proposed the reason for the poor decellularisation of porcine femoral nerves 
was due to the large amount of fat present.  This fat could be reducing the diffusion 
of decellularisation solutions throughout the nerves.  Sections of native femoral 
and acellular nerves were stained using Oil Red O, to locate regions of fat and 
adipocytes. The Oil Red O stain revealed a large presence of fat globules within 
the internal structure of the nerves, which stained a reddish-orange colour (Figure 
4.5 A). In the acellular nerve there was a notable loss of lipids (Figure 4.5 B). 
Following decellularisation macroscopic observations indicated a large volume of 
external fat and connective tissue still surrounding the nerves (Figure 4.5 C).  
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Figure 4.5. Femoral nerve contained a large amount of adipose tissue. Internal structure of 
native femoral nerve stained with Oil Red O revealed large globules of lipid (red) surrounding the 
tissue (blue) (A).  Internal structure of decellularised femoral nerve stained with Oil Red O showing 
loss of lipids after decellularisation (B). An acellular femoral nerve showing large amount of 
external fat and connective still present (C). Scale bar at 500µm and 10 mm.  
 
An investigation was carried out to evaluate a method to remove the fat 
from femoral nerves prior to decellularisation. Femoral nerves were submerged for 
two hours in individual containers containing 200 mL of hexane, acetone or 
chloromethanol (2:1 ratio) under agitation at 120 rpm.  Each sample was washed 
three times using PBS-EDTA solution for 15 minutes.  Sections of each solvent 
treated nerve were evaluated histologically.  Haematoxylin & eosin staining 
demonstrated all three solvents had a destructive effect on the tissue structure, 
albeit less so in the acetone solution (Figure 4.6). 
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Figure 4.6. Removal of fat from femoral nerves.  Nerves immersed in acetone (A and D) show 
retention of structure, however nerve fascicles have lost their shape. Nerves immersed in 
chloromethanol (B and E) and hexane (C and F) show complete destruction of tissue architecture. 
Tissue structure shown in pink and cell nuclei in blue. Figures A-C at x10 magnification and D-F 
at x20 magnification Scale bar at 100 µm and 200 µm. 
4.6 Decellularisation of sciatic branches and sural nerves  
Due to difficulties in the decellularisation of porcine femoral nerves, the sciatic 
branches (tibial and peroneal) and sural nerves were used. All steps of the following 
decellularisation processes were carried out at 42 °C and the nuclease step carried 
out at 37 °C unless otherwise stated. 
4.6.1 Method for the decellularised sciatic branches and sural nerves  
After freeze thaw and disinfection, the sural and sciatic branches nerves were 
washed in 200 mM EDTA solution for 24 hours at 4 °C. The nerves were then 
subjected to three cycles of hypotonic buffer in the presence of aprotinin at 42 °C 
for 24 hours with one of the buffers containing 0.1 % (w/v) SDS. The nerves were 
then washed with PBS and 0.1 % (w/v) EDTA containing aprotinin for 48 - 56 
hours at 4 °C.  The nerves were subjected to one cycles of hypotonic buffer 
containing 0.1 % (w/v) SDS for 24 hours and were then washed three times in PBS 
at 42 °C for 30 minutes each time before being further washed in PBS overnight. 
200 µm 
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The following day the nerves were incubated in two nuclease cycles for three hours 
at 37 °C at 50 rpm agitation for each cycle. Each nerve was then washed three times 
in PBS at 42 °C for 30 minutes each time before being further washed in PBS 
overnight. The nerves were then washed in hypertonic buffer at 42 °C and 
incubated for 24 hours with agitation. The nerves were washed three times in PBS, 
30 minutes each time at 37 °C before being sterilised with 0.1 % (v/v) peracetic 
acid in PBS for three hours at room temperature (20 - 25°C) with agitation. Nerves 
were then washed a further three times in sterile PBS at 37°C for 30 minutes each 
with agitation and stored in the fridge at 4 °C.  
In method 4 the nerves were subjected to two cycles of SDS and in method 
5 three cycles of SDS was applied to the nerve samples. Table 4.3 summarises the 
variables for decellularisation method 4 and 5. 
 
 
 
 
 
 
 
 
 
Table 4.3 Summary of the decellularisation runs carried out on the sural and sciatic 
branches  
4.6.2 Results of the decellularised sciatic branches and sural nerves  
Haematoxylin & eosin staining of decellularised sural nerve and sciatic branches 
showed retention of the nerve fascicles and connective tissue when both 
decellularisation processes were applied. The use of SDS does cause damage to the 
connective tissues; however, this was noticeable less with the two SDS cycles.  
There was more pronounced damage and loss of connective tissue in the 
endoneurium and surrounding epineurium tissue when a three SDS cycle process 
was used (Figures 4.7 G and H). Under higher magnification it was also discovered 
that there were fewer and less compact collagen fibres within the endoneurium after 
three SDS washes (Figure 4.7 (I).  Despite the fact that two different nerve types 
were used (sciatic nerve branches and sural nerve) no cell nuclei were visible in 
Method Nerve 
type 
SDS 
cycles 
Incubation 
temp (°C) 
Agitation 
speed (rpm) 
Nuclease 
Cycles 
4 Sural  2 42 240 2 
Sciatic 
branches 
2 42 240 2 
5 Sural  3 42 240 2 
Sciatic 
branches 
3 42 240 2 
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either nerve type for both decellularisation protocols (Figure 4.8 and 4.10). This 
demonstrates that the decellularisation process can efficiently remove cells for 
nerves of all sizes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Decellularisation of sural nerve with two and three cycles of SDS. Haematoxylin and 
eosin of native sural nerves (A-C); Method 4 shows retention of nerve structure and connective 
tissue in the acellular sural nerves after decellularisation with two SDS cycles (D-F); Method 5 
shows retention of nerve structure and connective tissue in the acellular sural nerves after 
decellularisation with three SDS cycles (G-I). There was noticeable damage to the nerves 
endoneurium as indicated by the arrows (H) as well as loss of collagen within the endoneurium (I). 
Scale bar at 500 µm, 200 µm and 100 µm respectively. 
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Figure 4.8. Cells removed in both decellularisation runs. DAPI labelling showed no evidence of 
nuclei in both decellurisation runs (B & C) when compared to the native nerve (A). Tissue structure 
shown in green and cell nuclei in blue. Nuclei were imaged using an upright fluorescent microscope 
using a DAPI filter (λex = 300 nm / λem = 550 nm). Structure of tissue in green in the natural 
autofluorescence of the tissue when imaged under fluorescent microscope. Scale bar at 200µm 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Decellularisation of sciatic branches with two and three cycles of SDS. 
Haematoxylin and eosin of native sciatic branches (A-C); Method 4 shows retention of nerve 
structure and connective tissue in the acellular sciatic branches after decellularisation with two SDS 
cycles (D-F); Method 5 shows retention of nerve structure and connective tissue in the acellular 
sciatic branches after decellularisation with three SDS cycles (G-I). There was noticeable damage 
to the nerves structure as indicated by the arrow (H) as well as loss of collagen within the 
endoneurium (I). Scale bar at 500 µm, 200 µm and 100 µm respectively. 
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Figure 4.10. Cells removed in both decellularisation runs. DAPI labelling shows no evidence 
of nuclei in both decellurisation runs (B&C) when compared to the native nerve (A). Tissue 
structure shown in green and cell nuclei in blue. Nuclei were imaged using an upright fluorescent 
microscope using a DAPI filter (λex = 300 nm / λem = 550 nm). Structure of tissue in green in the 
natural autofluorescence of the tissue when imaged under fluorescent microscope. Scale bar at 
200µm  
The DNA was extracted from native and acellular porcine sciatic branches using a 
commercially available kit and quantified using spectrophotometry at 260 nm. The 
results revealed a significant reduction in the sciatic branches (n = 3) when both 
decellularisation processes were applied (Figure 4.11). There was an 84 % (w/w) 
DNA reduction using two cycles of SDS and an 88 % (w/w) reduction using three 
cycles of SDS when compared to fresh samples (p<0.05, Students t-test). The sural 
nerve could not be analysed due to the difficulty in obtaining a large enough sample 
size to quantify. 
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Figure 4.11. DNA content of fresh and decellularised porcine sciatic branches determined by 
Nanodrop spectrophotometry. A significant reduction of 84% using two cycles of SDS and 88% 
reduction using three cycles of SDS compared to fresh tissue. Data was analysed using the unpaired 
Student’s t-test and is presented as the mean (n =3) ± 95 % C.I (p<0.0001****) 
4.7 Optimising the decellularisation of sciatic branches  
The previous results indicated that both the sural and sciatic branches have the 
capacity to be decellularised however further optimisation was required to reduce 
to DNA content within the tissue whilst maintaining its structure. Two 
decellularisation process were applied to samples of nerve, in both processes the 
nuclease cycles were doubled, however one was subjected to one SDS cycle whilst 
the other to two SDS cycles.  The sciatic branches were chosen as the predominant 
nerves to be used throughout the study due to ease of procurement. 
4.7.1 Method for the optimised acellular sciatic branches  
After freeze thaw and disinfection, the sciatic branches nerves were washed in 200 
mM EDTA solution for 24 hours at 4 °C. The nerves were then subjected to three 
cycles of hypotonic buffer in the presence of aprotinin at 42 °C for 24 hours with 
one of the buffers containing 0.1 % (w/v) SDS. The nerves were then washed with 
PBS and 0.1 % (w/v) EDTA containing aprotinin for 48 - 56 hours at 4 °C.  The 
nerves were subjected to one cycles of hypotonic buffer containing 0.1 % (w/v) 
SDS for 24 hours and were then washed three times in PBS at 42 °C for 30 minutes 
each time before being further washed in PBS overnight. The following day the 
nerves were incubated in two nuclease cycles for three hours at 37 °C at 50 rpm 
agitation for each cycle. The nerves were then washed overnight in PBS at 42 °C. 
The following day the nerves were again incubated in two nuclease cycles for three 
hours at 37 °C at 50 rpm agitation for each cycle.  Each nerve was then washed 
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three times in PBS at 42 °C for 30 minutes each time before being further washed 
in PBS overnight. The nerves were then washed in hypertonic buffer at 42 °C and 
incubated for 24 hours with agitation. The nerves were washed three times in PBS, 
30 minutes each time at 37 °C before being sterilised with 0.1 % (v/v) peracetic 
acid in PBS for three hours at room temperature (20 - 25°C) with agitation. Nerves 
were then washed a further three times in sterile PBS at 37°C for 30 minutes each 
with agitation and stored in the fridge at 4 °C.  
In method 6 the nerves were subjected to one cycle of SDS and in method 
7 two cycles of SDS was applied to the nerve samples. Table 4.4 summarises the 
variables for decellularisation method 6 and 7. 
 
 
Table 4.4 Summary of the decellularisation runs carried out on the sciatic branches. 
4.7.2 Results of the optimised decellularisation for the sciatic branches 
Haematoxylin & eosin staining   revealed that both processes preserved the native 
nerve structure with intact fascicles, perineurium and epineurial connective tissue 
(Figure 4.12). Higher magnification of fascicles revealed damage to collagen 
within the endoneurium when method 7 was used (Figure 4.12 F) compared to 
method 6 (Figure 4.12 G). This showed that method 6 was more effective in 
retaining the native nerve structure. DAPI   revealed no cell nuclei or whole cells 
in both methods (Figure 4.13). This result provided evidence of removal of cells 
from porcine sciatic branches after both decellularisation runs.  
 
 
 
 
 
Method Nerve 
type 
SDS 
cycles 
Incubation 
temp (°C) 
Agitation 
speed (rpm) 
Nuclease 
Cycles 
6 Sciatic 
branch 
1 42 240 4 
7 Sciatic 
branch 
2 42 240 4 
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Figure 4.12 Decellularisation of sciatic branches with one and two cycles of SDS and extra 
nuclease wash. Method 6 showed good retention of nerve structure and connective tissues in the 
acellular sciatic branches after decellularisation with two SDS cycles (A-C); Method 7 showed 
retention of nerve structure and connective tissue in the acellular sciatic branches after 
decellularisation with three SDS cycles (D-F), however there was notable damage to the collagen 
in the endoneurium indicated by the arrow (F). Scale bar at 500 µm, 200 µm and 100 µm 
respectively. 
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Figure 4.13. Cells removed in both decellularisation runs. DAPI labelling showed no evidence 
of nuclei in Method 6 using one SDS cycle (D-F) and Method 7 using two SDS cycles (G-I) when 
compared to the native nerve which has cells within the endoneurium and around the 
perineurium(A-C). Each image shows the transverse sections of the nerve fascicles. Tissue structure 
shown in green and cell nuclei in blue. Nuclei were imaged using an upright fluorescent microscope 
using a DAPI filter (λex = 300 nm / λem = 550 nm). Structure of tissue in green in the natural 
autofluorescence of the tissue when imaged under fluorescent microscope. Scale bar at 100µm  
 
Quantification of DNA extracted from native and acellular porcine sciatic branches 
revealed a significant reduction in the sciatic branches (n = 3) in both 
decellularisation processes (Figure 4.14). There was a 95 % DNA reduction using 
one cycle of SDS and a 94 % reduction using two cycles of SDS, when compared 
to native samples (p < 0.0001, Students t-test). 
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Figure 4.14. DNA content of native and acellular porcine sciatic branches determined by 
Nanodrop spectrophotometry. The DNA was extracted from the tissue using a DNeasy blood and 
tissue kit. The extracted DNA samples were loaded onto a Nanodrop and read at an absorbance of 
260 nm. Results showed a significant reduction of 95% using one cycle of SDS and 94% reduction 
using two cycles of SDS compared to native tissue. Data was analysed using an unpaired students 
t-test and is presented as the mean (n =3) ± 95 % C.I (p < 0.0001****) 
4.7.3 Summary of the decellularisation method development for porcine 
peripheral nerves 
In this study three types of peripheral nerves (femoral, sural and sciatic branches) 
were assessed using seven methods. Each method used the steps shown in Figure 
4.1; however, the variables included a change in nerve type, temperature, agitation 
speed as well as the number of SDS and nuclease cycles. Table 4.5 summarises the 
experimental variables for each decellularisation run and the effects on the nerve 
tissue. Table 4.6 summarises the amount of DNA removed from methods 4 - 7.  
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     Table 4.5. Summary of experimental variables investigated to optimise peripheral nerve decellularisation
Method Nerve type SDS cycles Incubation temp 
(°C) 
Agitation 
speed (rpm) 
Nuclease 
Cycles 
Results 
1 Femoral  2 37 120 2 Cells found in the endoneurium 
2 Femoral  3 42 120 2 Cells removed but structure was 
damaged 
3 Femoral  2 45 120 2 Complete destruction of tissue 
4 Sural  2 42 240 2 Retention of structure and DAPI 
staining revealed no cells 
Sciatic 
branches 
2 42 240 2 Retention of structure. DNA assay 
revealed 84 % cell reduction 
5 Sural  3 42 240 2 Retention of structure albeit more 
damage due to increased SDS cycle.  
Sciatic 
branches 
3 42 240 2 Retention of structure albeit more 
damage due to increased SDS cycle. 
DNA assay revealed 88 % cell reduction 
6 Sciatic 
branches 
1 42 240 4 Retention of structure. DNA assay 
revealed 95 % cell reduction 
7 Sciatic 
branches 
2 42 240 4 Retention of structure albeit more 
damage due to increased SDS cycle. 
DNA assay revealed 94 % cell reduction 
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Table 4.6 Summary of DNA removal from decellularisation processes. DNA content of native 
(n = 6) and acellular (n = 6) porcine sciatic branches determined by Nanodrop spectrophotometry 
at 260 nm (mean ± 95 % C.I.) and percentage of DNA removal after decellularisation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Method DNA content of fresh 
tissue (ng.mg-1) 
DNA content of 
decellularised tissue 
(ng.mg-1) 
Percentage of 
DNA removed 
(%) 
4 325 ± 27.61 52.07±7.75 84 % 
5 325 ± 27.61 38.84±6.95 88 % 
6 698.40 ± 95.73 36.53 ± 10.72 95 % 
7 698.40 ± 95.73 43.85±7.03 94 % 
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4.8 Discussion 
The aim of the work presented in this Chapter was to develop a process for the 
decellularisation of porcine peripheral nerve, which eliminated the cellular content 
within the tissue whilst retaining the native histioarchitecture. 
The decellularisation procedure developed used a combination of chemical 
and enzymatic treatments, based on the process developed by Wilshaw et al (2012) 
and modified for porcine peripheral nerve (Wilshaw, Rooney et al. 2012) . The first 
step of the process was a single freeze-thaw cycle to open up the tissue ECM, 
increasing the susceptibility of subsequent decellularisation reagents. The nerves 
were disinfected and then exposed to a solution of 200 mM EDTA. EDTA inhibits 
matrix metalloproteases as well as chelating divalent metal ions (in particular such 
as Ca2+), which disrupts cell attachment to the ECM by interfering with the integrin 
secondary structure and consequent binding (McFetridge, Daniel et al. 2004).  
This was followed by sequential incubation in hypotonic Tris buffer to lyse 
the neuronal and glial (Schwann) cells and 0.1 % (w/v) SDS in hypotonic buffer. 
SDS is widely considered to be an excellent decellularisation agent effectively 
removes DNA remnants and cytoplasmic proteins by solubilising the lipid bi-layer 
of the cells and forming micelles around the cell membrane and its proteins. SDS 
has been shown to retain the structure of the nerves important ECM components 
such as the basal lamina, laminin and fibronectin  (Wakimura, Wang et al. 2015; 
Wang, Itoh et al. 2015). 
A nuclease step was incorporated with the addition of Benzonase, a 
nuclease which degrades both DNA and RNA followed by a wash in hypertonic 
buffer which was used to further remove cellular proteins. The activation of 
proteases in natural tissues during decellularisation can lead to extensive autolysis 
of ECM proteins and can cause major damage to the structure and function of the 
scaffold (Bodnar et al., 1986; Courtman et al., 1994; Pachence, 1996, Walles et al., 
2003). Aprotinin, a serine protease inhibitor was therefore incorporated to preserve 
the ECM components in all stages of decellularisation apart from prior to and 
during nuclease treatment in order to not compromise the action of nuclease 
enzymes. 
Sterilisation of the tissue was carried out using 0.1 % (v/v) peracetic acid 
for three hours followed by extensive washing in PBS to remove residual SDS. 
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Peracetic acid is a commonly used disinfection agent, widely used to disinfect 
surgical instruments due to excellent anti-viral properties (Rutala and Weber 2004) 
in addition to doubling up as a decellularisation agent (Gilbert, Sellaro et al. 2006). 
The femoral nerve was the first nerve to be identified due to its large size 
and easy location within the porcine leg. All three decellularisation methods for the 
femoral nerve were limited in their ability to eliminate the cell content, whilst 
preserving the tissue architecture. Method 1, a decellularisation protocol developed 
for porcine carotid arteries used a mild treatment which retained the nerves native 
structure; however, the presence of cells was still seen in the nerves endoneurium. 
Method 2 was based on the decellularisation of bovine carotid arteries saw an 
elimination of cells from the tissue however the increase in SDS cycles severely 
damaged the nerve fascicles. Method 3 saw the complete destruction of the tissue, 
most likely due to the increase in the temperature.  
Throughout all the decellularisation runs carried out on the femoral nerve 
the decellularised femoral nerves still contained a large amount of external fat and 
connective surrounding the tissue which may have prevented the chemical and 
enzymatic treatments from fully penetrating into the tissue structure. Adipose 
tissue in general plays a functional role in protecting nerves. Nerves which are 
subjected to high pressure and strain such as the femoral and sciatic nerves contain 
a higher portion of adipose tissue to protect the nerve by cushioning the fasciculi 
(Sunderland 1945). Native and decellularised nerves were stained with Oil Red O 
to deduce whether internal lipids within the tissue were also preventing the nerve 
from being successful decellularised. Histological characterisation of the native 
nerve showed large deposits of lipids shown in orange; however, for the 
decellularised nerve there were no signs of lipids.  The removal of lipids after 
decellularisation have been shown in porcine adipose tissue (Brown, Freund et al. 
2011) and adult and rat omentum (Porzionato, Sfriso et al. 2013).  
To try and eliminate the external fat from the femoral nerve the tissues were 
immersed in alcohols as they are known to remove the insoluble lipids from tissue 
(Flynn 2010; Brown, Freund et al. 2011). Femoral tissues were immersed into three 
different alcohol solvents which included chloromethanol, acetone and hexane. 
These solvents have all been used in previous decellularised studies to remove lipid 
in biological tissues such as porcine dermis, cartilage and omentum (Baldoni, 
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Bolognani et al. 1994; Yang, John et al. 2007; Lumpkins, Pierre et al. 2008; 
Prasertsung, Kanokpanont et al. 2008; Montoya and McFetridge 2009). 
Chloromethanol is formed from a chloroform-methanol mixture. The 
chloroform extracts mainly neutral lipids such as triglycerides whilst methanol 
extracts cell-membrane lipids such phospholipids, glycoproteins and cholesterol 
(Ferraz, Fiuza et al. 2004). Acetone which is polar solvent selectively removes 
hydrophobic lipids (Bancroft and Gamble 2008) whilst hexane which in non-polar 
solvent also removes neutral lipids such as triglycerides (Ferraz, Fiuza et al. 
2004).From our results  all of these solvents damage the ECM of the nerve tissue. 
Chloromethanol and hexane completely destroy the nerves ECM structure whilst 
the acetone is less damaging to the structure. Previous studies have reported 
damage to the ECM ultrastructure (Cole 1984) as well as precipitation of proteins 
(Jamur and Oliver 2010) using these alcohols. The use of alcohol solvents to 
eliminate to external lipid content of the femoral nerve tissue proved unsuccessful. 
The solvents damaged the internal structures of the nerves making them inadequate 
as a nerve graft.  
From these previous experiments it was deduced that the optimal 
temperature for nerves to be decellularised is at 42 °C and that it may be more 
feasible to choose a nerve which did not contain so much surrounding connective 
and fat tissue. The study focus subsequently shifted towards using smaller 
peripheral nerves such as sural nerve and the branches of the sciatic nerve. Sural 
nerves have been used as an autograft in patients and decellularised xenogeneic 
sural through cold preservation (Hess, Brenner et al. 2007) and peroneal/tibial 
nerves through chemical extraction (Hu, Zhu et al. 2007) have been used as 
scaffolds in tissue engineering applications.  
Methods 4 & 5 comprised of incubating the sural and peroneal / tibial 
nerves (sciatic branches) at 42 °C with increased agitation. In method 4 the nerves 
were subjected to two cycles of SDS whilst in method 5 they were subjected to 
three. Histological evaluation showed retention of the fascicles and the connective 
tissues for both methods. Nonetheless damage to the fascicles as well as loss of 
collagen within the endoneurium was more evident for method 5; this was not 
unexpected as SDS can cause damage to ECM components such as collagen. The 
quantification assay does show a slightly lower DNA content in method 5, most 
likely attributed by the extra SDS cycle. Nevertheless, when considering the 
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damage SDS does to the structure as well as the increased chance of residual SDS 
being retained in the tissue it was decided that increasing the SDS cycles was not 
an efficient way of removing cells whilst trying to maintain the nerves 
histioarchitecture.  
Methods 6 & 7 solely concentrated on the sciatic branches due to ease of 
procurement and availability. The nuclease cycle was doubled for both processes 
and the SDS cycles were reduced to one and two respectively. Haematoxylin and 
eosin and DAPI stained images showed no evidence of cell presence in the 
decellularised tissue, indicating the removal of cells. Haematoxylin and eosin 
staining showed that both decellularisation runs managed to retain the native nerve 
structure. In both processes the fascicles as well as the connective tissues were 
maintained.  Evidence of damage was more evident in the nerves subjected to two 
cycles of SDS which caused more extensive damage to the collagen within the 
endoneurium.  This may be due to the cells being predominantly located within the 
endoneurium.   
Both methods achieved the criteria defined by Crapo et al (2011) in terms 
of removal of cells from the tissue and a 95 % DNA reduction was made possible 
with just one SDS cycle.  This DNA reduction value is comparable to the Sondell 
method and Hudson method whose overall reduction in cell content was 98 % 
(Sondell, Lundborg et al. 1998) and 97 % (Hudson, Liu et al. 2004), respectively. 
It is important to note that the Hudson study was carried out on rat sciatic nerve 
and analysed for removal of cellular protein whilst our study used porcine nerves 
and quantified total DNA content (single and double stranded DNA) in the tissue. 
Further characterisation of the decellularised sciatic branches according to Method 
6 will be discussed in the subsequent chapter. This will include the effects our 
decellularisation process has on the nerves ECM and how it compares to other 
methods.    
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4.9 Conclusions 
A decellularisation method for porcine peripheral nerves was developed based on 
the original method described by Wilshaw et al. (2012).  Several methods were 
tried and tested on different segments of peripheral nerves found in the lower limb. 
It was deduced that sural and sciatic branches (peroneal/tibial) can be successfully 
decellularised. The sciatic branches were however chosen solely as the nerves to 
be used throughout the study for consistency. The sciatic branches were selected 
due to their size, ease of procurement and the availability of the tissue. Unlike the 
femoral and sciatic nerve, the sciatic branches are smaller and contain less 
surrounding adipose tissue which makes it easier for the decellularisation solutions 
to penetrate into the tissue and remove the cells. The study has also demonstrated 
that porcine sural nerve may also be efficiently decellularised. Nonetheless there is 
a limited amount of sural tissue which can be obtained from the porcine leg, making 
it difficult to use for certain experimental analysis such as DNA quantification. 
The optimised decellularisation process (Method 6) consists of the nerves 
being subjected to four nuclease cycles and one SDS cycle at a temperature of 42 
°C with agitation. Histological characterisation revealed overall better retention of 
the nerve fascicles, along with its connective tissues, most likely due to the use of 
only one SDS cycle. The DNA quantification assay revealed a 95 % DNA 
reduction, which adheres to the decellularisation criteria as well as being 
comparable to the established Sondell and Hudson protocol. Further evaluation of 
the decellularisation method will be discussed in Chapter 5. 
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Chapter 5. Characterisation of Native and Acellular Porcine 
Peripheral Nerves 
 
5.1 Introduction 
A successful decellularisation process should be able to produce an acellular 
scaffold which retains its native architecture and be devoid of cells. A 
decellularisation process has the capacity to alter the native histioarchitecture, 
biocompatibility, strength and composition of the extracellular matrix (ECM) and 
its components. Therefore, if being used clinically it is vital to assess the effect of 
the process by undertaking biological characterisation and mechanical testing of 
the acellular nerve and comparing it to its native counterpart. 
Peripheral nerves consist of a three dimensional ECM and basal lamina. 
These are the non-cellular components of the nerve tissue that along with Schwann 
cells and axons comprise the endoneurium and form nerve fascicles. The ECM is 
a highly organised dynamic three dimensional network which is the product of 
resident cells (i.e. Schwann cells) such as proteins, glycoproteins and 
proteoglycans. The ECM provides structural support for tissues, cell layers and 
individual cells as well as fundamental cell processes such as cell growth, adhesion, 
migration, proliferation, differentiation and gene expression (Gao, Wang et al. 
2013) by sensing different environmental stimuli and providing specific inputs to 
the surrounding cells. In addition, the ECM captures and releases a wide range of 
growth factors.  In the peripheral nervous system (PNS) the three dimensional 
ultrastructure, surface topology and composition of the ECM provide precise 
guidance for axonal regeneration.  
The basal lamina is a Schwann cell product consisting of continuous 
laminin tubes (~10 μm diameter) embedded within the ECM. The basal lamina also 
contains important components such as fibronectin, collagen and proteoglycans, all 
of which help promote axonal outgrowth (Weinstein 1999). In peripheral nerve 
tissue, the important ECM components include collagen types - I, III and IV, 
laminin, fibronectin and chondroitin sulphate proteoglycans (CSPGs) (Gao, Wang 
et al. 2013). 
Collagen is a structural protein and is the main ECM constituent found in 
all three connective tissue layers within the PNS. Collagen type I and III together 
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constitute approximately 49 % of total protein in the nerves (Bunge, Bunge et al. 
1989). The collagenous matrix surrounds and protects individual axons and their 
Schwann cell sheaths from trauma (Lundborg 2004). In the PNS, two classes of 
collagen molecules are expressed; fibril forming collagens (types-I, III, and V) and 
basement membrane collagen (type-IV) (Koopmans, Hasse et al. 2009). Collagen 
I, the most predominant collagen in the human body, is localised primarily in the 
epineurium whilst collagen III is located within the endoneurium and perineurium.  
Whilst the bulk of fibril forming collagen is synthesized by fibroblasts, 
Schwann cells and perineurial cells secrete the non-fibrillar type IV collagen of 
basal lamina. Collagen IV is an important structural component of basement 
membranes, integrating ECM proteins such as laminin and perlican into a stable 
supramolecular aggregate (Hudson, Reeders et al. 1993), lining the outer aspect of 
endoneurial capillaries  as well as surrounding the processes of Schwann cells and 
perineurial cells (Alovskaya, Alekseeva et al. 2007).  
Laminins are glycoproteins, existing within the endoneurium and 
perineurium of the peripheral nerve (Palm and Furcht 1983), forming a major 
structural element of the basement membrane, the basal lamina (Timpl 1996). They 
are produced by Schwann cells and are distributed along the cell surface in a 
continuous band. Evidence suggests that Schwann cells require an organised basal 
lamina to properly ensheath and myelinate axons (Obremski, Johnson et al. 1993).   
Laminin plays many roles within the PNS including promoting neurite outgrowth 
and survival (Edgar, Timpl et al. 1984) such as laminin-2 (α2β1γ1) and laminin-8 
(α2β1γ1) which are important for postnatal nerve development and are upregulated 
for axonal regeneration after injury (Wallquist, Patarroyo et al. 2002). Laminin also 
provides attachment sites for cells via cell surface proteins (Palm and Furcht 1983) 
(Henry and Campbell 1996) as well as providing attachment points for  axons to 
extend and exert forces on the ECM (Laura, Leipzig et al. 2008). In addition, 
laminin act as a ligand for cell receptors (e.g. integrins), thereby initiating signals 
that influence cell behaviour and survival (Schwartz 2001). Cellular studies have 
also revealed laminin enhances neuronal cell survival (Edgar, Timpl et al. 1984) 
and guide growth cones (Dodd and Jessell 1988). A study conducted by Lein 1992 
also showed that laminin had the ability to enhance axonal growth using 
hippocampal neurons in culture (Lein, Banker et al. 1992).   
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Fibronectin is a cell surface associated glycoprotein produced by Schwann 
cells, predominantly located in the perineurium. It contains different functional 
domains that directly bind onto various molecules such as fibrin, collagen and 
heparin (White and Muro 2011) as well as two domains that support cell adhesion. 
One is the central cell-binding domain that is recognized by a variety of cell types 
via the integrin alpha 5 beta 1. The second  is located in the alternatively spliced 
type III connecting segment (IIICS) (Komoriya, Green et al. 1991). In the PNS 
neurons can extend neurites on the two domains (Humphries, Akiyama et al. 1988).  
Fibronectin plays a role in peripheral nerve repair as they promote Schwann cell 
growth and motility (Baron-Van Evercooren, Kleinman et al. 1982; Ahmed, 
Underwood et al. 2003).  
CSPGs are proteoglycans consisting of a protein core and a chondroitin 
sulphate side chain which are produced by Schwann cells. In the PNS they exist 
mainly in the basal lamina and ECM surrounding collagen fibrils (Aquino, 
Margolis et al. 1984). These proteoglycans have been implicated in the regulation 
of axonal growth, however it has been found that CSPGs bind to and inhibit the 
neurite-promoting activity of laminin. It has been observed that after a nerve injury 
there are markedly upregulated levels of inhibitory CSPGs levels which 
accumulate in the endoneurial tissue surrounding the Schwann cell basal laminae 
(Zuo, Hernandez et al. 1998); consequently CSPGs play a negative role in nerve 
regeneration.  
The decellularisation process can alter the ECM composition as well as the 
components of the nerve. The solutions used in the process such as sodium dodecyl 
sulphate (SDS) have been associated with ultrastructure disruption and GAG 
depletion (Kasimir, Rieder et al. 2003; Gilbert, Sellaro et al. 2006; Ott, Clippinger 
et al. 2010), whilst peracetic acid (PAA) treatment has been show to disrupt the 
collagen structure (Lomas, Jennings et al. 2004). It is therefore important to try and 
retain the significant ECM components. By doing so the acellular nerve can provide 
a suitable environment for cellular growth and nerve regeneration.  
The biocompatibility of any acellular scaffold is important whether it is to 
be used as a clinical graft or in vitro model.  Solutions used in the decellularisation 
process such as SDS detergent, EDTA, aprotinin and the PAA are known to be 
cytotoxic (Koulaouzidou, Margelos et al. 1999; Newby, Barr et al. 2000; Sagripanti 
and Bonifacino 2000). Therefore, to ensure that the reagents used in the 
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decellularisation protocol were adequately removed from the tissue in vitro 
cytotoxicity testing is carried out. 
Under normal physiological conditions nerves are exposed to various 
mechanical forces. These include tensile, compressive or shear stress or as a 
combination of stresses (Figure 5.1). Uniaxial tensile testing is a standard method 
used in the evaluation of the mechanical properties of biological tissues (Kwan, 
Wall et al. 1992; Millesi, Zoch et al. 1995; Borschel, Kia et al. 2003; Phillips, Smit 
et al. 2004). 
 
 
 
 
 
Figure 5.1. Physical stresses placed on peripheral nerve. Tensile stress applied longitudinally 
to the peripheral nerve creates an elongation of the nerve (and an increase in strain). The 
transverse contraction that occurs during this elongation is greatest at the middle of the 
section undergoing tensile stress. Reproduced from Topp and Boyd (2006)  
The mechanical behaviour of a nerve segment under longitudinal tensile force can 
be described by a standard stress-strain curve. The typical stress-strain behaviour 
of peripheral nerves has been illustrated in Section 2. When a load is first applied 
to a resting nerve the nerve lengthens markedly relative to the applied load, this is 
known as the “toe region” of the curve. As the tensile load increases the nerve 
elongates at a steady rate, demonstrated by the linear region of the stress-strain 
curve. This elongation is due to extension of the epineurium and straightening of 
the funiculi and of the nerve fibres. Such elongation is “physiological” in the sense 
that it does not affect the nerve fibres (Haftek 1970). The slope of this portion of 
the curve is a measure of the resistance of the nerve to deformation and is known 
as the Young’s Modulus or modulus of elasticity. A steep slope indicates that the 
nerve has more stiffness and less elasticity whilst a shallower slope shows that the 
nerve is more compliant.  
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At a certain point the amount of applied load starts to permanently deform 
particular elements of the nerve. This ultimate stress or ultimate strain represents 
the transition between the recoverable (elastic) strain and plastic (permanent) 
deformation areas of the stress-strain curve. In the plastic region of the curve the 
nerve reaches its ultimate elongation and undergoes mechanical failure (Topp and 
Boyd 2006). 
Minor increases in tensile load create significant elongation of the nerve 
because of the failure of the infrastructure of the nerve, including perineurial 
components. There are fewer intact structural elements to provide resistance and at 
this point the nerve behaves like a viscous material (Haftek 1970).  
Decellularisation solutions applied to biological tissues have been shown to 
affect the mechanical properties of the ECM (Courtman, Pereira et al. 1994; 
Palsson BO 2004). In terms of nerve repair any change in biomechanical properties 
can impede the regeneration of the nerve.  Properties such as stiffness must be 
equivalent with their native counterpart so as to resist in vivo physiological loads 
during nerve regeneration. In addition, the nerve scaffold must be flexible to allow 
bending without kinking. It is important to have a balance between stiffness and 
flexibility as scaffolds that are too stiff can easily become dislocated and scaffolds 
which are too flexible fail to support axonal regeneration (So and Xu 2015). It is 
therefore important to study the effect these solutions have on the biomechanical 
properties of the acellular tissue.  This can be achieved by uniaxial tensile testing 
the acellular nerve and comparing them with their native counterpart. 
The acellular porcine peripheral nerves used in all of the studies in this 
chapter were produced using decellularisation Method 6 (described in Section 4.3). 
In this chapter the acellular nerves were assessed in terms of their retention of key 
ECM components, in vitro biocompatibility and mechanical integrity.  
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5.2 Aims and objectives 
Aims: 
The aim of this Chapter was to investigate the effects of a newly developed 
decellularisation process on porcine peripheral nerves 
Objectives: 
 To determine the effects of decellularisation on the presence of specific ECM 
proteins by comparison with native porcine peripheral nerves 
 To determine the biocompatibility of the acellular scaffold using in vitro techniques 
 To determine the effects of decellularisation on the biomechanical properties by 
comparison with native porcine peripheral nerves 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
138 
 
5.3 Methods 
Decellularisation of porcine sciatic branches (peroneal and tibial nerves) nerves 
was performed according to the methodology described in in Section 4.3 (Method 
7).  The sciatic branches (5cm) and sural nerve (3cm) were subject to 
decellularisation (n =3) and were used for histology. Acellular sciatic branches (n 
=3) were also used for immunohistochemistry, biochemical and contact 
cytotoxicity analysis. The peroneal (10cm) and tibial (10cm) were subject to 
decellularisation (n =3) and were used for mechanical testing. 
5.3.1 Histological staining 
Specific histological stains were used to determine the histioarchitecture of the 
decellularised porcine peripheral nerves and locate specific ECM components. 
Native and acellular nerves were fixed with 3.7 % (v/v) formaldehyde for 24 hours 
and embedded into paraffin wax as described in Section 2.2. Tissue sections of 6 - 
10 μm were prepared transversely and collected onto glass slides. The following 
stains were used: Picro Sirius red / Miller’s elastin stain, a single stain, was used to 
identify the distribution of collagen and elastin in the tissue. Reticulin stain for 
collagen III and Alcian blue PAS stain to localise GAG`s in tissue. The slides were 
viewed using an upright microscope under either Khöler or polarised illumination. 
5.3.2 Biochemical assays  
Samples of native (n = 6) and acellular (n= 6) porcine sciatic branches were 
lyophilized to a constant weight prior to biochemical assay collagen and sulphated 
GAG content. Each sample consisting of 100 mg tissue were macerated with a 
scalpel blade and placed in a sterile 1.5 mL microcentrifuge tube. The samples were 
then freeze-dried; the mass of each sample was recorded daily until a consistent 
weight was achieved (approximately 25 mg).  
5.3.2.1 Glycosaminoglycan (GAG) quantification of porcine peripheral nerves 
A modified GAG assay according to (Farndale, Buttle et al. 1986) was used to 
quantify the amount of sulphated GAGs present in tissue following 
decellularisation. The assay is based  on changes in the absorption spectrum of the  
cationic dye 1,9-dimethylmethylene blue (DMB dye) when bound to sulfated 
GAGs to form a complex (Farndale, Buttle et al. 1986). The amount of GAGs 
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present was determined by comparing the proteoglycan levels in the native tissue 
to the acellular tissue.  
Papain was used to digest lyophilized samples by adding 5 mL of 50 U. 
mL-1 papain digestion solutions (1250 Units of papain in 25 mL of digestion 
buffer; 5 mM L-cysteine hydrochloride; 5 mM Na2EDTA).  
Samples were incubated for 36 - 48 hours in an oven at 60 °C and diluted 
1:50 in GAG assay buffer (68.5 mL of 0.1 M sodium di-hydrogen orthophosphate 
and 31.5 mL 0.1 M di-sodium hydrogen orthophosphate). The pH was adjusted to 
6.8 so that the absorbance of the unknown falls within the linear region of the 
standard curve.  
GAG assay standards were prepared by diluting the primary standard (10 
mg Chondroitin sulphate B in 10 mL GAG assay buffer) to known concentrations: 
 
Standard concentration 
(µg. mL-1) 
Volume of primary 
standard (µL) 
Volume of buffer (µL) 
200 40 160 
150 30 170 
100 12 180 
50 10 190 
25 5 195 
12.5 5 395 
6.25 5 795 
3.125 5 1595 
0 0 250 
Table 5.1 Table of GAG assay standards 
40µL of each standard, blank (GAG assay buffer only) or tissue samples 
were added to a clear flat-bottomed 96 well plate and 250 µL of DMB dye solution 
(0.008 mg 1,9 dimethylene blue in 2.5 mL ethanol, 1 mL of formic acid and 1 g of 
sodium formate; volume made up to 500 mL using distilled water and pH adjusted 
to 3.0) was added to each well and rocked slowly for two minutes on a plate rocker. 
Sample optical density was measured using a micro plate spectrophotometer at 525 
nm. The blank values (GAG assay buffer) were subtracted from all standards and 
tissue samples and a standard curve of chondroitin sulphate B concentration against 
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absorbance was created using GraphPad Prism. The unknown values were 
interpolated using a linear regression of the standard curve.   
5.3.2.2 Quantification of hydroxyproline content in porcine peripheral nerves 
A hydroxyproline assay was carried out to determine the total remaining collagen 
remaining in tissue following decellularisation by comparing the hydroxyproline 
(amino acid found in collagen tripeptide) levels in native and acellular nerves. The 
procedure adopted was based on the method described by Woessner and 
subsequently modified by (Edwards and O'Brien 1980). This assay is centered on 
the oxidation of hydroxyproline by chloramine - T (sodium N-chloro-p-toluene 
sulfonamide) which reacts with p-dimethylaminobenzaldehyde to form a 
chromophore that can be measured at 570 nm (Stegemann and Stalder 1967).  
Prior to the assay the tissue samples were hydrolysed (hydrolysis of peptide 
bound hydroxyproline) in 5 mL of 6 M hydrochloric acid at 120 ˚C for four hours. 
For the assay a series of known concentrations was made up using primary and 
secondary standards. The primary standard was prepared by adding 25 mg trans-4-
hydroxyproline in 25 mL assay buffer (13.3 g citric acid, 3.2 mL glacial acetic acid, 
32 g sodium acetate, 9.1 g sodium hydroxide and 80 mL propan-1-ol in 400 mL 
distilled water with pH adjusted to 6.0 - 6.5 using 6 M HCL). The secondary 
standard was prepared by diluting 1 mL of the primary standard in 9 mL assay 
buffer.  
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Standard concentration 
(µg. mL-1) 
Volume of secondary 
standard (µL) 
Volume of buffer (µL) 
30 750 1750 
25 625 1875 
20 500 2000 
15 375 2125 
10 250 2250 
8 200 2300 
6 150 2350 
4 100 2400 
2 50 2450 
0 0 2500 
Table 5.2 Table of hydroxyproline assay standards 
50 µL of each standard and acid hydrolysed test solutions (diluted 1:20 in 
assay buffer so that readings fall within the range of the assay) were added to a 
clear flat-bottomed 96 well plate. 100 µL Chloramine T solution (1.41 g chloramine 
T in 100 mL distilled water) was added to each well and the plate was shaken for 
5 minutes at 60 rpm on a shaker. 100uL Ehrlich’s reagent (7.5 g p-
dimethylaminobenzaldehyde), 30.0 mL propan-1-ol, 13.4 mL 60 %; v/v 
perechloric acid and 6.6 mL distilled water) was added to each well and the plate 
was incubated at 60 ˚C for 45 minutes. The optical density of each well was 
determined at 570 nm using a micro plate spectrophotometer, which measured the 
optical densities. The blank values (assay buffer) were subtracted from all 
standards and tissue samples and a standard curve of hydroxyproline concentration 
against absorbance was determined by interpolation from a trans-4-hydroxy-L-
proline standard curve. The total collagen content was calculated by using a 
hydroxyproline to collagen ratio of 1: 7.69 (Ignat'eva, Danilov et al. 2007). 
5.3.3 Immunohistochemical evaluation of acellular peripheral nerves 
Laminin and fibronectin proteins were localised using fluorescent 
immunolabelling. (Table 5.3). Native and acellular nerve samples were fixed using 
3.7 % (v/v) formalin and embedded into paraffin wax; each sample was sectioned 
at 6 - 10 μm. Sections were permeabilised with 0.1 % (v/v) Triton X-100 diluted in 
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PBS for 20 minutes. Samples were then incubated with 7.5 % (w/v) bovine serum 
albumin diluted in PBS at room temperature for an hour, followed by washing once 
with 1 % (w/v) BSA in PBS. Tissue samples were incubated with primary antibody 
(diluted to appropriate concentration with 1% BSA) at 4 °C overnight in a 
humidified chamber. The following day the samples were washed three times with 
PBS, five minutes each time and then incubated with secondary FITC conjugated 
anti-rabbit antibody at room temperature in the dark for one hour. Each section was 
then washed three times with PBS for five minutes and counterstained with 300 
nM DAPI in PBS and incubated for twenty minutes in the dark at room 
temperature. Sections were then washed three times with PBS for five minutes and 
imaged using a Zeiss LSM510 META upright confocal microscope (xenon arc 
lamp to excite FITC (λex = 495 nm / λem = 515 nm). Nuclei were visualised at λex = 
300 nm / λem = 510 nm. Secondary antibody alone served as a negative control to 
rule out non-specific antibody binding 
Antigen Clone Working dilution 
Rabbit anti-laminin 
antibody 
 
Polyclonal 1°Ab 1:50 
2°Ab 1:100 
Rabbit anti-
fibronectin antibody  
 
Polyclonal 1°Ab 1:400 
2°Ab 1:100 
Table 5.3. Table of antibodies and working dilutions used throughout the study. 1°Ab = 
primary antibody; 2°Ab = secondary antibody 
5.3.4 Biomechanical evaluation of native and acellular porcine 
peripheral nerves  
The biomechanical properties of native and acellular porcine sciatic branches 
(peroneal and tibial nerves) were evaluated using uniaxial tensile testing. Native 
porcine peroneal nerves (n = 5) and tibial nerves (n = 10) and acellular peroneal 
nerves (n = 3) and tibial nerves (n = 4) were tested under uniaxial tensile loading 
to failure in order to characterised their stress-strain behaviour. All peroneal nerves 
tested ranged from 5 - 7 mm in width and tibial nerves ranged 6 - 7 mm in width. 
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All specimens were 10 mm in length (initial gauge length). Tissue specimens were 
taken from three different animals within each test group. The methodology 
followed during uniaxial tensile testing was described in Section 2.2.6. The mean 
stress-strain curves for each group were generated using the Origin 8.0 software 
package.  
5.3.5 In vitro biocompatibility 
In order to determine the biocompatibility of the decellularised tissues in vitro, 
decellularised peripheral nerves were assessed using a qualitative contact 
cytotoxicity assay. For the assay, two types of cells were used: human dermal 
fibroblasts and primary rat Schwann cells. Human dermal fibroblasts cells were 
isolated from donor skin of abdominoplasty or breast reduction donated from 
patients of the Royal Hallamshire Hospital, Sheffield.  Primary Schwann cells were 
isolated and cultured in vitro from freshly dissociated adult rat nerve following a 
protocol developed by (Kaewkhaw, Scutt et al. 2012). These cells resurrected from 
frozen, cultured and passaged as described in Section 2.2.5. Human dermal 
fibroblasts at passage eight and primary rat Schwann cells at passage five were 
used for contact cytotoxicity assay.  
5.3.5.1 Contact cytotoxicity assay 
Three acellular nerve tissue samples (approximately 5 mm2) were attached to the 
center of six-well tissue culture plates using rat-tail collagen (neutralised using 
sterile 0.1 M sodium hydroxide) and left for 15 minutes at room temperature to 
allow the gel set.  A drop of cyanoacrylate contact adhesive was placed in the centre 
of control wells (n = 3). This was used as a positive control, as it has been 
demonstrated to produce a cytotoxic response. Collagen gel (20 μL) was added to 
the centre of the wells and neutralised with 10 μL of 0.1 M sterile NaOH (n =3). 
This served as a negative control as rat-tail collagen gel is biocompatible.  All the 
wells containing samples, positive and negative controls were washed three times 
using sterile PBS, each for ten minutes. Human dermal fibroblasts and primary 
Schwann cells were seeded into each well at a density of 5x105 cells per well and 
incubated at 37 C in 5 % CO2 (v/v) for 48 hours. Following incubation, the culture 
medium was discarded and the wells were gently washed with PBS containing 
calcium and magnesium and fixed with 3.7 % (v/v) formaldehyde for ten minutes. 
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Each well was stained with Giemsa solution (2 mL per well) for five minutes. Each 
well was gently rinsed with tap water until running clear and left to air dry. The 
plates were examined under Khöler illumination and any changes in cell 
morphology and density were recorded.  
5.4 Results 
5.4.1 Histological evaluation of acellular porcine peripheral nerves 
Samples of native and acellular nerves were stained using general and specific 
histological stains to evaluate the gross effects of the decellularisation process on 
the histioarchitecture of porcine sciatic branches and sural nerves. Nerve sections 
were stained with Picro Sirius red (Figures 5.2 and 5.3), Miller’s elastin (Figures 
5.4 and 5.5) and Alcian blue PAS (Figures 5.6 and 5.7). In terms of ECM staining 
there was no apparent difference between native and acellular sural nerve and 
sciatic branches.  
Picro Sirius red is a strong anionic dye which stains collagen by reacting 
via its sulphuric acid groups, with basic groups present in the collagen molecule. 
The elongated dye molecules are attached to the collagen fibre in such a way that 
their long axes are parallel. This parallel relationship between dye and collagen 
results in an enhanced birefringency. It has been hypothesised that staining with 
Sirius Red, when combined with enhancement of birefringency, may be considered 
specific for collagen (Junqueira, Bignolas et al. 1979).  The Picro stains thicker 
collagen fibres red-orange and thinner newly formed fibres appear green, when 
viewed under polarized illumination.  
Following staining using Picro Sirius red (Figures 5.2 and 5.3) it was 
observed that acellular nerves retained a large portion of the collagen fibres within 
the endoneurium, perineuiurm and epineurium when compared to native controls. 
There was no evidence of elastic fibres (blue/black stained fibres) in the native or 
acellular nerves when stained using Miller’s elastin stain (Figures 5.4 and 5.5).  
Following staining using Alcian blue GAGs were found to be located 
predominatly within the endoneurium and perinerium (stained  purple; Figures 5.6 
and 5.7).  Following decellularistaion the distribution of GAGs remained the same 
as native nerves samples, however the staining intesnity was lower when compared 
to native nerve (Figures 5.6 and 5.7). 
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Figure 5.2 Transverse sections of acellular porcine sural nerve stained with Picro Sirius red. 
(A-C) Native sural nerve; (D-F) acellular sural nerve. Acellular nerves retained a large portion of 
the collagen fibres within the endoneurium, perineuiurm and epineurium when compared to native 
tissue. Thicker collagen fibres stained red-orange are seen predominatly within the epineurium. 
Thinner fibres stained green are located within the endoneurium and are more prominent in the 
acellular nerves. Sections imaged under polarized illumination. Scale bars at 500 μm, 200μm and 
100 μm respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Transverse sections of acellular porcine sciatic branches stained with Picro Sirius 
red. (A-C) Native nerve; (D-F) acellular sural nerve. Acellular nerves retained a large portion of 
the collagen fibres within the endoneurium, perineuiurm and epineurium when compared to native 
tissue. Thicker collagen fibres stained red-orange are predominatly within the epineurium. Thinner 
fibres stained green are located within the endoneurium and are more prominent in the acellular 
nerves. Sections imaged under polarized illumination. Endo = endoneurium. Scale bars at 500 μm, 
200μm and 100 μm respectively.  
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Figure 5.4 Sections of decellularised porcine sural nerves stained with Miller’s elastin. (A-C) 
Native sural nerve; (D-F) acellular sural nerve. No elastin (blue/black stain) was detected within the 
connective tissues of the native or acellular nerves. Scale bars at 500 μm, 200μm and 100 μm 
respectively 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Sections of decellularised porcine sciatic branches stained with Miller’s elastin. (A-
C) Native nerve; (D-F) acellular nerve. No elastin (blue/black stain) was detected within the 
connective tissues of the native or acellular nerves. Scale bars at 500 μm, 200μm and 100 μm 
respectively 
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Figure 5.6 Transverse sections of decellularised porcine sural nerves stained with Alcian blue 
PAS. (A-C) Native sural nerve; (D-F) acellular sural nerve. Glycosaminoglycan’s are detected 
predominantly within the endoneurium and perineurium in the native and acellular nerve, however 
when compared to native controls this staining was less intense in the acellular nerve.  Scale bars at 
500 μm, 200μm and 100 μm respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Transverse sections of decellularised porcine sciatic branches stained with Alcian 
blue PAS. (A-C) Native nerve; (D-F) acellular nerve. Glycosaminoglycan’s are detected 
predominantly within the endoneurium and perineurium in the native and acellular nerve, however 
when compared to native controls this staining was less intense in the acellular nerve.  Scale bars at 
500 μm, 200μm and 100 μm respectively. 
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Sections of native and acellular porcine sciatic branches were stained using a 
reticulin stain to highlight reticular or collagen type III fibres, which were observed 
as black structures or fibres.  Following staining collagen type III was found to be 
predominantly localised within the nerve fascicles (perineurium) and endoneurium 
(Figure 5.8). There was a similar distribution of collagen type III observed in 
sections of acellular porcine sciatic branches, however when compared to native 
controls this staining was less intense (Figure 5.8).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Longitudinal and transverse sections of acellular porcine sciatic branches stained 
for collagen III fibres.  Intense black stain show collagen III   localised around the perineurium 
and within the endoneurium in the native nerve as indicated by the arrows (A-B). A less intense 
black stain is shown in the acellular sciatic branches (C-D). Scale bar at 500 μm.  
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5.4.2 Biochemical analysis of native and decellularised porcine sciatic 
branches 
Samples of native and acellular porcine sciatic branches were lyophilized to a 
constant weight prior to quantification of collagen and sulphated sugars as 
described in Section 5.3.3.  
5.4.2.1 Sulphated sugar assay 
The amount of sulphated GAGs extracted from native and decellularised porcine 
sciatic branches was quantified using a sulphated sugar assay. The assay produced 
a liner relationship between absorbance at 525 nm and GAG content (Figure 5.9). 
The results shown in Figure 5.10 showed a significant 33 % reduction in sulphated 
GAGs after decellularisation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 Figure 5.9 Standard curve for glycosaminoglycan (GAG) assays 
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Figure 5.10 Sulphated proteoglycan content of native and acellular porcine sciatic branches 
determined by glycosaminoglycan (GAG) quantification assay at 525 nm.  There is a significant 
reduction in GAG content after the decellularisation process. Native nerves have an average GAG 
content of 16.15 ± 1.30 µg/mg (n=6); acellular nerves have an average GAG content of 10.81 ± 
1.02 µg/mg (n=6). Data was analysed using a student’s t-test and is presented as the mean ± 95 % 
C.I (p<0.0052**) 
5.4.2.2 Hydroxyproline assay 
The collagen content of native and decellularised porcine sciatic branches was 
quantified using a hydroxyproline assay; these values were multiplied by 7.69 to 
calculate total collagen content. The hydroxyproline assay produced a liner 
relationship between absorbance at 570 nm and hydroxyproline content (Figure 
5.11).  Native porcine nerves were found to contain 1212 ± 194.8 µg/mg collagen 
and decellularised 1124 ± 100.70 µg/mg (Figure 5.12). This represented a 6.7 % 
decrease in collagen after decellularisation. This was not found to be statistically 
significant.  
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Figure 5.11 Standard curve for hydroxyproline assays 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 Collagen content of native and acellular porcine sciatic branches determined by 
a hydroxyproline assay at 570 nm.  There was a slight reduction in collagen after the 
decellularisation process. Native nerves have an average collagen content of 1206 ± 195.50 µg/mg 
(n=6); acellular nerves have an average collagen content of 1124 ± 100.70 µg/mg (n=6). Data was 
analysed using a student’s t-test and is presented as the mean ± 95 % C.I  
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5.4.3 Immunofluorescent evaluation of native and decellularised 
porcine sciatic branches  
Antibody labelling was used to localise specific proteins in porcine sciatic 
branches. By comparing the images of the native and acellular samples, it was 
possible to determine if there was any change in specific extracellular matrix 
components. A FITC conjugated secondary antibody was used to visualise primary 
antibodies used to label laminin and fibronectin. Samples were imaged using an 
upright Zeiss LSM510 META confocal microscope (xenon arc lamp to excite FITC 
at λex = 495 nm / λem = 515 nm). Nuclei were visualised using (λex = 300nm / λem = 
550nm). 
5.4.3.1 Immunolabelling for laminin 
The images of porcine sciatic branches labelled with antibody specific to laminin 
are shown in Figure 5.13. Immunofluorescent labelling of native porcine sciatic 
nerve branches demonstrated laminin to be located around areas known to contain 
the basal lamina. These include the circumference around each Schwann 
cell/neuron unit (myelinated or ensheathed) within the endoneurium, the lamellar 
perineurial sheaths and the outer walls of blood vessels. The staining pattern was 
similar in samples of acellular sciatic nerve branches (Figure 5.13) 
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Figure 5.13 Representative histological images from the central region of native and acellular 
porcine peripheral nerves labelled using a monoclonal antibody against laminin. Antibodies 
to laminin delineate a discrete ring around each Schwann cell/neuron unit in the endoneurium (B 
and D), the lamellar structure of the perineurium (A-D) and around blood vessels (A and B). 
Unstained round areas are spaces occupied by axon/myelin units as indicated by the arrows (A and 
D). Images (C - D) show retention of laminin within the endoneurium and around the perineurium 
of the fascicle following decellularisation. The ring-like appearance of the open tubes in the native 
nerve (A-B) as well as the acellular nerves (C-D) suggests preservation of the basal lamina. Image 
E is a negative control for the antibodies raised against laminin. For the negative control the sample 
was stained with only the FITC conjugated secondary antibody. Scale bar at 20 µm for images B 
and D and 100 µm for images A, C and E. 
5.4.3.2 Immunolabelling for fibronectin  
The images of porcine sciatic branches labelled with antibody specific to 
fibronectin are shown in Figure 5.14. Immunofluorescent labelling of native 
porcine sciatic nerve branches indicated presence of fibronectin within the 
endoneurium and epineurium.  The lamellar perineurial sheaths and the outer walls 
of blood vessels also indicated a strong presence of fibronectin. The staining pattern 
was similar in samples of acellular sciatic nerve branches (Figure 5.14) 
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Figure 5.14 Representative histological images from the central region of native and acellular 
porcine peripheral nerves labelled using a monoclonal antibody against fibronectin. 
Antibodies to fibronectin delineate a discrete ring around each Schwann cell/neuron unit in the 
endoneurium (B-C), the lamellar structure of the perineurium (B), the epineurium and around blood 
vessels within the epineurium (A and C). Unstained round areas are spaces occupied by axon/myelin 
units (C). Image C shows retention of fibronectin within the epineurium, endoneurium and around 
the perineurium of the fascicle following decellularisation. The ring-like appearance of the open 
tubes in the native nerves endoneurium (A-B) as well as the acellular nerves as indicated by the 
arrows (C) suggests preservation of fibronectin within the connective tissues following 
decellularisation. Image D is a negative control for the antibodies raised against fibronectin. For the 
negative control the sample was stained with only the FITC conjugated secondary antibody and 
DAPI. Scale bar at 20 µm and 100 µm. 
5.4.4 In vitro biocompatibility assays 
A contact cytotoxicity assay was used to evaluate the in vitro biocompatibility of 
the acellular porcine sciatic branches. The effect of the acellular tissue on 
proliferation and morphology of human dermal fibroblasts and primary rat 
Schwann cells was evaluated. 
Cells were cultured directly in contact with the samples of decellularised 
nerve, collagen type I and cyanoacrylate contact adhesive (Figure 5.15. There was 
no evidence of cells found in a circular area around the cyanoacrylate contact 
adhesive (positive control; Figure 5.15 E). Collagen gel (negative control) had no 
effect on either cell type, both dermal fibroblasts and Schwann cells grew up to and 
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in contact with the collagen gel and exhibited normal morphologies (Figure 5.15 
B).  
Both cell types were found to grow up to and in contact with the samples 
of acellular nerve (Figure 5.15 A-D). The acellular nerves had no effect on cell 
growth or morphology for both cell types.  No differences were observed between 
the morphology of cells cultured with the acellular porcine sciatic branches and 
cells cultured with the collagen gel. 
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Figure 5.15 Contact cytotoxicity assays of acellular porcine nerve scaffolds following 48 hours’ 
culture with human fibroblasts and primary rat Schwann cells. (A and C) acellular scaffold 
with fibroblasts; fibroblasts are observed growing up to and in contact with the scaffolds as well as 
retaining their elongated spindle shaped morphology under higher magnification (C) suggesting that 
the scaffold is not cytotoxic to fibroblasts; scale bar at 100 μm and 200 μm respectively; (B and D) 
acellular scaffold with Schwann cells; Schwann cells are observed growing up to and in contact 
with the scaffolds as well as retaining their bi- or tripolar elongated morphology suggesting that the 
scaffold is not cytotoxic to Schwann cells; scale bar at 100 μm and 200 μm respectively; (E) 
Cyanoacrylate contact adhesive (positive control) shows clumps of necrotic  fibroblast cells as 
indicated by the arrows  due to cytotoxic effect of the cyanoacrylate adhesive , scale bar at 100 μm; 
(F) Image F shows fibroblast  cells growing up to and in contact with the collagen gel (negative 
control), scale bar at 100 μm. 
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5.4.5 Biomechanics of native and acellular porcine sciatic branches 
The biomechanical properties of the tissues were assessed under uniaxial tensile 
loading to failure in order to assess the effect of the decellularisation treatment on 
the mechanical behaviour of the porcine peroneal and tibial nerves.  
5.4.5.1 Biomechanical characterisation of the porcine sciatic branches 
The stress-strain behaviours of native and acellular peroneal and tibial nerves are 
illustrated in Table 5.4. The table shows that the peroneal and tibial nerves ultimate 
tensile strength (UTS), strain and Young’s modulus (YM) had increased after 
decellularisation. There was a significant increase in UTS for both the acellular 
peroneal and tibial nerve when compared to native (control) tissue. There was also 
a significant increase in strain for the acellular tibial nerve when compared to 
control.  
 
 
Table 5.4 Biomechanical evaluation of native and acellular porcine nerves.  Mechanical 
analysis showed a significant increase in UTS in both the acellular peroneal (1.81 MPa) and tibial 
nerve (2.69 MPa) when compared to their native nerve counterparts (native peroneal nerve; 1.23 
MPa and tibial nerve; 0.87 MPa). There was a significant increase in strain at UTS for the acellular 
tibial nerve (0.36) when compared to its native counterpart (0.16). All data is expressed as mean 
(peroneal nerve n = 8; tibial nerve n = 11; acellular peroneal n = 3; and tibial nerve n = 4). Data was 
analysed using the Students t-test and is presented as the mean ± 95 % C.I (*p<0.05). 
 
 
 
Nerve  Young’s 
Modulus  
(MPa) 
Ultimate tensile  
strength (MPa)                                                              
Strain at ultimate  
tensile strength 
Native peroneal  
7.75 ± 0.56, n=5 
 
 
1.23 ± 0.056, n=5* 
 
 
0.23 ± 0.036, n=5 
 
Acellular 
peroneal 
8.03 ± 0.81, n=3 
 
1.81 ± 0.30, n=3 
 
0.43 ± 0.10, n=3 
 
Native tibial 7.43 ± 0.53, n=10 
 
0.87 ± 0.09, n=10* 
 
0.16 ± 0.01, n=10* 
 
Acellular tibial 8.45 ± 0.36, n=4 
 
2.69 ± 0.51, n=4 
 
0.36 ± 0.09, n=4 
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5.5 Discussion  
In this Chapter, the biological characteristics of acellular porcine peripheral nerves 
were evaluated and compared to native controls. The decellularisation method used 
to obtain the acellular tissue in this chapter was referred to as ‘Method 7’ in Chapter 
4. Histological, immunohistochemical and biochemical characterisation of the 
native and acellular nerve was used to demonstrate that the decellularisation 
process can retain the nerves native endoneurial structure and important ECM 
components. This study further revealed that acellular nerves are not cytotoxic to 
cells and that the nerves retain its mechanical properties.    
Collagen is an important structural ECM component of the peripheral nerve 
(Seyer, Kang et al. 1977; Bunge, Bunge et al. 1989). Previous decellularisation 
studies have reported that SDS is more effective in removing cell residues from 
tissues compared to other detergents such as Triton X-100, however it tends to be 
more disruptive to the ECM ultrastructure and collagen fibres (Kasimir, Rieder et 
al. 2003; Gilbert, Sellaro et al. 2006; Gratzer, Harrison et al. 2006; Ott, Clippinger 
et al. 2010). By decreasing the SDS cycle and using a low concentration of SDS as 
described in Chapter 5, the histological stain using Picro Sirius red showed that the 
nerves collagen fibres and structure were maintained. Unlike previous chemical 
processes which have left the nerve with an unpreserved ECM (Hall 1986; Sondell, 
Lundborg et al. 1998; Krekoski, Neubauer et al. 2001) the acellular tissue in this 
study  retained its ultrastructure along with its connective tissue layers (epineurium, 
endoneurium and perineurium) and intact fascicles. Tissue preservation has also 
been noted with other SDS treated tissues (Elder, Eleswarapu et al. 2009; Wilshaw, 
Rooney et al. 2012; Wang, Itoh et al. 2016). 
Histological staining also revealed a reduction in the intensity of the 
reticulin staining of collagen III; nevertheless, a quantification assay demonstrated 
that SDS does not significantly reduce the overall collagen content. Previous 
decellularisation  studies using SDS  have  also demonstrated the  preservation of  
collagen content  including  collagens type I and IV which construct the basal 
lamina tubes  in peripheral nerves (Kheir, Stapleton et al. 2011; Xu, Xu et al. 2014; 
Wang, Itoh et al. 2016). 
Alcian Blue staining and GAG assay demonstrated a significant reduction 
of sulphated proteoglycans within the decellularised nerves. The removal in GAGs 
has been noted in other SDS based decellularisation processes (Kheir, Stapleton et 
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al. 2011; Xu, Xu et al. 2014). The absence of GAGs reduces the restriction on water 
flow and causes a reduction in the water retention of the tissue, which also 
facilitates the diffusion of decellularisation solutions to remove soluble cellular 
components (Gilbert, Sellaro et al. 2006).  
The importance of GAGs in terms of nerve regeneration is relatively 
unknown. Hyaluronic acid the predominant GAG found in the PNS 
(Chandrasekaran and Bachhawat 1969) assists with fibrin organization, which may 
facilitate a pathway for cellular and axonal ingrowth during the acellular fibrin 
matrix phase of peripheral nerve regeneration (Wang, Nemeth et al. 1998). 
Chondroitin sulphate GAGs however inhibits the neurite promoting activity of 
laminin, and therefore may have a negative role in nerve regeneration (Zuo, 
Hernandez et al. 1998). A study by Krekoski (2001) treated acellular rat sciatic 
nerve grafts with chondroitinase ABC that inactivated CS-GAG chains and 
observed an enhancement in the growth promoting properties of the acellular 
scaffold (Krekoski, Neubauer et al. 2001). Therefore, the removal of sulphated 
GAGs may actually be beneficial in terms of its regeneration capacity.      
Millers Elastin staining indicated no presence of elastin in either the native 
or decellularised nerves.  A reason for this may be due to the fact that both collagen 
and elastin cross-stain with the traditional histochemical techniques such as 
Weigert and Verhoeff-VanGiesson, therefore making it more difficult to 
distinguishing the presence of elastin from collagen.  Through immunolabelling 
Tassler (1994) was able to locate small amounts of elastin in the epineurium, 
endoneurium and perineurium, adjacent to the collagen fibres (Tassler, Dellon et 
al. 1994). 
Immunohistochemical staining of the acellular nerves revealed the retention 
of the basal lamina, tubes of structural proteins comprised of collagen, laminin and 
fibronectin that surround the axons.  The basal lamina is an important component 
of the nerve as both laminin and fibronectin play essential roles in nerve 
regeneration (Gao, Wang et al. 2013). Research has also shown that bands of 
Bünger cannot be formed by Schwann cell without the basement membrane. This 
implies that the ECM may play a more important role than Schwann cell in nerve 
regeneration (Donzelli, Maiuri et al. 2006). Other nerve decellularisation methods 
including thermal (Ide, Tohyama et al. 1998) and chemical (Sondell, Lundborg et 
al. 1998) processes have been known to fracture and damage the basal lamina. The 
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Sondell method which uses Triton X-100  has  shown to decrease the laminin and 
fibronectin content (Grauss, Hazekamp et al. 2005). In contrary SDS studies have 
been shown to retain the basal lamina, laminin and fibronectin  (Wakimura, Wang 
et al. 2015; Wang, Itoh et al. 2015).   
The importance of an intact basal lamina was highlighted in the nerve study 
which compared two well-known detergents based decellularisation processes.  
The Hudson method, which used zwitterionic detergents (SB-10 and SB-16 in 
combination with Triton X-200), produced acellular nerve grafts which retained 
the basal lamina more effectively than the Sondell method which used Triton X-
100. As a result the Hudson graft displayed higher axon densities and stronger 
regeneration potential than the Sondell graft (Hudson, Liu et al. 2004).  A separate  
study also showed the Hudson acellular nerve graft outperforming NeuraGen® (an 
FDA-approved and commercially available type I collagen NGC) (Hudson, Liu et 
al. 2004). The study proposed that the presence of intact basal lamina within the 
acellular nerve graft contributes to the enhanced regenerating capacity to support 
axonal growth (Whitlock, Tuffaha et al. 2009). The method developed by Hudson 
et al.  (2004) is currently licensed by AxoGen® Inc. to produce Avance®, the only 
commercially available acellular nerve graft.  
Residual SDS can be retained in decellularised tissues, and has been 
suggested in previous studies that it can potentially be cytotoxic to cells (Cartmell 
and Dunn 2004; Rieder, Kasimir et al. 2004).  Therefore, a biocompatibility assay 
was performed. Both fibroblast and Schwann cells were observed microscopically 
and found to proliferate up and in contact with the scaffold.  Both cell types 
maintained membrane integrity, native phenotype and there was no sign of cell 
lysis, indicating that the tissue was not cytotoxic. Other studies using SDS based 
treatments to treat tissues have reported on similar findings (Wilshaw, Rooney et 
al. 2012; Luo, Korossis et al. 2014)  
Biomechanical testing of the native and decellularised nerve was 
undertaken to see if there was any change in the nerves mechanical properties as 
loss of GAGs has been associated with a reduction in the ultimate tensile strength 
of the tissue (Partington, Mordan et al. 2013). The biomechanical result showed an 
increase in Young’s modulus, UTS and strain at UTS. There was no significant 
difference in the Young’s modulus; however, there was significance in the UTS for 
both the decellularised peroneal and tibial nerves, as well as strain for the tibial 
161 
 
nerves when compared to their native counterparts. These results were found to be 
similar in other decellularisation studies (Stapleton, Ingram et al. 2008; Williams, 
Liao et al. 2009; Abdelgaied, Stanley et al. 2015). As previously discussed, elastin 
and collagen fibres contribute to the mechanical properties native nerves (Tassler, 
Dellon et al. 1994; Mason and Phillips 2011). During the decellularisation process 
the tissue becomes ‘looser’ due to cell removal and the collagen fibre network starts 
to uncrimp (Williams, Liao et al. 2009). Uncrimping or relaxation of the collagen 
fibres has been associated with increased stiffness in soft tissues (Freed and 
Doehring 2005). In addition increased fibre mobility due to the less compact nature 
of the acellular tissue allow collagen fibres to reorient easily towards the direction 
of applied strain, which would also lead to increased stiffness (Williams, Liao et 
al. 2009).  
Peripheral nerves have visco-elastic properties and are able to respond to a 
normal range of motion of the joints (Tassler, Dellon et al. 1994).  It was first 
suggested that the visco-elastic properties of the nerves were due to the elastin 
fibres found within the connective tissue supporting elements (Sunderland 1968). 
However, the relatively small percentage of elastin fibres found in the nerve 
suggests that the visco-elastic properties of the peripheral nerve may also be due 
not only to elastin but to collagen as well. When viewed at a molecular level it was 
noted that collagen fibres were arranged in such a way to allow some degree of 
longitudinal stretch (Ushiki and Ide 1990). It is thought that this specialised 
arrangement of layers of collagen fibres is likely to be the underlying structural 
component, in conjunction with fluid pressure, which provides the nerve with its 
viscoelasticity (Phillips, Smit et al. 2004).  It was postulated by Tassler et al.  (2004) 
that elastin plays a role in the first phase of the stress-strain curve (strain less than 
20 %) and collagen thereafter, making collagen the predominant molecule 
responsible for the elasticity of the nerve (Tassler, Dellon et al. 1994).  
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5.6 Conclusion 
Porcine peripheral nerves were successfully decellularised using a low 
concentration SDS and hypotonic buffers. Qualitative and quantitative analysis of 
the ECM revealed preservation of important ECM components including collagen, 
laminin and fibronectin, however there was a significant loss of GAGs observed 
by quantitative analysis. In vitro contact cytotoxicity assays demonstrated the 
acellular nerves were not cytotoxic to human dermal fibroblasts and primary rat 
Schwann cells fibroblasts. Biomechanical evaluation of the acellular nerves 
revealed a slight increase in the YM’s, UTL and strain, however the 
decellularisation process did not decrease the mechanical properties of the nerves.  
The retention of the ECM components and its biomechanical properties 
translates to suitable acellular graft which can be used for in vivo or in vitro 
analysis.  For clinical purposes the acellular nerve grafts would be easy to handle 
and suture due to the retention of their structure and mechanical properties, in 
addition to the well preserved ECM and basal lamina structure, making it an ideal 
environment for axonal regeneration. The retention of laminin and fibronectin 
within the basal lamina tubes also provides a suitable environment for the 
introduction of Schwann cells into the acellular graft, by providing cell adhesion 
sites as well as stimulating cell growth. In summary, the decellularised porcine 
peripheral nerve scaffold demonstrated good retention of ECM components as well 
as biocompatibility and biomechanical properties. The use of the acellular graft, 
both as an in vitro and in vivo model with and without the inclusion of Schwann 
cells will be discussed in subsequent chapters.  
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Chapter 6. An Ultrastructural Study on Porcine Peroneal and 
Tibial Nerve  
6.1 Introduction 
The tibial and peroneal nerves are two terminal branches of the porcine sciatic 
nerve, the largest nerve in the lower limb. The tibial nerve is the larger of the 
branches and provides motor innervation to the muscles of the posterior 
compartment of the leg, and sensory innervation to the posterior aspect of the leg. 
The peroneal nerve provides motor innervation to the muscles of the lateral 
compartment of the leg, which innervates the foot, and sensory innervation to the 
distal section and dorsum of the foot (McCrory, Bell et al. 2002). 
Under normal physiological conditions nerves are exposed to various 
mechanical stresses. Each peripheral nerve consists of connective tissues 
(endoneurium, perineurium and epineurium), which encase the nerve bundle to 
ensure flexibility as well as protecting the nerve fibres from stretch and 
compression forces during body movement. When the nerve undergoes elongation, 
pressure produced in the endoneurium will resist the resulting transverse 
contraction and contribute to the stiffness of the nerve when stretched (Millesi, 
Zoch et al. 1995; Layton and Sastry 2004). The perineurium is the primary 
contributor to the nerve’s tensile strength and elasticity. The collagen fibrils as well 
as the elastic fibres are orientated in circumferential, oblique and longitudinal 
orientations which together provide multidirectional tensile strength to the 
fascicles, making the perineurium the load bearing portion of the nerve (Topp and 
Boyd 2006). The epineurium is composed of collagen, elastin and adipose tissues. 
Is the last layer to be affected by an increase in tensile stress and is generally 
maintained after the other layers have been compromised (Rydevik, Kwan et al. 
1990; Kwan, Wall et al. 1992). It has been suggested that   the collagen fibres in 
the epineurium provide resistance to stretch (Campbell, Samlan et al. 2013), while 
the adipose protects against compression (Sunderland 1965). 
Our previous study on the characterisation of porcine peripheral nerves 
reported that the porcine peroneal nerve has a higher ultimate tensile strength value 
in comparison to the porcine tibial nerve when undergoing mechanical testing 
(Zilic, Garner et al. 2015). In the posterior femoral region, the tibial nerve continues 
in the direction of the sciatic nerve towards the popliteal fossa. In contrast, the 
peroneal nerve changes direction and descends laterally to the neck of the fibula. 
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Consequently, it is believed that the peroneal nerve tolerates a greater tensile 
strength during the leg movement than the tibial nerve due to the anatomical 
position (Ugrenović 2014).   
Studies have shown that the ultrastructure of the connective tissues and 
associated ECM components play important roles in the biomechanics of 
peripheral nerves.  Research has shown that the mechanical properties may be 
attributed by various factors such as the number and arrangement of fascicles 
(Sunderland and Bradley 1961), the internal fluid pressure maintained by the 
perineurium (Low, Marchand et al. 1977),  ECM components such as collagen and 
elastin (Ushiki and Ide 1990; Tassler, Dellon et al. 1994) and variance in collagen 
fibril diameter within the connective tissue (Parry, Barnes et al. 1978; Mason and 
Phillips 2011). 
Developing a clear understanding of the biomechanical features of 
peripheral nerves is important in tissue engineering applications where xenogeneic 
nerves are increasingly being investigated for clinical application (Gutmann and 
Sanders 1943; Osawa, Tohyama et al. 1990; Hudson, Liu et al. 2004; Whitlock, 
Tuffaha et al. 2009; Zhang, Luo et al. 2010). Identifying the maximum tension 
which nerves can withstand and understanding the origin of their mechanical 
resilience is of great importance to improving the outcome of surgical nerve repairs. 
Nerve graft coaptations are tension free by design; however in situ stress is always 
present in peripheral nerves and varies with joint position (Sunderland and Bradley 
1961). Properties such as suture holding ability to maintain a mechanically robust 
interface with the native nerve stump are critical for axon regeneration (Borschel, 
Kia et al. 2003).  
As the mechanical properties of the nerve tissue are known to depend on a 
variety of factors it is difficult to give a precise role to any one component. Our 
previous study reported that collagen was the predominant extracellular matrix 
protein in porcine nerve, and so its role in the mechanical property of nerve may 
be more discernible. Alterations in the mechanical properties of nerves, such as 
increased stiffness have been associated with an increase in the diameter of 
collagen fibrils in the endoneurium of diabetic rat models (Muona, Jaakkola et al. 
1989). Furthermore, the association between collagen fibril diameter and the 
functional properties of tissues is well established elsewhere in tissues such as 
tendons, ligaments and skin (Ottani, Raspanti et al. 2001). It has been postulated 
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that if the tissue consists of smaller diameter sized collagen fibrils then it is 
designed to be a more compliant material, and consequently large collagen fibrils 
are predicted to have a greater tensile strength than smaller fibrils (Parry, Barnes et 
al. 1978). 
 
6.2 Aims and objectives 
Aims: 
The aim of this Chapter was to evaluate the ultrastructure of porcine peroneal and 
tibial nerves and investigate if differences in ultrastructure explain experimentally 
derived differences in mechanical properties. The study focused on the connective 
tissue of the endoneurium, perineurium and epineurium.   
 
Objectives: 
 Histologically determine the size, number and area of nerve fascicles and 
surrounding epineurium tissue. 
 Analyse size, number and area of the fascicles and surrounding epineurium tissue 
through histological staining and image analysis.  
 Quantify the diameter and density of collagen fibrils in transverse sections of the 
peroneal and tibial nerves using transmission electron microscopy (TEM). 
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6.3 Materials and methods 
6.3.1 Dissection of peroneal and tibial nerves 
Large White Yorkshire pigs (24-26 weeks old) were sourced from a local abattoir 
and hind legs obtained within 2-3 hours of slaughter. Legs were stored at 4C 
between slaughter and delivery to the laboratory. Upon arrival, peripheral nerves 
were immediately dissected from the porcine leg. Dissection of the nerves from 
each leg took approximately 20 minutes. Once dissected, nerves were immediately 
fixed in 10 % (v/v) neutral buffered formalin (NBF) for histological analysis or 2 
% paraformaldehyde and 2 % (w/v) glutaraldehyde in 0.2 M phosphate buffer for 
TEM analysis.    
The tibial and common peroneal were isolated and dissected, with initial 
reference to the anatomy of human nervous system anatomy of the lower leg. The 
sciatic nerve was dissected from the posterior compartment of the leg. The sciatic 
nerve divided into two terminal branches; the tibial and common peroneal nerve. 
The tibial nerve was observed to travel in the posterior section of the leg and the 
peroneal nerve in the lateral section. Excess fat and connective tissue was removed 
from the nerve samples and tissues washed three times in phosphate buffered saline 
solution containing 0.1 % (w/v) ethylene diamine tetra acetic acid (EDTA) to 
remove excess blood and tissue fluid. 
  For histological and electron microscopy, three peroneal and three tibial 
nerves were used.  Thus, in total six nerves were harvested from three porcine legs.  
The number of individual measurements in total for each characterisation method 
is given below, for each nerve.     
6.3.2 Characterisation of tibial and peroneal nerves 
Native porcine nerve tissue was cut into 1 cm segments, dissected from either end 
of the nerve (n=3) and fixed in 10 % (v/v) neutral buffered formalin (NBF) for 24 
hours. Paraffin embedded samples were then processed as described in Section 
2.2.3.  
6.3.2.1 Haematoxylin and eosin staining of peripheral nerves 
Transverse sections (6 µm) of each nerve sample were stained with haematoxylin 
& eosin was undertaken to evaluate the histioarchitecture and nerve fascicular 
pattern. Samples were viewed using an Olympus BX51 microscope and images 
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captured using an Olympus XC50 digital camera (with Olympus Soft Imaging 
Solutions software). The number and size of the nerve fascicles present within each 
peripheral nerve was analysed using ImageJ (NIH, USA).    
6.3.2.2 Fixation and embedding nerves for TEM analysis  
Prior to excision, nerves were marked and measured then following excision they 
were maintained at their in situ length on a piece of card during fixation. Peroneal 
and tibial nerves were fixed at room temperature for four hours in 2 % 
paraformaldehyde and 2 % (w/v) glutaraldehyde in 0.2 M phosphate buffer.  Each 
nerve (5 mm in length) was post fixed in 1 % (w/v) osmium tetroxide in 0.1 M 
phosphate buffer for 1 hour at room temperature. Nerve samples were dehydrated 
using increasing concentrations of acetone (30 %, 50 %, 70 % and 90 % (v/v) 
acetone in distilled water for 20 minutes each and in three changes of 100 % (v/v) 
acetone for ten minutes each).  The samples were left in a 50:50 mix of acetone and 
Epon 812 resin for 12 hours then embedded in Epoxy resin (after Luft 1961).  Semi-
thin sections were cut at 2 μm and stained with 1 % toluidine blue in 2 % borax 
solution for one minute to confirm transverse tissue orientation under a light 
microscope.  Ultrathin sections of 70 nm were cut using a Leica Ultracut UCT 
ultramicrotome.  Sections were mounted onto copper grids and stained with 4 % 
uranyl acetate (UAc) solution under dark conditions for 30 minutes.  Three changes 
of double distilled water (ddH20) were used to wash the excess UAc from the tissue 
and excess ddH2O then removed by blotting the backs of the copper grids with 
filter paper. The sections were stained with Reynold’s lead citrate solution for ten 
minutes under carbon dioxide free conditions (achieved by adding a small number 
of sodium hydroxide granules to an enclosed staining environment). The grids were 
then rinsed with a final three changes of ddH2O to remove excess stain and the 
sections were left to dry before imaging.   
6.3.2.3 Collagen fibril diameter analysis 
Images were captured at x4800 magnification using a FEI Tecnai G2 Spirit 
transmission electron microscope with attached 11 MP digital camera. The 
diameters of 150 collagen fibrils were sampled from the endoneurium, 150 from 
the epineurium and 50 from the perineurium of peroneal and tibial nerves.  Images 
were captured around the circumference of the epineurium and of the perineurium 
until a quarter of the circumference was fully mapped. Five images were captured 
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from the endoneurium, and 150 fibrils were measured from each image using a 
standardised approach to obtain images from equivalent positions in each nerve 
region. The largest fibril diameter was measured using ImageJ software. 
6.3.2.4 Perineurium thickness 
Transmission electron micrographs were taken of nerves at x 1900 magnification.  
For each sample, ten perineurium measurements were sampled from the 
circumference of the nerve, with the typical anatomy of the perineurium providing 
morphological identification enabling measurements to be made.  
6.3.2.4 Data Analysis 
All numerical values are shown as mean values ± 95 % confidence limits. Data was 
displayed as box and whisker plots. Statistical significance was assessed by the T-
method and P-values of <0.05 were considered significant.    
6.4 Results  
6.4.1 Histioarchitecture and fascicular pattern of peroneal and tibial 
nerves 
Qualitative characterisation of transverse porcine peroneal and tibial nerve sections 
stained using haematoxylin and eosin showed that the tibial nerve (Figure 6.1 1A) 
was significantly larger and contained more fascicles than the peroneal nerve 
(Figure 1B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.  Histioarchitecture of porcine tibial and peroneal nerves. Haematoxylin and eosin 
staining of transverse nerve sections. The tibial nerve (A) is larger and contains more fascicles than 
the peroneal nerve (B) nerve. Scale bar at 500 µm.  
 
A B 
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Quantitative analysis using Image J revealed that the tibial nerve contained a 
significantly larger proportion of nerve fascicles, with tibial nerves having on 
average 37 fascicles per section in contrast to the peroneal nerve, which had an 
average 13 fascicles (Figure 6.2 A). The average fascicle size for the tibial nerves 
was 84,717 ± 3,839 µm2. The average size for the peroneal nerve was 76,450 ± 
6,198 µm2 (Figure 6. 2 B), this was not statistically different. 
The tibial nerve was shown to have a significantly larger fascicular and non-
fascicular area in comparison to the peroneal nerve (Figure 6. 2 C and D).  The 
tibial nerve had an average fascicular area of 28,069 ± 5,959 µm2, whilst the 
peroneal had an average fascicular area of 9,214 ± 1,037 µm2.   The average non-
fascicular area of the tibial nerve was 24,130 ± 3,855 µm2 and the peroneal average 
area was 8,869 ± 9678 µm2. Overall, the peroneal nerve had approximately 49 % 
non-fascicular tissue whilst the tibial nerves had 47 % non-fascicular tissue, in 
relation to the total area of the nerve. Table 6.1 summarises the fascicular pattern 
and area of the peroneal and tibial nerves.  
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Figure. 6.2 Analysis of collagen fibrils in porcine common peroneal and tibial nerve connective 
tissue.  (A) Box and whisker plots summarising the distribution of collagen fibril diameters in 
common peroneal and tibial nerve. 150 fibrils measured in epineurium, endoneurium and 50 fibrils 
measured in perineurium. The number of collagen fibrils was counted from three common peroneal 
and three tibial nerves. The mean collagen fibril diameter found in the tibial epineurium was 108.90 
± 1.7 nm whilst for the common peroneal nerve was 88.59 ± 1.3 nm. The mean collagen fibril 
diameter found in the tibial nerve endoneurium was 84.20 ± 0.8 nm and for the common peroneal 
nerve, 63.87 ± 0.3 nm. The mean for the collagen fibrils found in the perineurium for the tibial nerve 
was 63.98 ± 0.6 nm and for the common peroneal nerve was 65.04 ± 0.4 nm. (B) Box and whisker 
plots summarising the thickness of perineurium in common peroneal and tibial nerve. The tibial 
nerve had an average thickness of 7 µm, which was approximately 11 cells thick. The perineurium 
within the common peroneal nerve had an average thickness of 10 µm and was approximately 9 
cells thick. Box and whisker plots summarise the number of collagen fibrils found in epineurium 
(C) and endoneurium (D). The number of collagen fibrils was counted in three 580 x380 nm areas 
sampled from endoneurium, epineurium and perineurium micrographs of common peroneal and 
tibial nerves in three common peroneal and three tibial nerves. An average of 645.0 ± 102.5/µm2 
fibres were found in the epineurium of the peroneal nerve and 849.4 ± 64.3/µm2 within the tibial 
nerve (C). An average of 854.4 ± 67.4/µm2 fibres were found in the endoneurium of the common 
peroneal nerve and 806.6 ± 32.5/µm2 within the tibial nerve. Data are means ± SEM (n =3) *p< 
0.05  
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Table 6.1. Summary of fascicular pattern and area of porcine peroneal and tibial nerves. 
Tibial nerve contained a significantly larger proportion of nerve fascicles, with an average of 37 
fascicles in contrast to the peroneal nerve, which had an average 13 fascicles. The average size of 
fascicles was slightly larger in the tibial nerves with an average size of 84,717 ± 3,839 µm2 whilst 
the peroneal had an average size 76,450 ± 6,198 µm2, this was not statistically different. The tibial 
nerve has a significantly larger fascicular and non-fascicular area in comparison to the peroneal 
nerve.  The tibial nerve had an average fascicular area of 28,069 ± 5,959 µm2, whilst the peroneal 
had an average fascicular area of 9,214 ± 1,037 µm2.   The average non-fascicular area of the tibial 
nerve was 24,130 ± 3,855 µm2 and the peroneal average area was 8,869 ± 9678 µm2. Data are 
presented as means ± SEM (n =3) 
6.4.3 Collagen fibril analysis 
Analysis of collagen fibrils located within the connective tissues of the 
endoneurium, perineurium and epineurium was undertaken using TEM. In 
addition, the size and thickness of the perineurium was measured using image J 
(Figure 6. 3). 
 
 
 
 
 
 
 
 
Figure 6.3.  Measurement of perineurium and collagen fibril diameter by TEM. The 
perineurium is an area of dense connective tissue situated between the endoneurium and epineurium 
in the peripheral nerve.  The white arrow shows a typical measurement of perineurium thickness 
(A). Collagen fibrils from transmission electron micrographs were measured using ImageJ software.  
The white arrow represents a typical fibril diameter measurement (B). Scale bars at (A) 1 µm and 
(B) 200 nm. 
 Peroneal Nerve Tibial Nerve p-value  
Fascicle number 12.80 ± 2.396 37.00 ± 3.847 < 0.0007 
Fascicle area 
(µm)2 
76450 ± 6198 84,717 ± 3,839 0.278 
Fascicular 
area(µm)2  
9,214 ± 1,037 28,069 ± 5,959 < 0.0279 
Non-fascicular 
area(µm)2   
8,869 ± 968 24,130 ± 3,855 < 0.0110 
Epineurium 
Perineurium 
B A 
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TEM analysis of the porcine nerves revealed the location of collagen fibrils in the 
endoneurium, epineurium, and to lesser extent the perineurium (Figure 6.4).  TEM 
images and analyses revealed that the tibial nerve contained significantly larger 
collagen fibrils within the epineurium and endoneurium (Figure 6.5 A). The mean 
collagen fibril diameter found in the tibial epineurium was 108.90 ± 1.7 nm whilst 
for the peroneal nerve it was 88.59 ± 1.3 nm. The mean collagen fibril diameter 
found in the tibial nerve endoneurium was 84.20 ± 0.8 nm and for the peroneal 
nerve, 63.87 ± 0.3nm. The peroneal nerve contained slightly larger collagen fibrils 
within the perineurium with an average mean of 65.04 ± 0.4 nm compared to the 
tibial nerve which was 63.98 ± 0.6 nm; however, this was not statistically 
significant. 
The perineurium of both the peroneal and tibial nerve was measured in 
terms of size and perineurial cell thickness (Fig. 6.5 B). The tibial nerve had a 
thicker perineurium with an average thickness of 7 µm, which was approximately 
11 cells thick. In contrast, the perineurium within the peroneal nerve had an average 
thickness of 10 µm and was approximately 9 cells thick. This was not statistically 
significant (t test). The density of collagen fibrils located within the epineurium 
and endoneurium of both nerves was analysed by TEM and Image J (Figs. 6.5 C 
and D). On average, the tibial nerve contained 849.4 ± 64.27 fibrils within the 
epineurium and 806.6 ± 32.49 within the endoneurium. The peroneal nerve on 
average contained 645.0 ± 102.5 fibrils within the epineurium and 854.4 ± 67.41, 
this was not statistically significant.  Table 6.2 summarises the TEM analysis of 
the porcine nerves.  
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Figure 6.4.  TEM of collagen fibrils in porcine common peroneal and tibial nerve.  
Transmission electron micrographs showing collagen fibrils in the epineurium, perineurium and 
endoneurium in common peroneal (A-C) and tibial nerves (D-F).  The perineurium consists of 
flattened perineurial cells (PC), circumferentially orientated collagen fibrils (C) and fibroblasts (F). 
Scale bar at 0.2 µm.  
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Fig. 6.5.  Analysis of collagen fibrils in porcine common peroneal and tibial nerve connective 
tissue.  (A) Box and whisker plots summarising the distribution of collagen fibril diameters in 
common peroneal and tibial nerve. 150 fibrils measured in epineurium, endoneurium and 50 fibrils 
measured in perineurium. The number of collagen fibrils was counted from three common peroneal 
and three tibial nerves. The mean collagen fibril diameter found in the tibial epineurium was 108.90 
± 1.7 nm whilst for the common peroneal nerve was 88.59 ± 1.3 nm. The mean collagen fibril 
diameter found in the tibial nerve endoneurium was 84.20 ± 0.8 nm and for the common peroneal 
nerve, 63.87 ± 0.3 nm. The mean for the collagen fibrils found in the perineurium for the tibial nerve 
was 63.98 ± 0.6 nm and for the common peroneal nerve was 65.04 ± 0.4 nm. (B) Box and whisker 
plots summarising the thickness of perineurium in common peroneal and tibial nerve. The tibial 
nerve had an average thickness of 7 µm, which was approximately 11 cells thick. The perineurium 
within the common peroneal nerve had an average thickness of 10 µm and was approximately 9 
cells thick. Box and whisker plots summarise the number of collagen fibrils found in epineurium 
(C) and endoneurium (D). The number of collagen fibrils was counted in three 580 x380 nm areas 
sampled from endoneurium, epineurium and perineurium micrographs of common peroneal and 
tibial nerves in three common peroneal and three tibial nerves. An average of 645.0 ± 102.5/µm2 
fibres were found in the epineurium of the peroneal nerve and 849.4 ± 64.3/µm2  within the tibial 
nerve (C). An average of 854.4 ± 67.4/µm2 fibres were found in the endoneurium of the common 
peroneal nerve and 806.6 ± 32.5/µm2 within the tibial nerve. Data are means ± SEM (n =3) *p< 
0.05  
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 Common 
Peroneal Nerve 
Tibial Nerve p-value 
Fascicle number 12.80 ± 2.396 37.00 ± 3.847 < 0.05 
Fascicle area 
(µm)2 
76450 ± 6198 84,717 ± 3,839 0.278 
Fascicular area 
(µm)2  
9,214 ± 1,037 28,069 ± 5,959 < 0.05 
Non-fascicular 
area (µm)2   
8,869± 968 24,130 ± 3,855 < 0.05 
Table 6.2. Summary of perineurium size and collagen fibril analysis within porcine peroneal 
and tibial nerves 
6.5 Discussion 
In this Chapter we investigated the endoneurium, perineurium and epineurium 
connective tissue of porcine peroneal and tibial nerves in order to evaluate if their 
structure can account for the difference in their reported mechanical strength. In 
our previous study we determined porcine peroneal nerves to have significantly 
larger ultimate tensile stress value of 1.23 ± 0.13 MPa when compared to porcine 
tibial nerves which had an average value of 0.87 ± 0.29 MPa (Zilic, Garner et al. 
2015).     
 We found that the porcine tibial nerve had a significantly larger number of 
fascicles, total fascicular and non-fascicular area, in comparison to the peroneal 
nerve. The average fascicular area was however similar for both the peroneal and 
tibial nerves. These findings resonate with previous fascicular studies carried out 
on the peroneal and tibial nerves (Sunderland and Ray 1948); (Ugrenović 2014). 
The average fascicular pattern regarding number and size in the porcine peroneal 
and tibial nerve closely match comparable human nerves (Ugrenović 2014). This 
concurs with the conclusions from our previous study, that porcine peripheral 
nerves in the lower limb are anatomically similar to human nerves (Zilic, Garner et 
al. 2015). 
Our previous study reported on the peroneal nerve possessing a higher 
ultimate tensile strength in comparison to the tibial nerve (Zilic, Garner et al. 2015). 
Herein, a detailed analysis was undertaken to understand which component of the 
tissue contributed to the differences in tensile strength of the nerves. Collagen is 
reported as a contributing factor to the viscoelastic properties of nerve under 
loading (Ushiki & Ide 1990). Our previous study revealed that the majority of the 
peroneal nerve is composed of collagen type I (as the predominant collagen), 
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located in the epineurium. In this study we identified collagen type III localised 
within the endoneurium and perineurium, which agrees to previous findings 
(Luque, Angulo et al. 1983; Kaemmer, Bozkurt et al. 2010)  
Analysis of the collagen fibrils within the three connective layers of both 
nerve types revealed the collagen fibres, which have the largest diameter, are found 
in the epineurium, whilst both the endoneurium and perineurium contained similar 
sized albeit smaller collagen fibrils. Further analysis showed no difference in the 
density of fibrils within the endoneurium and epineurium of the two nerves. 
Information regarding the dimensions of collagen fibrils in porcine tissue is limited, 
however this pattern correlates with other peripheral nerve studies performed on 
xenogeneic models such as rabbit (Thomas 1963) and rat sciatic nerve (Mason and 
Phillips 2011) as well as human brachial plexus (Gamble and Eames 1964), noting 
that the overall sizes varies from species to species. Investigation into the thickness 
of the perineurium in both nerves revealed the peroneal nerve to possess a thicker 
perineurium sheath than the tibial nerve. This links to previous studies which state 
that as the number of fascicles increases within a nerve, the width of the 
perineurium decreases (Piña-Oviedo and Ortiz-Hidalgo 2008).  
Evaluation of the collagen fibrils between the two nerves revealed the 
peroneal nerve to contain significantly smaller collagen fibrils when compared to 
the tibial nerve. Studies have correlated smaller collagen fibril diameter with more 
compliant tissues (Parry, Barnes et al. 1978); (BINKLEY and PEAT 1986; Mason 
and Phillips 2011). However, in regards to their anatomical position the tibial nerve 
is found to be more compliant and less susceptible to injury than the peroneal nerve 
(Rossi 2014). The tibial nerve has a singular and loose fixation site, as opposed to 
the peroneal nerve which has dual fixation at the sciatic notch proximally, and the 
fibular neck distally (Murovic 2009). Consequently, traction of the sciatic nerve 
results in more damage to the peroneal nerve as it is stretched between two points, 
whereas for the tibial nerve, displacement can be dissipated over a greater length 
of (Sunderland 1953). This may also be a reason why the ultimate tensile strength 
was found to be greater in the peroneal nerve, as its anatomical course means it has 
to withstand more stress under loading.   
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6.6 Conclusion  
This study found that porcine tibial nerves are significantly larger than the peroneal 
nerves in terms of fascicle number, fascicular area and total fascicular area. 
Previously, we showed these nerves to be primarily composed of collagen, and we 
identified collagen type III present within the endoneurium and perineurium. TEM 
analysis of the porcine nerves revealed larger fibril diameters located within the 
epineurium and smaller diameters within the endoneurium and perineurium. The 
tibial nerve was found to possess significantly larger collagen fibril diameters when 
compared to the peroneal nerve. That the peroneal nerve possess smaller fibrils 
than the tibial nerve, yet has a greater ultimate tensile strength, does not correlate 
with previous studies (Parry, Barnes et al. 1978; Ottani, Raspanti et al. 2001) . 
However other investigations suggest that collagen fibril diameter alone cannot 
predict the structural properties of the tissues (Bay, Howell et al. 1993; Derwin and 
Soslowsky 1999). Researchers have shown that other factors besides collagen fibril 
diameter distribution are important for mechanical integrity and strength of the 
nerve such as endoneurial fluid pressure and nerve vasculature (Low, Marchand et 
al. 1977; Myers, Murakami et al. 1986). Our leading explanation as to the 
difference based on current data suggests that the mechanical properties of nerves 
cannot be determined exclusively by their fascicle size or collagen fibril diameter, 
but supports further investigation in to the relationship between structure and 
biomechanical properties of nerve.     
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Chapter 7.  Repopulation of Acellular Nerve Scaffold with 
Cells 
7.1 Introduction 
Inclusion of neuronal support cells such as Schwann cells into nerves grafts have 
been shown to be vital for effective nerve regeneration. Although the exact 
underlying mechanism through which Schwann cells and damaged axons 
communicate is relatively unknown, studies have highlighted the close relationship 
between Schwann cells and axons as a “regenerating unit” (Morris, Hudson et al. 
1972; Brushart 2011).   
Following nerve injury Schwann cells undergo a phenotypic change from 
myelinating to growth supportive in order to direct and support regenerating axons 
towards the distal nerve stump. This phenotype switch is associated with the up-
regulation of several growth associated genes including neurotrophic factors, cell 
adhesion molecules and receptors (Rodrigues, Rodrigues et al. 2012). These 
molecules help support axonal migration and recruit further cells such as 
macrophages, mast cells and activated endothelial cells into the injury site (Hall 
2005; Walsh and Midha 2009). Activated Schwann cells also provide a supportive 
environment by producing collagen and laminin which results in Schwann cell 
proliferation and the formation of longitudinally orientated strands (known as 
bands of Büngner) that guide the regrowing axons (Bunge 1994). 
If axonal contact is not re-established or the gap length increases, Schwann 
cell migration, proliferation and alignment decreases and the growth supportive 
environment cannot be maintained. This is due to the denervated Schwann cells 
losing their ability to interact with regenerating axons and express regeneration-
assisting genes. As the capacity of the denervated distal nerve to support axonal 
regeneration is dependent on proliferating Schwann cells, this translates to poor 
reinnervation outcomes (Walsh and Midha 2009). In an attempt to aid the 
regenerative cellular response to injury and to help stimulate nerve regeneration 
across long peripheral nerve defects, cellular based therapies are considered 
essential for nerve repair.   
 
Schwann cells have been used in synthetic and biological nerve guide 
conduits (NGC’s) to improve functional recovery, regeneration and remyelination 
of injured peripheral nerves. There have been a number of studies which have used 
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Schwann cells as part of a nerve graft.   Such cell based studies have demonstrated 
an increase in nerve regeneration and enhanced axonal regeneration rate (Guenard, 
Kleitman et al. 1992; Mosahebi, Woodward et al. 2001; Evans, Brandt et al. 2002; 
Udina, Rodriguez et al. 2004; Nilsson, Dahlin et al. 2005; Stang, Fansa et al. 2005). 
In vivo studies using acellular nerve tissue repopulated with cells have been 
undertaken with great success (Hess, Brenner et al. 2007; Tulla, Huhtala et al. 2007; 
Zhang, Luo et al. 2010). However, understanding the molecular, biochemical, and 
biological changes that occur in vivo during reinnervation such as the influence of 
Schwann cells and the impact of local pro-inflammatory cytokines is difficult, due 
to the inherent complexity of the regeneration process (Gingras, Bergeron et al. 
2003).  
In vitro models have value in a number of areas, serving as an 
investigational platform for studies including developmental biology, disease 
studies and the design of devices and scaffolds for peripheral nerve repair (Daud, 
Pawar et al. 2012). With a three dimensional nerve model there is degree of 
experimental control which is not possible in vivo. Factors such as cell source, cell 
orientation and delivery of exogenous compounds can be delivered in a controlled 
manner to a three dimensional system which has a similar microenvironment to 
that found in vivo (Cullen, Wolf et al. 2011).  
Current nerve studies involve the use of collagen gels and sponges which 
have shown to support axon ingrowth and Schwann cell proliferation (Allodi, 
Guzmán-Lenis et al. 2011) as well as myelination (Gingras, Beaulieu et al. 2008). 
A study by Daud et al. (2012) developed a three dimensional in vitro peripheral 
nerve model using aligned electrospun polycaprolactone fibre scaffolds showed 
aligned neurite formation with dorsal root ganglion explants and co-localisation of 
Schwann cells with the neurites (Daud, Pawar et al. 2012). However, there is very 
little research currently in three dimensional in vitro peripheral nerve model using 
acellular scaffolds.  This is in contrast to other tissues such as skin, where extensive 
work has been conducted (MacNeil 2007).  
In order to create a three dimensional acellular model there are various 
factors that need to be considered. Acellular nerves are comprised of dense 
collagenous tissue, which makes it more difficult to populate with cells.  Current 
methods of introducing cells into acellular scaffolds include opening up the 
collagenous matrix by ultrasonification (Ingram, Korossis et al. 2007) or by 
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injecting cells directly using a syringe into the ends of a graft (Brenner et al 2005; 
Fox et al 2005; Hess et al 2007).   
The migration and survival of the cells within the scaffold is dependent on 
the maintenance of nutrient diffusion throughout the scaffold (Sun, Norton et al. 
2005).  For Schwann cell culture it is likely that continuous perfusion with medium 
will better support metabolic activity rather than changing the medium every few 
days (Sun, Norton et al. 2008). In situ peripheral nerve cells receive constant 
nutrients from blood vessels which are located within the epineurium with smaller 
branches of these blood vessels penetrating into the perineurium. In addition, with 
long-term culture of seeded scaffolds that requires repetitive handling (e.g. 
changing medium every few days) can increase the risk of contamination.  
Therefore, to introduce continuous perfusion to scaffolds in sterile 
environment bioreactors can be implemented for the reproducible production of 
tissue-engineered nerve for both experimental and clinical use. Bioreactors have 
been used extensively in nerve tissue engineering applications for growing 
functional cells and tissues for transplantation, as well for controlled in vitro studies 
(Kallos and Behie 1999; Hadlock, Sundback et al. 2000; Lin, O'Shaughnessy et al. 
2004; Sun, Norton et al. 2008; Cullen, Wolf et al. 2011; Murray-Dunning, 
McArthur et al. 2011). These systems can help establish spatially uniform cell 
distributions on 3D scaffolds as well as maintaining desired concentrations of gases 
and nutrients in the culture medium, which are important step towards the 
development of functional grafts (Korossis, Bolland et al. 2005; Chen and Hu 
2006).   
There have been many different types of bioreactors that have been used 
for growing neuronal cells and for tissue engineered nerve applications such as 
suspension bioreactors (Kallos and Behie 1999), NASA designed rotating wall 
vessel bioreactors (Lin, O'Shaughnessy et al. 2004) and a micro-perfusion 
bioreactor (Cullen, Wolf et al. 2011). Previous studies have successfully developed 
simple closed loop perfusion system (Hadlock, Sundback et al. 2000; Sun, Norton 
et al. 2008; Murray-Dunning, McArthur et al. 2011). 
A study on perfusion by Sun et al. (2008) established a simple closed loop 
bioreactor system to introduce and culture Schwann cells on longitudinally aligned 
microfibers of viscose rayon and polystyrene model materials. It was discovered 
that a continuous medium flow of 0.8 mL.H-1 increased total cell number by 2.5-
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fold verses static culture. In addition, results from the perfused conditions showed 
a nine-fold increase in cell viability as well as cellular adhesion and alignment on 
the longitudinal axis (Sun, Norton et al. 2008). This study showed that perfusion 
was a factor in cell viability and proliferation. In addition, the study also showed 
that the use of a bioreactor can permit a quick and systematic evaluation for the 
introduction, growth and evaluation of support cells in vitro.  
Therefore, in this study focus was on the development of a three 
dimensional in vitro nerve model using acellular nerve tissue. The acellular model 
was used as a basis for the study of perfused flow within the tissue for the 
introduction of Schwann cells using a simple closed loop perfusion system. 
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7.2 Aims and objectives 
Aims: 
The aim of this chapter was to determine the conditions for the introduction of 
primary rat Schwann cells into acellular porcine peripheral nerves that would be 
appropriate both for experimental and clinical use. The reseeded nerves were then 
compared under static and perfused conditions. 
 
Objectives: 
 Taking a systematic approach determine methodology for introducing cells into 
the acellular scaffold. RN22 Schwann cells were used initially at the 
developmental stage, and then replaced with primary rat Schwann cells once the 
seeding technique was established; 
 To develop a bioreactor for the reseeded tissue which will provide continuous 
flow of medium to the recellularised nerve tissue; 
 Localise cells within the tissue using histological methods – hematoxylin and 
eosin, nuclei (DAPI) and CellTracker™; 
 Identification of primary Schwann cells within re-seeded acellular nerve tissue 
by Immunolabelling for S100β, Glial Fibrillary Acidic Protein (GFAP) and p75 
nerve growth factor receptor (NGFR) markers; 
 To determine viability and function of Schwann cells seeded onto the acellular 
nerve scaffold. 
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7.3 Methods 
7.3.1 Cell culture medium for RN22  
The standard cell culture medium used for RN22 Schwann cells was Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10 % (v/v) FCS, 100 U. mL-1 
penicillin / 100 µg. mL-1 streptomycin, 0.25 µg. mL-1 amphotericin and 2 mM L-
glutamine. The culture medium was stored at 4 °C for up a month. 
7.3.2 Cell culture medium for primary rat Schwann cells 
The standard cell culture medium used for primary rat Schwann cells was MEM–
D-valine containing 10 % (v/v) FCS, 100 U. mL-1 penicillin, 100 µg. mL-1 
streptomycin, 0.25 µg. mL-1 amphotericin, 5 µM forskolin and 2 mM L-glutamine. 
The culture medium was stored at 4°C for up a month. 
7.3.3 Labelling Schwann cells with CellTracker™ Red CMPTX dye 
CellTracker™ fluorescent probes can be used to visualise cells by fluorescence 
microscopy. These probes pass freely through cell membranes. Once inside the 
cells these mildly thiol-reactive probes undergo a glutathione S-transferase-
mediated reaction to produce membrane-impermeable glutathione-fluorescent dye 
compounds   that are retained inside the cells for at least 24 hours after loading and 
can be passed onto daughter cells. The probes contain amino groups, so can be 
cross-linked using formaldehyde for sample storage and analysis.  
The red CellTracker™ solution was prepared by dissolving 50 µg of 
CellTracker™ in 7 µL DMSO. This was then added to 7 mL of the required cell 
medium. The medium from either RN22 or primary rat Schwann cells was removed 
from the flask and washed once with 5 mL PBS. The CellTracker™ solution was 
then added to the flask and incubated for 45 minutes in 37 °C in 5 % CO2 (v/v). 
The flask was subsequently washed three times using 10 mL of PBS to remove 
excess cell tracker. Normal cell seeding as described in Section 2.2.5 was then 
undertaken.  
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7.3.4 Histology 
Histology was used to determine the localisation of cells within the repopulated 
acellular nerves. Repopulated acellular nerves (n=3) were fixed with 3.7 % (v/v) 
formaldehyde for 24 hours. Histological evaluation was performed as described in 
Section 2.2. Native and acellular nerves were processed for tissue architecture and 
cell distribution analysis. Paraffin embedded tissue sections of 10 μm were 
prepared transversely and longitudinally. The slides were stained with 
haematoxylin and eosin and labelled with DAPI and CellTracker ™ to enable the 
identification of tissue structure as well as the cell nuclei and cell distribution. 
Hematoxylin and eosin stained sections were viewed by light microscopy. Cell 
nuclei and cell distribution samples were viewed under a Zeiss LSM510 META 
upright confocal microscope.  DAPI nuclei were visualised at λex = 300 nm / λem = 
510 nm and CellTracker ™ Red at λex = 577 nm / λem = 602 nm. 
7.3.5 Immunolabelling seeded Schwann cells within acellular nerve 
tissue 
Schwann cells in two dimensional culture and within the three dimensional 
acellular construct were fluorescently immunolabelled for the Schwann cell protein 
markers S100β, GFAP and p75 NGFR. Acellular nerve samples and primary 
Schwann cells tissue grown in two dimensional cultures were fixed using 3.7 % 
(v/v) formalin and embedded into paraffin wax; each sample was sectioned at 6 - 
10 μm. Sections were permeabilised with 0.1 % (v/v) Triton X-100 diluted in PBS 
for 20 minutes. Samples were then incubated with 7.5 % (w/v) bovine serum 
albumin diluted in PBS at room temperature for an hour, followed by washing once 
with 1 % (w/v) BSA in PBS. Tissue samples were incubated with primary antibody 
(diluted to appropriate concentration with 1 % BSA) at 4 °C overnight in a 
humidified chamber. The following day the samples were washed three times with 
PBS, five minutes each time and then incubated with secondary FITC conjugated 
anti-rabbit antibody at room temperature in the dark for one hour. Each section was 
then washed three times with PBS for five minutes and counterstained with 300 
nM DAPI in PBS and incubated for twenty minutes in the dark at room 
temperature. Sections were then washed three times with PBS for five minutes and 
imaged using a Zeiss LSM510 META upright confocal microscope (xenon arc 
lamp to excite FITC (λex = 495 nm / λem = 515 nm). Nuclei were visualised at λex = 
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300 nm / λem = 510 nm. Secondary antibody alone served as a negative control to 
rule out non-specific antibody binding 
 
Antigen Isotype Clone Working dilution 
Anti-S100 astrocyte 
marker ab868 
IgG Rabbit Polyclonal 1°Ab 1:250 
2°Ab 1:200 
Anti-GFAP delta 
primary antibody 
ab28926 
IgG Rabbit Polyclonal 1°Ab 1:250 
2°Ab 1:200 
Anti-p75 NGF 
receptor antibody 
IgG Rabbit Polyclonal 1°Ab 1:50 
2°Ab1:100 
Table 7.1. Table of antibodies and working dilutions used throughout the study  
7.3.6 Determination of Schwann cell viability  
MTT Assay 
The MTT assay is a colorimetric method for assessing cell viability. MTT (3-
(4,5dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide) is a yellow water 
soluble tetrazolium salt. The MTT acts as an artificial hydrogen acceptor substrate 
for mitochondrially-located dehydrogenase enzymes (NAD (P) H-dependent 
cellular oxidoreductase) in living cells. Reduction of MTT is converted to insoluble 
purple formazan crystals by cleavage of the tetrazolium ring by the dehydrogenous 
enzymes. The insoluble purple formazan can be solubilised using acidified 
isopropanol.   
RN22 Schwann cells were seeded and grown in 24 well plates. Culture 
medium was removed and 1 mL of MTT solution was added to each well. The 
MTT solution was made by dissolving 0.5 mg MTT in 1 mL PBS and filter 
sterilized before use. The plate was left to incubate for 1 hour at 37 °C / 5 % CO2 
(v/v). The MTT solution was removed from the well and 400 µL acidified 
isopropanol added to elute the stain. The acidified isopropanol was made by adding 
25 µL of 6 M HCL to 20 mL isopropanol.  Once all the stain had been eluted (after 
approximately 15 minutes), 150 µL of solution was transferred to a clear 96 well 
plate (triplicates of each sample) and optical density determined at a wavelength of 
540 nm with a reference filter at 630 nm.    
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Alamar Blue Assay 
Alamar Blue is a cell viability assay reagent which contains the cell permeable dye 
resazurin. Resazurin (7-hydroxy-10-oxidophenoxazin-10-ium-3-one) is a water 
soluble non-fluorescent blue dye which is reduced to the pink-coloured and highly 
fluorescent resorufin. The resazurin dye is highly dichromatic and acts as an 
intermediate electron acceptor. Resazurin undergoes the colorimetric change in 
response to cellular metabolic reduction usually in the presence of mitochondrial 
reductases NADPH dehydrogenase or NADH dehydrogensase. As the resazurin 
dye accepts electrons, it changes from the oxidized, non-fluorescent, blue state to 
the reduced, fluorescent, pink state.  The intensity of fluorescence produced is 
proportional to the number of living cells (Rampersad 2012).  
  Schwann cells were seeded and grown in 24 well plates. Medium was 
removed from the well and 1 mL of Alamar blue working solution was added. The 
Alamar blue working solution was prepared by diluting the Alamar blue stock 
solution (12.6 mg resazurin salt powder diluted in 50 mL distilled water and filter 
sterilize) 1 in 10 with culture medium to obtain a 0.1 mM working solution. The 
samples were incubated for four hours in 37 °C/5 % CO2 (v/v). 200 µL of the 
reduced pink resorufin solution was then pipetted into a clear 96 well plate 
(triplicates of each sample) and read at a wavelength of 540 nm with a reference 
filter of 630 nm.      
7.3.7 Bioreactor setup 
The perfused bioreactor system comprised of a 1-litre Duran bottle with three 
connections drilled into the bottle cap. Two of the connections were used for the 
inlet and outlet tubes. These tubes were PharMed® BPT tubes with an internal 
diameter of 3.1 mm. One end of the PharMed® BPT tube was inserted into the inlet 
connection and the tube was pulled downwards until it skimmed the bottom surface 
of the Duran bottle. The other end of the tube was then lengthened with more 
PharMed® BPT tubing (approximately one metre in length) which were connected 
via male luer connectors and passed through the Masterflex peristaltic pump and 
into the outlet connection to allow media to flow in and out in a closed looped 
system. In the outlet connection the tube was pulled half way down towards the 
bottom surface of the Duran bottle. Enough space was left to allow the nerve 
scaffold to be attached onto the outlet tube. The third connection was for the air 
187 
 
filter to allow gaseous exchange. The air filter was comprised of a Nalgene ™ 
syringe filter (25 mm diameter) attached onto the PharMed® BPT tube. A picture 
and design of the bioreactor setup is shown in Figure 7.1.  
To sterilise the bioreactor system the Duran bottle along with the connected 
tubes were autoclaved. Once sterilised the syringe filter and media was added to 
the bioreactor system in a sterile hood.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1. Bioreactor setup. Bioreactor is comprised of a Duran bottle with inlet, outlet and air 
filter connections. The inlet and outlet tubes are connected to a peristaltic pump in a series circuit. 
The pump allows the media to flow into the inlet tube and come back out the outlet tube in a closed 
loop system. The flow of media is shown by the direction of the blue arrows.     
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7.4 Introduction Schwann cells into acellular porcine nerve 
scaffolds 
Several experimental techniques were undertaken to reseed acellular nerve 
scaffolds with Schwann cells. Following each seeding iteration, the reseeded 
scaffolds (n =3) were placed under static and perfused conditions. Under static 
conditions the reseeded scaffolds were placed in a 90 mm petri dish immersed in 
medium (5-10 mL). Under perfused conditions the reseeded scaffold was placed in 
the bioreactor system as described in Figure 7.1.   
RN22 Schwann cells were used in the initial experimental procedures to 
reintroduce cells back into the porcine acellular scaffolds. RN22 cells are an 
immature rat Schwannoma cell line, which are relatively easy to maintain, divide 
relatively quickly and can be used up to passages of typically 100.  
7.4.1 Method 1- introduction of RN22 Schwann cells into cannulated 
nerve scaffolds 
To introduce RN22 Schwann cells into the acellular nerve scaffolds, a 2 cm 
acellular scaffold was cannulated by inserting a cannula (24-gauge x 75mm x50) 
through the nerve and suturing (4-0 sutures) into place (Figure 7.2).  The cannulated 
nerve sample was then sterilised in 0.1 % (v/v) peracetic acid for three hours under 
agitation. Under sterile conditions the nerve sample was immersed with 10 % (v/v) 
DMEM overnight.  1x106 cells were resuspended in 100 µL medium and injected 
into the scaffold with a 1 mL syringe.   
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Figure 7.2 Cannulation of acellular nerve for reintroduction of cells. Acellular scaffold sutured 
to a cannula syringe with a 24-gauge needle. 
The recellularised scaffolds were left either under static condition or under perfused 
flow. For the perfused conditions Figure 7.3 shows a schematic diagram of how 
the cannulated scaffold was attached to the outlet tube within the bioreactor. 
For static conditions the reseeded cannulated scaffolds were left in a Petri 
dish immersed in medium and incubated at 37 °C in 5 % CO2 (v/v) for three days. 
Reseeded scaffolds that needed to be perfused were left overnight for cells to 
adhere and placed in the bioreactor the following day as shown in Figure 7.1. The 
bioreactor was placed inside an incubator 37 °C in 5 % CO2 (v/v). Medium was 
perfused through the tissue at a rate of 30 mL.min-1 for 48 hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acellular scaffold 
Suture 
Cannula syringe 
190 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 7.3. Schematic diagram of cannulated nerve scaffold attached inside the bioreactor.  
Bioreactor consists of a Duran bottle with an outlet and inlet tube for media to flow through and air 
syringe filter for gaseous exchange. Nerve scaffold is attached to outlet tube via cannula syringe 
and media flows towards the scaffold. 
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7.4.2 Results for Method 1 
Histological analysis of the recellularised scaffold under static conditions showed 
no presence of cells apart from the region where cells were initially introduced. 
Clumps of RN22 Schwann cells can be observed within the epineurium, around the 
edge of the tissue with no signs of migration (Figure 7.4) 
 
 
 
 
 
 
 
 
 
 
Figure 7.4 Reseeded acellular scaffold under static conditions at day three.  Hematoxylin and eosin 
of RN22 Schwann cells within acellular porcine nerve tissue.  Transverse section of proximal nerve 
shows cells located within the epineurium, clumped together at the edge of the scaffold. Scale bar 
at 500 µm, 200 µm and 100 µm respectively. Tissue structure seen in pink and cells in purple. Endo 
= endoneurium; Epi = epineurium. 
 
Results for the perfused conditions showed that similarly to the static conditions a 
majority of the cells were located predominantly around the edges of the tissue, at 
the site of the injection. In addition, the results showed cells distributed around the 
perineurium and within the endoneurium of the nerve fascicles as indicated by the 
arrows (Figure 7.5).  This indicates that perfusion may have a positive effect on 
cell distribution. 
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Figure 7.5 Reseeded acellular scaffolds under perfused conditions at day three.  Hematoxylin and 
eosin staining show presence of RN22 Schwann cells within transverse tissue sections. Black arrows 
show cells within endoneurium (B), epineurium and surrounding the perineurium (D) Endo = 
endoneurium; Epi = epineurium; Peri = perineurium. Scale bar at 200 µm and 100 µm. Tissue 
structure seen in pink and cells in purple.  
Hematoxylin and eosin staining of cells seeded scaffolds (Figure 7.4 and 7.5) 
demonstrated could be introduced into acellular scaffolds via cannulation. 
However, this method was unable to distribute cells through the entire tissue. 
7.4.2.1 Method 2 -introduction of RN22 Schwann cells into nerve 
scaffolds via syringe pump 
A syringe pump seeding system was developed to introduce cells into scaffolds 
(Figure 7.6). Prior to reseeding, the RN22 Schwann cell population was labelled 
with CellTracker (as described in Section 7.3.3). RN22 Schwann cells (1 x106) 
were suspended in 1 mL of standard medium and drawn up into a 1 mL syringe. 
Under sterile conditions the syringe was then placed on a syringe pump and 1 cm 
length of scaffold was placed inside a sterile 1.5 cm PharMed® BPT tube (I.D 3.1 
mm) which was then attached to the end of the syringe. The cells were injected 
B A 
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193 
 
through the syringe into the proximal end of the scaffold. Once half the cell 
suspension was injected the distal portion of the scaffold was placed towards the  
syringe. This was to ensure that cells were introduced to the entire scaffold. The 
pump was set to a rate of 40 µL.min-1. 
 
 
 
 
 
 
 
 
 
 
Figure 7.6. Reseeding cells into nerve scaffold using a syringe pump. RN22 Schwann cell 
suspension was injected into the scaffold encased within a tube using a syringe and motor pump set 
at a rate of 40µL.min-1.  
The recellularised scaffolds were incubated either under static condition or under 
perfused flow as shown in Figure 7.1. For the static samples the reseeded scaffolds 
were left in petri dishes immersed in media for three days at 37 °C in 5 % CO2 
(v/v). For the perfused samples cells the reseeded scaffolds were left overnight to 
adhere. The following day the samples were attached to the bioreactor (Figure 7.7).   
Figure 7.7 shows a schematic diagram of how the reseeded scaffold was 
attached to the outlet tube within the bioreactor. The reseeded scaffold was placed 
in a 3 mm silicone tube with two luer connectors with a male adapter placed on the 
top and bottom. The top connectors attached the scaffold and the tube to the outlet 
tube, allowing medium to flow through, whilst the bottom connector allowed the 
medium to pass through. A polymer mesh filter was placed at the bottom of the 
tube to prevent the scaffold from being pushed into the bottom connector. The 
bioreactor was placed inside an incubator 37 °C in 5 % CO2 (v/v). Media was 
perfused through the tissue at a rate of 0.5 mL.min-1 for 48 hours. 
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Figure 7.7 Schematic diagram describing how nerve scaffold was attached inside the 
bioreactor.  The bioreactor consisted of a Duran bottle with an outlet and inlet tube for medium to 
flow through and an air syringe filter for gaseous exchange.  The reseeded scaffold was placed in a 
3 cm silicon tube with a top connector attaching to the outlet tube to allow medium in to and through 
the scaffold and a bottom connector to allow medium to pass through. The polymer mesh filter kept 
the scaffold within the tube.  
 
7.4.2.2 Results for Method 2 
 
Figures 7.8 and 7.9 illustrate that Schwann cells can be detected by epifluorescence 
microscopy in acellular porcine nerve when using the motor pump device.  Under 
static conditions the cells were observed to perfuse through the proximal and 
middle regions of the scaffold (Figure 7.8). However, no cells were located in the 
distal region. 
 
 
 
 
 
Outlet 
Scaffold 
Polymer 
mesh filter 
Media 
Top 
connector 
Bottom 
Connector 
195 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8 Reseeded CellTracker red labelled RN22 Schwann cells grown under static 
conditions at day three. RN22 Schwann cells were detected primarily surrounding the edges of 
the epineurium and some cells residing within epineurium in the proximal (A-D) and middle 
sections (E-F) of the nerve as indicated by the arrows. No cells were detected in the distal region 
(G). Endo = endoneurium; Epi = epineurium. Scale bar at 100 µm.   
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Under perfusion Schwann cells were located throughout the entire scaffold, and 
were observed within all three connective tissue layers (Figure 7.9). The proximal 
section of the scaffold under perfusion shows that the cells were located within the 
endoneurium of the nerve fascicles as well as surrounding the perineurium (Figure 
7.9 A-C) unlike the static conditions where the cells were predominantly located 
within the epineurium (Figure 7.8 A-D). Furthermore, under perfused conditions 
there is a larger portion of cells observed in the distal region (Figure 7.9 F-H) when 
compared to the static results (G) which suggests that perfusion helps cells migrate 
throughout the entire scaffold.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9 Reseeded CellTracker red labelled RN22 Schwann cells under perfused conditions 
at day three. RN22 Schwann cells are seen within the endoneurium, surrounding the perineurium 
and within the epineurium in the proximal region (A-C); in the epineurium in the middle (D-E) and 
distal (F-H) regions of the nerve as indicated by the arrows. Endo = endoneurium; Epi = epineurium; 
Peri = perineurium. Scale bar at 100 µm.   
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7.4.3 Method 3-introduction of primary Schwann cells into nerve 
scaffolds via syringe pump 
The seeding method devised using a syringe pump and RN22 Schwann cells was 
observed by histology and epifluorescence microscopy to introduce cells 
throughout the whole acellular porcine scaffold. Thus, RN22 cells were replaced 
with primary rat Schwann cells to investigate if primary cells could be re-
introduced into an acellular scaffold. The scaffold was left under static and perfused 
condition to investigate whether perfused conditions had a similar effect on 
primary Schwann cells in terms of migrating throughout the entire scaffold as 
observed with the RN22 cells in Method 2.  
Acellular scaffolds were seeded with primary Schwann cells (1x106 
cells/50 µL) via the motor syringe pump (1 mL). Cells were injected via both ends 
and left under static or under perfused flow as shown in Figure 7.1. Reseeded 
statically cultured samples were left in petri dishes immersed in media for three 
days at 37 °C in 5 % CO2 (v/v). For the perfused samples cells the reseeded 
scaffolds were left overnight to adhere. The following day each sample was 
attached to the bioreactor as shown in Figure 7.7. Medium was perfused through 
the tissue at a rate of 0.5 mL/min for 48 hours. Thereafter, the samples were 
processed for histology with longitudinal and transverse sections taken from the 
same block/sample. Cell Tracker and DAPI were used to verify the location of 
cells.   
7.4.3.1 Results for Method 3 
Figure 7.10 shows the primary Schwann cells under static conditions. The cells 
were located predominantly within the epineurium. A large portion of cells were 
seen in the proximal section of the nerve and to a lesser extent in the middle and 
distal portion. Figure 7.11 shows the cells under perfusion. As was observed for 
the static samples, the majority of cells were located in the proximal and middle 
sections and to a lesser extent in the distal portion. The cells were found to be within 
the middle and near the edge of the epineurium (Figure 7.11).  
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Figure 7.10 Primary rat Schwann cells introduced into porcine acellular nerve by the motor 
pump method at day three under static conditions. CellTracker and nuclei (DAPI) labelled cells. 
Schwann cells were detected in the epineurium and were observed to a greater extent in proximal 
(A-B) and middle (C-D) sections of the nerve. Fewer cells were observed in the distal (E-F) sections 
of the nerve. CellTracker labelled Schwann cells are in red, cell nuclei are blue. Epi = epineurium. 
Scale bar at 100µm.   
P
ro
x
im
a
l 
A 
B 
Nuclei                                         CellTracker                       Combined 
 
 
 
C 
D 
E
 
M
id
d
le
  
Epi 
Epi 
Epi 
Epi 
 
 
 
E 
F
D
is
ta
l 
 
Epi 
Epi 
199 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.11 Primary rat Schwann cells introduced in to porcine acellular nerve by the motor 
pump method at day three under perfused conditions. CellTracker and nuclei (DAPI) labelled 
cells. Schwann cells were observed to a greater extent in proximal (A-B) and middle (C-D) sections 
of the nerve. Fewer cells were observed in the distal (E) sections of the nerve. CellTracker labelled 
Schwann cells are in red, cell nuclei are blue. Endo = endoneurium; Epi = epineurium. Scale bar at 
100µm.   
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7.4.4 Method 4-introduction of primary Schwann cells into nerve 
scaffolds via Hamilton syringe 
The motor pump seeding technique was noted on being able to introduce cells 
through the entire scaffold; however, a large portion of cells were lost during the 
seeding process as there was a notable leakage of cell suspension in the gap 
between the syringe and the nerve scaffold.  This system was therefore refined to 
include the use of a Hamilton syringe with a 26-gauge needle (0.41 mm in 
diameter) to allow direct injection of Schwann cells into the scaffold. 
A Hamilton syringe was used to inject 1x106 Schwann cells resuspended in 
60 µL media underneath the epineurium of the nerve.  Cells were injected in equal 
volumes (approximately 10 µL) at three evenly spaced points on both sides of the 
nerve in order to create minimal damage and observed under a dissection 
microscope (Figure 7.12).  
The recellularised scaffolds were placed into static or perfused flow culture 
conditions as shown in Figure 7.1. Samples placed into static culture were initially 
immersed in media for three days at 37 °C in 5 % CO2 (v/v). For the perfused 
samples cells the reseeded scaffolds were left overnight to adhere. The following 
day the samples were aseptically transferred to the perfusion bioreactor as shown 
in Figure 7.7. Medium was perfused through the tissue at a rate of 0.5 mL/min for 
48 hours. Thereafter, each sample was processed for histology, with longitudinal 
and transverse sections taken from the same block/sample. CellTracker and DAPI 
were used to locate cells within the scaffold. 
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Figure 7.12 Seeding primary Schwann cells using Hamilton syringe and dissection 
microscope. Schwann cells were seeded directly underneath the epineurium of the nerve at three 
evenly spaced points on both sides of the nerve as indicated by the arrow for minimal damage using 
a Hamilton syringe with a 26-gauge needle and a dissection microscope.   
7.4.4.1 Results for Method 4 
7.4.4.1.1 Viability of primary Schwann cells post injection with a Hamilton 
syringe 
Due to the small diameter of the Hamilton syringe, there was concern that the shear 
force of the needle could potentially damage the Schwann cells, and in turn, have 
a damaging effect on cell viability when injected into the scaffold.  Therefore, a 
viability assay using Alamar blue was undertaken.  A 50 µL cell suspension was 
injected into a six well plate using the Hamilton syringe and as a control 50 µL of 
cell suspension using a 200 mL pipette was also plated. 
 The viability assay demonstrated that Schwann cell viability was affected 
post injection (Figure 7.13).  There was a significant decrease in cell after 48 hours, 
however the cell number significantly increase by day five (120 hours).  
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Figure 7.13. Graph showing Schwann cell viability post Hamilton syringe injection. Alamar 
blue assay shows viability of primary Schwann cells. There was a significant decrease of cells at 48 
hours post injection but the viability significantly increased by 120 hours. There was a significant 
difference in the cell number between 24 hours and 120 hours. 24 hours; control 728.5 ± 10.55 RFU 
and syringe injected 606.8 ± 22.06 RFU. 48 hours; control 1122 ± 23.78 and syringe injected 224.9 
± 15.15 RFU. 120 hours; control 1161 ± 19.74 RFU and syringe injected 976.1 ± 13.30 RFU. Data 
was repeated three times in triplicates and analysed using an unpaired Students t-test and is 
presented as SD (n = 3) ± 95 % C.I (p < 0.0002***) RFU = relative fluorescent units 
 
7.4.4.2.2 Introduction of primary Schwann cells into nerve scaffolds via 
Hamilton syringe  
Figure 7.14 and 7.15 illustrates that the use of a Hamilton syringe to introduce 
Schwann cells underneath the nerve epineurium was a suitable method. The figures 
show a distribution of cells throughout the entire nerve with no indication of 
damage to the nerve structure as a result of the injection. In terms of cell 
distribution, the majority of the cells under static and perfused conditions were 
located within the epineurium. Figure 7.14 A and E revealed the presence of cells 
around the fascicles, surrounding the perineurium. 
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Figure 7.14 CellTracker and DAPI labelled reseeded Schwann cells via Hamilton syringe 
under static conditions at day three. Schwann cells were seen in proximal (A) middle (B-C) and 
distal (D-E) sections of the nerve. Cells are predominantly located within the epineurium but some 
cells are seen around the perineurium as indicated by the arrows. CellTracker labelled Schwann 
cells are seen in bright red, cell nuclei are seen in blue. Endo = endoneurium; Epi = epineurium; 
Peri = perineurium. Scale bar at 100µm.   
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Figure 7.15 CellTracker and DAPI labelled reseeded Schwann cells via Hamilton syringe 
under perfused conditions at day three. Schwann cells were seen in proximal (A-B), middle (C-
D) and distal (E-F) sections of the nerve. Cells were predominantly located within the epineurium. 
CellTracker labelled Schwann cells were bright red, cell nuclei in blue. Endo = endoneurium; Epi 
= epineurium. Scale bar at 100µm.   
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7.4.5 Analysis of recellularised acellular nerve scaffolds  
The Hamilton syringe method (method 5) was concluded to be the most effective 
method for introducing primary Schwann cells into the acellular scaffold. Cells 
were seeded at three time points (1, 3 and 7 days) under static and perfused culture 
conditions to determine the viability over the time course and whether the cells 
proliferate. 
7.4.5.1 Results  
7.4.5.1 Analysis of cellular migratory pattern under static and perfused 
conditions  
Histological analysis of the reseeded scaffolds showed the presence of cells 
throughout the entire scaffold under both static and perfused conditions (Figure 
7.16-7.21). The majority of the cells were clumped together, however higher 
magnification revealed that cells were located around the perineurium, as seen in 
Figure 7.16 (I); 7.17 (J) and 7.21 (C). Some cells were also seen entering the 
endoneurium, as illustrated in Figure 7.18 (E) and Figure 7.20 (I).  
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Figure 7.16 Reseeded Schwann cells via Hamilton syringe under static conditions at day one. 
Longitudinal (A-F) and transverse (G-I) recellularised nerves sections stained with haematoxylin 
and eosin. Longitudinal sections reveal the presence of cells within the epineurium as indicated by 
the arrows (C and F). Transverse sections (G-I) show cells within the epineurium and surrounding 
the perineurium indicated by the arrows (I). Endo = endoneurium; Epi = epineurium; Peri = 
perineurium.  Scale bar at 500µm (A, D and G), 200µm (B, E and H) and 100µm (C, F and I) 
respectively.   
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Figure 7.17 Reseeded Schwann cells via Hamilton syringe under static conditions at day three. 
Transverse and longitudinal recellularised nerves sections stained with haematoxylin and eosin. 
Longitudinal section (D-F) reveals presence of cells within the epineurium as indicated by the arrow 
(F). Transverse sections show cells within the epineurium (C) and surrounding the perineurium (I) 
as indicated by the arrows. Endo = endoneurium; Epi = epineurium; Peri = perineurium.  Scale bar 
at 500µm (A, D and G), 200µm (B, E and H) and 100µm (C, F and I).   
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Figure 7.18 Reseeded Schwann cells via Hamilton syringe under static conditions at day seven. 
Longitudinal recellularised nerves sections stained with haematoxylin and eosin. Longitudinal 
sections reveal presence of cells around the perineurium (D) and within the endoneurium (E) as 
indicated by the arrows. Endo = endoneurium; Epi = epineurium; Peri = perineurium. Scale bar at 
500µm (A), 200µm (B-C) and 100µm (D-E). 
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Figure 7.19 Reseeded Schwann cells via Hamilton syringe under perfused conditions at day 
one. Transverse and longitudinal recellularised nerves sections stained with haematoxylin and 
eosin. Longitudinal sections (A-F) reveal presence of cells surrounding the epineurium (C, F and 
I), and surrounding the perineurium (C) as indicated by the arrows. Transverse sections (G-I) show 
cells surrounding the perineurium and entering the endoneurium indicated by the arrows (I). Endo 
= endoneurium; Epi = epineurium; Peri = perineurium. Scale bar at 500µm (A, D and G), 200µm 
(B, E and H) and 100µm (C, F and I).   
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Figure 7.20 Reseeded Schwann cells via Hamilton syringe under perfused conditions at day 
three. Transverse and longitudinal recellularised nerves sections stained with haematoxylin and 
eosin. Longitudinal sections (A-F) reveal large presence of cells within the epineurium (C and F) 
as indicated by the arrows. Transverse sections (G-I) show cells entering the endoneurium of the 
nerve fascicle (I). Endo = endoneurium; Epi = epineurium; Peri = perineurium. Scale bar = 500µm 
(A, D and G), 200µm (B, E and H) and 100µm (C, F and I).   
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Figure 7.21 Reseeded Schwann cells via Hamilton syringe under perfused conditions at day 
seven. Longitudinal recellularised nerves sections stained with haematoxylin and eosin. 
Longitudinal sections revealed presence of cells within the epineurium and endoneurium (B-C). 
The sections also showed cells surrounding the perineurium of the fascicle indicated by the arrows 
(C). Endo = endoneurium; Epi = epineurium; Peri = perineurium.  Scale bar = 500µm (A) and 
200µm (B-C).   
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To assess the viability of the cells within the scaffold over seven days a cell 
viability analysis was undertaken (by MTT). The viability assay was inconclusive 
(Figure 7.22). It was noted that when the MTT solution was placed on the samples, 
both the recellularised and acellular samples turned purple on the outer (Figure 7.22 
B) and inner surfaces of the nerve (Figure 7.22 C), in addition the acidified 
isopropanol could not elute all of the dye from the samples. Therefore, the MTT 
assay was concluded as an inaccurate technique for measuring cell viability of these 
samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.22 Schwann cell viability within recellularised nerves under static conditions.  Graph 
(A) shows both the recellularised and decellularised scaffolds fluorescence readings increased from 
day 1 to day 7. Mean fluorescent reading of sample day one = 0.70; day three = 0.75; day seven = 
0.99. Mean fluorescent reading of positive control day one = 0.25; day three = 0.12; day seven = 
0.34. Mean fluorescent reading of negative control day one = 0.39; day three = 0.59; day seven = 
0. 81. (B and C) Image of decellularised scaffold reducing the MTT reagent (seen in purple) which 
could have attributed to the high fluorescence reading observed in the scaffold. Image B shows the 
retention of the MTT reagent on the outer surface of the nerve whilst Image C reveals inner surface 
of the nerve which also shows retention of the MTT reagent.   Data was analysed using two-way 
ANOVA presented as the mean (n =3) ± SD  
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A DNA quantification assay was undertaken as an indicator of the amount of DNA 
present within the scaffolds (as described in Section 5.3.3). This assay gave a more 
accurate reading to the DNA content as the controls (acellular scaffold) remained 
significantly lower than the receullarised scaffolds over the duration (Figure 7.24 
A).  Under static conditions the DNA content significantly increased from day 1 to 
day 3 indicating that cells were proliferating within the scaffold. By day 7 however 
there was a dramatic decrease in the DNA number (Figure 7.24 B). The low number 
of DNA suggests that the cells within the scaffold had ceased to proliferate; this 
may have been due to lack of media/nutrients reaching the cells. Under perfused 
conditions (0.5 mL.min-1) there was a similar trend.  However, more of a gradual 
increase of DNA was detected from day one and day three; with a slight decrease 
by day seven (Figure 7.24 C). This suggests that perfusion helps maintain cell 
proliferation within the scaffold. The slight decrease by day 7 may have been due 
to the limited space within the scaffold. 
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Figure 7.23. Graph showing DNA content in reseeded scaffolds under static and perfused 
conditions. Primary Schwann cells-introduced scaffolds under static and perfused conditions 
showed a significant increase in DNA when compared to the control (decellularised scaffold) 
*(p<0.0001).  Under static conditions there was a significant increase in DNA from day 1 to day 3 
in the recellularised nerves and a significant decrease in DNA from day 3 to 7 *(p<0.0001). Overall 
there was a significant change in DNA content from day 1 to day 7 under static 
conditions*(p<0.0002). Under perfused conditions there was no significant increase from day 1 to 
3 however there was a significant decrease in DNA from day 1 to day 7 in the recellularised 
nerves*(p<0.0002) Overall there was a significant change in DNA content from day 1 to day 7 
under perfused conditions *(p<0.0027). Mean DNA content under static conditions, day 1 = 189 
ng/mg; day 3 = 583 ng/mg; day 7 = 189 ng/mg. Mean value under perfused conditions, day 1 = 321 
ng/mg; day 3 = 326 ng/mg; day 7 = 238 ng/mg.  Control decellularised sample day 1 = 25 ng/mg; 
day 3 = 38 ng/mg; day 7 = 57 ng/mg. Data was analysed using two-way ANOVA and unpaired 
Students t-test presented as the mean (n =3) ± SD  
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7.4.5.3 Analysis of cellular phenotype under static and perfused conditions  
Following static or perfused culture each scaffold was processed from normal 
histology and immunolabelled with the Schwann cell markers S100 (calcium-
binding protein), GFAP (cytoskeleton component) and p75 NGFR (neurotrophin). 
Schwann cells cultured on tissue culture plastic served as positive controls for 
antibody labelling, in each case DAPI was used as a counter stain (Figure 7.24 & 
7.25).  Cultured Schwann cells labelled positively for S100 (green), p75 NGFR 
(red) and GFAP (yellow; Figure 7.24).  Omission of a primary antibody served as 
a negative control (Figure 7.25). 
Figures 7.24 and 7.25 show the positive and negative controls for the 
proteins expressed by the Schwann cells; each control was counterstained with 
DAPI to show the cell nuclei seen in blue.  Figure 7.24 shows the positive controls 
(Schwann cells grown on tissue culture plastic grown) and expression of S100 
(green), p75 NGFR (red) and GFAP (yellow), which indicated the presence of 
Schwann cells. Figure 7.25 shows the acellular scaffolds reseeded with cells which 
have been incubated with only the secondary antibody (omission of the primary 
antibody step), serving as a negative control. This was to show the level of 
background fluorescence (nonspecific binding) arising from the secondary 
antibody under identical illumination.  
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Figure 7.24. Schwann cells immunolabelled for S100, P75 and GFAP grown on polystyrene 
(positive control).  Schwann cells grown on tissue culture plastic were immunolabelled for S100 
(green); p75 NGFR (red); GFAP (yellow). The majority of cells stained positive for all three 
markers, which confirmed the cells as having a Schwann cell phenotype.  Cells were counterstained 
with DAPI to show cell nuclei (blue). Scale bar at 100µm 
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Figure 7.25. Schwann cells incubated with secondary antibody alone (negative control). 
Schwann cells introduced in to porcine acellular nerve showed no indication of non-specific binding 
of the secondary antibody at different concentrations (A and B). Cells were counterstained with 
DAPI to shown cell nuclei (blue). Scale bar at 100µm 
Figures 7.26 - 7.31 illustrates confocal micrographs of porcine acellular scaffolds 
seeded with primary Schwann cells and cultured under static and perfused 
conditions for one, three and seven days. The cells were found to be located 
predominantly within the epineurium and some around the perineurium (Figure 
7.26) within the proximal, middle and distal sections of the nerve. The 
recellularised samples expressed all three Schwann cell markers (p75 NGFR, 
S100 and GFAP). These markers are important for cell proliferation; migration, 
myelination and cell adhesion. These results demonstrate that the nerve scaffold 
provides a suitable environment in which primary Schwann cells are able to retain 
their phenotypic markers, when cultured in both static and perfused conditions.  
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Figure 7.26. Reseeded acellular scaffold at day one under static conditions.  Schwann cells 
immunolabelled for p75 NGFR (red); S100 (green) and GFAP (yellow). Recellularised cells, 
which were located within the epineurium and around the perineurium within the proximal section 
of the nerve stained positive for all three Schwann cell markers. Cells were counterstained with 
DAPI to shown cell nuclei (blue). Scale bar at 100µm. 
 
 
 
 
 
 
 
       DAPI                  Schwann cell marker               Combined 
Peri 
Epi 
Epi 
Epi 
 
 
p75 
NGFR  
 
 
 
 
 
 
 
 
 
 
S100 
 
 
 
 
 
 
 
 
 
GFAP 
219 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.27. Reseeded acellular scaffold at day 3 under static conditions.  Schwann cells 
immunolabelled for p75 NGFR (red); S100 (green) and GFAP (yellow). Recellularised cells 
within the epineurium of the middle section of the nerve stained positive for all three Schwann cell 
markers.  Cells were counterstained with DAPI to shown cell nuclei (blue). Scale bar at 100µm. 
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Figure 7.28. Reseeded acellular scaffold at day 7 under static conditions.  Schwann cells 
immunolabelled for p75 NGFR (red); S100 (green) and GFAP (yellow). Recellularised cells 
within the epineurium of the distal section of the nerve stained positive for all three Schwann cell 
markers.  Cells were counterstained with DAPI to shown cell nuclei (blue). Scale bar at 100µm. 
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Figure 7.29. Reseeded acellular scaffold at day 1 under perfused conditions.  Schwann cells 
immunolabelled for p75 NGFR (red); S100 (green) and GFAP (yellow). Recellularised cells 
within the epineurium of the proximal section of the nerve stained positive for all three Schwann 
cell markers.  Cells were counterstained with DAPI to shown cell nuclei (blue). Scale bar at 100µm.  
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Figure 7.30. Reseeded acellular scaffold at day three under perfused conditions.  Schwann cells 
immunolabelled for p75 NGFR (red); S100 (green) and GFAP (yellow). Recellularised cells 
within the epineurium of the middle portion of the nerve stained positive for all three Schwann cell 
markers.  Cells were counterstained with DAPI to shown cell nuclei (blue). Scale bar at100µm.  
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Figure 7.31. Reseeded acellular scaffold at day seven under perfused conditions.  Schwann 
cells immunolabelled for p75 NGFR(red); S100 (green) and GFAP (yellow). Recellularised cells 
within the epineurium of the distal region of the nerve stained positive for all three Schwann cell 
markers.  Cells were counterstained with DAPI to shown cell nuclei (blue). Scale bar at 100µm.  
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7.5 Discussion 
This Chapter describes an investigation into recellularising acellular porcine nerve 
scaffolds using RN22 Schwann cells, and subsequently primary rat Schwann cells. 
Reseeded scaffolds were placed in a closed loop bioreactor system to investigate if 
Schwann cells would grow more efficiently under perfused conditions. The cells 
were under constant perfusion at a maximum flow rate of 0.5 mL.min-1. A low flow 
rate was chosen, based upon previous work reporting that the viability of Schwann 
cells increased 2.5-fold under low flow conditions compared to static conditions 
(Sun, Norton et al. 2008).  
The first aim of the study was to create an efficient seeding technique in 
which Schwann cells could be delivered directly into the acellular scaffold, 
infiltrating throughout the entire nerve. Early attempts of reseeding cells included 
cannulating the nerve and injecting through a cannula. This however proved to be 
ineffective as histological analysis showed Schwann cells clumped at the point of 
insertion, with no presence towards the rest of the scaffold. Reseeded scaffolds 
under perfusion also showed cells predominantly around the edges of the tissue, 
where cells were initially introduced. However, there were signs of cells located 
around the perineurium and within the endoneurium of the nerve fascicles. This 
showed that perfusion may play an important role in cellular migration following 
introduction.  
In an attempt to introduce Schwann cells throughout the entire scaffold, the 
seeding technique was modified, by injecting cells (1x106/mL) to the proximal and 
distal ends using a syringe pump. Schwann cells were also pre-labelled with 
CellTracker for tracking their location within the scaffold. Under static conditions 
there was evidence of Schwann cells within the proximal and middle sections; 
however, no cells were observed at the distal end. The lack of cells in the distal end 
may be due to a low number of cells being delivered to the distal end or the cell 
suspension leaking from the nerve end. In the perfused system the cells were 
observed to be present throughout the entire scaffold, which suggested that 
perfusion and migration were associated. 
After demonstrating the efficacy of using a syringe pump to seed RN22 
Schwann cells throughout the scaffold, normal primary rat Schwann cells were then 
employed using similar conditions. A slight alteration was made where the 
Schwann cells were resuspended in a smaller volume (1x106 / 50 µL). As the 
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previous problem with this technique was the extended time it took to seed the cells 
into the scaffold which may have caused cell death during the seeding process.  
Data showed that cells were present throughout the scaffold under both static and 
perfused conditions. However, under both conditions, there was not a 
homogeneous distribution of cells and the majority were located within the 
proximal and middle sections.   
A study by Jesuraj et al. (2011) established a systematic approach to seeding 
Schwann cells in cold preserved acellular grafts. The authors found that a sub-
epineurial injection with a Hamilton syringe resulted in the highest viability of 
cells, and the least damage to the epineurium (Jesuraj, Santosa et al. 2011). To 
inject Schwann cells underneath the epineurium a needle should be used the 
dimensions of which are small enough to penetrate the epineurium connective 
tissue, and large enough to enable Schwann cells to pass through without damage. 
The average size of a Schwann cell can be assumed as approximately <50 µm in 
diameter, and therefore a 26-gauge needle (0.41 mm outer diameter / 0.26 mm inner 
diameter / 0.10 mm wall thickness) was selected.  
Prior to commencing the tissue experiment, Schwann cells were injected 
into 24 well plates using a Hamilton syringe and cultured for five days to establish 
if cell damage arose. Previous cell injection procedures have resulted in reduced 
cell viability, with viabilities as low as 1 %–32 % post-transplantation (Zhang, 
Methot et al. 2001). 
A viability assay was subsequently undertaken on the injected cells and it 
was found that there was a significant decrease in cell viability 48 hours post 
injection. Research has shown that cell damage may occur during ejection because 
of the sheer stress forces placed upon cells during this procedure. When flowing 
through a needle, cells experience three types of mechanical forces, that can lead 
to cell disruption; a pressure drop across the cell, shearing forces attributed to linear 
shear flow, and stretching forces due to extensional flow (Aguado, Mulyasasmita 
et al. 2011). Forces at the transition point between syringe and needle can also 
damage cells. In a syringe-based injection system, the inner diameter of a syringe 
is typically larger than that of the needle, so cells experience an increase in linear 
velocity as they pass into the needle. This generates an extensional force that has 
been suggested as the main contributing factor to cell injury during injection 
(Amer, White et al. 2015). The cell viability had significantly increased by day five 
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post injection.  The improved viability may be due to cellular repair mechanisms 
being activated, which suggests that cell recovery is possible in a favourable 
environment. In addition, cells may have undergone exponential growth by this 
time point (Amer, White et al. 2015). 
Using this method, a syringe was used and Schwann cells inserted along 
the full length of the nerve segment underneath the epineurium. Cells were injected 
in equal volumes at three evenly spaced points (Walsh, Biernaskie et al. 2009; 
Jesuraj, Santosa et al. 2011; Jesuraj, Santosa et al. 2011; Jia, Wang et al. 2012; Fan, 
Yu et al. 2014).  Histological analysis confirmed that the injected cells were 
arranged along the longitudinal acellular nerve graft, however some cells albeit in 
smaller quantities were also found in transverse sections. A much larger number of 
Schwann cells were revealed to be present in both perfused and static conditions 
using this method of injection with the Hamilton syringe.  It was also interesting to 
observe through haematoxylin and eosin stained sections that the cells were located 
around the perineurium, as well as entering the endoneurium, akin to a native 
anatomy of peripheral nerve.  
An MTT assay was undertaken to assess the viability of the cells within the 
scaffolds. The results were inconclusive as the negative controls (using 
decellularised scaffold) along with the cell-introduced showed high false positive 
readings at each time point.  Evidence exists that the MTT reduction is also 
catalysed by a number of non-mitochondrial enzymes. It has been demonstrated 
that the endoplasmic reticulum (Berridge and Tan 1993), cytosol (Goodwin, Holt 
et al. 1996) and plasma membranes (Bernas and Dobrucki 2000) can also 
participate in the reduction of MTT (Bernas and Dobrucki 2002). During the 
decellularisation process, not all the cellular remnants such as nuclear material and 
cytoplasmic debris can be removed from the tissue (Crapo, Gilbert et al. 2011), 
with the consequent retention of released enzymes which maintain activity when 
bound to the extracellular proteins, and may consequently contribute to the 
reduction of MTT in the decellularised scaffolds. MTS and Alamar blue assays also 
showed similar false positive artefacts.  
As an alternative, a DNA quantification assay was carried out on the 
recellularised tissue samples. A DNA quantification assay measures the amount of 
DNA present in the tissue. The amount of DNA present in each tissue was 
quantified; an increase in DNA within the tissue would signify an increase in cell 
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number. Results showed that under both static and perfused conditions the DNA 
content increased from day one to day three and then decreased towards day seven.  
The decline in cell number by day seven could be attributed to numerous factors. 
Previous studies have shown that when 106 Schwann cells were injected only 10 % 
remained within the graft (Jesuraj, Santosa et al. 2011). The failure to transfer all 
the cells may be either due to the death of the cells post injection, or via Schwann 
cells leaking from grafts post injection. When 1 x105 Schwann cells were injected 
there was a 40 % successful transfer (Jesuraj, Santosa et al. 2011). Nonetheless 
previous studies with 1x105 Schwann cells injected in the acellular graft had shown 
little effect on peripheral nerve regeneration (Fox, Schwetye et al. 2005), whilst 
injection with 1x106 Schwann cells enhanced regeneration (Brenner, Lowe et al. 
2005). Therefore, it is possible that a lower cell density may be more beneficial for 
the design of an investigational in vitro model, and a higher Schwann cell density 
for in vivo / clinical applications.  Although in both static and perfused conditions 
there was a decrease in DNA by day 7, under perfused conditions the decrease in 
number was far less and more gradual than when compared under static conditions. 
This suggests that a controlled medium flow rate was more effective in maintaining 
cell viability (Sun, Norton et al. 2008).  For future reference cell viability assays 
specifically designed for 3 D culture such as CellTiter-Glo ® which measures the 
amount of ATP in metabolically active cells may be a more effective way of 
assessing cell viability within biological tissue. 
The cell seeded scaffolds were labelled using antibodies against the 
following Schwann cell markers: GFAP, S100 and p75 NGFR. GFAP is a major 
cytoskeletal component. In addition to playing a structural role, it has also been 
implicated in cytoskeletal reorganization, myelination maintenance and cell 
adhesion (Eng, Ghirnikar et al. 2000). The S100 protein stimulates cell 
proliferation and migration, while simultaneously inhibiting apoptosis and 
differentiation (Selinfreund, Barger et al. 1991). The p75 nerve growth factor 
receptor plays a role in Schwann cell migration and myelination during 
development, apoptosis, as well as axonal regeneration (Barrett and Bartlett 1994). 
The cell introduced scaffolds labelled positively for all three markers, under static 
and perfused conditions. This confirmed that the Schwann cells maintained their 
phenotype within the acellular nerve.  
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7.6 Conclusions 
In conclusion, this study has evaluated a number of methods to seed Schwann cells 
into an acellular nerve scaffold, the data indicates the optimal method to be using 
a Hamilton syringe and injecting cells underneath the epineurium. Histological 
analysis using haematoxylin and eosin, DAPI and CellTracker reveal cells 
throughout the entire scaffold. Immunolabelling of reseeded Schwann cells within 
the acellular scaffold show expression of GFAP, S100 and p75. DNA 
quantification assay showed that Schwann cells proliferated up to day three and 
this started to decrease by day seven. This may be a shift from cells proliferating 
to differentiating, given the positive markers immunolabelled for Schwann cell 
differentiation.     
This study also shows the potential of using the recellularised nerve graft 
as an in vitro model. Using a simple closed loop bioreactor system, the 
recellularised nerve grafts were subjected to perfusion to assess cell viability. The 
study revealed that the Schwann cells under perfusion maintained their phenotype 
and had a lower rate of cell death when compared to static conditions. This suggests 
that constant medium flow plays a positive role in cell viability.  
The in vitro nerve model can provide a platform for further study in 
directing the accurate organisation of Schwann cells within an acellular nerve 
matrix.  In addition the model can also be used to acquire a body of preliminary 
data on aspects including the signalling pathways activated by new 
molecules/drugs, (Armstrong, Wiberg et al. 2008; Magnaghi, Parducz et al. 2010; 
Gnavi, Blasio et al. 2014) and cell behaviour changes due to environmental 
alterations induced by physical agents such as magnetic fields, mechanical forces 
and electrical stimuli (Chafik, Bear et al. 2003; Gamboa, Gutiérrez et al. 2007; 
Koppes, Nordberg et al. 2013). 
The use of primary cell models can be used to answer complex questions 
related to peripheral nerve regeneration processes, as they are the best 
representation of cells found in vivo.  Therefore, the data obtained from these in 
vitro models are more likely to predict the phenomena occurring in vivo during 
nerve regeneration than cell line-based models (Geuna, Raimondo et al. 2015). 
 Furthermore the in vitro model can progress to the introduction of different 
cell types such as adipose derived stem cells (di Summa, Kalbermatten et al. 2011; 
Kaewkhaw, Scutt et al. 2011), genetically modified Schwann cells (Lavdas, 
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Franceschini et al. 2006) and macrophages (Franzen, Schoenen et al. 1998) . 
Alongside cells other exogenous factors such as neurotrophins can also be 
introduced into the nerve model, as neurotrophins such as Nerve Growth Factor 
(NGF)  promote the growth, survival and differentiation  of cells (Schmidt and 
Leach 2003).   
The in vitro nerve model does provide an environment which can help 
reseeded primary Schwann cells mimic the cell–cell interactions and cell–ECM 
interactions observed in vivo. However, the model lacks the complex vascular 
systems that support tissues in vivo for oxygenation, nutrients, and waste removal. 
Cells grown in 3D culture perform these functions only by diffusion. This in turn 
will present a problem in maintaining cells over a long period of time in vitro.  
Therefore, for long term maintenance an in vivo environment would be more 
favourable for Schwann cells. 
Using the combined approach of an acellular scaffold with the inclusion of 
cells is a valuable tool for the preliminary screening of a number of elements. The 
in vitro model permits a systematic controlled evaluation of novel acellular grafts 
where promising results can be studied in further detail using in vivo injury models. 
An in vivo study using acellular nerve grafts with / without the inclusion of primary 
Schwann cells is described in Chapter 8.  
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Chapter 8 In Vivo Analysis of the Regenerative Capacity of 
Acellular Nerve Scaffolds 
 
8.1 Introduction 
When inflicted with an injury the peripheral nerve has the ability to regenerate 
naturally. If the nerve gap injury is less than 5-10 mm spontaneous axonal 
regeneration will occur. In humans nerve regeneration occurs at a rate of 3-4 mm 
per day after crush and 2-3 mm per day if the nerve is transected (Stoll and Müller 
1999). If, however, the gap size is greater than 5-10 mm regeneration is infrequent, 
misdirected and often results in poor functional recovery (Pfister, Gordon et al. 
2011). For longer nerve gaps the current “gold standard” treatment is autologous 
grafting; using donor sensory nerve tissue harvested from another site in the body 
to replace the injured tissue. Limitations using this method include donor site 
morbidity and chronic pain the autologous clinical functional recovery rates is only 
80 % (Schmidt and Leach 2003).  It is commonly accepted that physical guidance 
of axons is a vital component of nerve repair and regeneration. Current research 
focuses on “entubulating” opposing nerve stumps of the severed nerve in an 
autograft tube known as a Nerve Guidance Conduit (NGC) (Kehoe, Zhang et al. 
2011). These conduits can be used for defects of 20 mm - 25 mm and eliminates 
the need to graft.  
The Food and Drug Administration (FDA) and Conformit Europe (CE) 
have approved a relatively small number of guidance conduits for clinical repair of 
peripheral nerves. In clinical trials, NGCs have been reported to have a comparable 
efficacy to autologous grafting in defects up to 20 mm (Meek and Coert 2008). 
However, limitations of conduits include the production of acidic degradation 
products and high rates of degradation which have been observed in Neurotube®; 
high rigidity reported in Neurolac®, and caused needle breakages when suturing 
the NGC in place. Also, the slow degradation rate of NeuraGen® (up to 48 months 
in vivo) can lead to nerve compression (Meek and Coert 2008). For nerve defects 
greater than 30 mm, autografts are still considered as the gold standard, as NGCs 
are not considered as effective for these gap sizes.   
 It has been hypothesised that the limited efficacy of NGCs in promoting 
nerve regeneration over longer distances is due to the lack of a suitable surface 
topography (Spivey, Khaing et al. 2012). As previously mentioned, the nerve basal 
231 
 
lamina and ECM components such as collagen, laminin and fibronectin play 
important roles in both the development and repair of the PNS, including neurite 
formation (Davis, Varon et al. 1985, Spivey, Khaing et al. 2012). The ECM has an 
ability to influence cell morphology, phenotype and function through cell-substrate 
interactions, as well as promoting cell-cell interactions. The basal lamina forms a 
close relationship with the regenerating nerve fibres, and a study by Ide et al.  
(1983) concluded that the basal lamina provides a pathway not only for the initial 
axonal elongation but also for the maintenance and maturation of regenerating 
axons (Ide, Tohyama et al. 1983). 
Chapters four and five have described in detail the creation of acellular 
nerve grafts using low concentration SDS, hypotonic buffers and nuclease 
enzymes. These grafts replicated the nerve architecture at a subcellular level as well 
as retaining important ECM components. AxoGen is the only company to have a 
clinically approved acellular human nerve graft on the market, Avance® Nerve 
Graft. Current research suggests that Avance® Nerve Graft implants increases 
reinnervation and improves clinical outcome when compared to commercial 
available NGCs (Whitlock, Tuffaha et al. 2009). A multicentre study demonstrated 
that out of all the commercially available nerve products the Avance® Nerve Graft 
was the only one that had the ability to support repair in motor, sensory and mixed 
nerve types, as well as having the ability to repair both short (5 - 14 mm), medium 
(15 - 29 mm) and long (30 - 50 mm) nerve gaps, making it comparable to an 
autograft (Brooks, Weber et al. 2012). Despite success, the Avance® Nerve Graft 
does have limitations, in particular the supply of human nerves for 
decellularisation, the risk of product supply and disease transmission, which limits 
clinical potential (Zilic, Garner et al. 2015).  
Previous in vivo studies have shown that inclusion of Schwann cells into 
acellular grafts have shown improved regeneration. In these studies, significant 
regeneration was observed in terms of structural and functional repair as well as 
the formation of bands of Bünger (Hess, Brenner et al. 2007, Hu, Zhu et al. 2007, 
Zhang, Luo et al. 2010).  This chapter describes a three week in vivo animal study 
using acellular and reseeded acellular porcine nerve grafts in an 11mm rat sciatic 
nerve gap model. Acellular nerves were decellularised using a combination of 
chemical and enzymatic treatments, based on the process developed by Wilshaw et 
al. (2012) and modified for porcine peripheral nerve (Zilic, Wilshaw et al. 2016) . 
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Acellular nerves were then recellularised with primary rat Schwann cells as 
described in Section 7.4.4.2.  
 
8.2 Aims and objectives 
Aim: 
To evaluate the host cellular response to acellular and recellularised acellular sural 
nerves as a graft in a rat sciatic nerve gap model. 
 
Objectives: 
 Implant six acellular, nerve grafts versus six acellular nerve grafts reseeded with 
primary Schwann cells, into a 11 mm rat sciatic nerve injury model 
 
 Use Micro CT to analyse the internal structure of the autologous and acellular nerve 
grafts post implantation  
 
 Immunolabel grafts with axonal marker PGP9.5 to analyse the regenerating axons 
within acellular and recellularised nerve grafts  
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8.2 Methods 
8.2.1 Sural nerve harvesting and decellularisation 
Three sural nerves were obtained from large white Yorkshire pigs (24 - 26 weeks 
old) within 24 hours of slaughter. Each sural nerve was dissected by a longitudinal 
incision made from the popliteal fossa along the posterior midline and towards the 
posterior-inferior aspect of the lateral malleolus. Excess fat and connective tissue 
was removed from the nerve samples and tissues washed three times in PBS 
containing 0.1 % (w/v) EDTA to remove excess blood. Each individual sural nerve 
was cut into 10 cm segments and stored at -80 C on PBS moistened filter paper 
for future use. The diameter of the sural nerve was approximately 1.4 mm.  From 
each individual sural nerve 4 x 2 cm nerve segments were cut from the proximal 
segment of each nerve, giving a total of 12 nerve segments altogether. The sural 
nerve segments were then decellularised according to the methodology described 
in in Section 6.3 (Method 7).   
8.2.2 Reseeding primary Schwann cells into acellular graft 
Six of the acellular scaffolds were incubated with DMEM with 10% (v/v) FCS 
overnight before being reseeded with primary rat Schwann cells the following day. 
A suspension of 1x106 cells suspended in 20 µL of media was injected into the 
epineurium of the sural nerve using a Hamilton syringe as described in Section 
7.4.4.2.  The recellularised scaffolds were allowed to adhere overnight at 37° C 
/5% CO2 before being implanted the following day.  
8.2.3 In vivo surgical procedure 
The in vivo work was carried out collaboratively with Dr James Phillips, UCL, UK. 
All the surgery was carried out by Dr James Phillips under Home Office approved 
procedures (project licence PPL 70/7557 to Dr James Phillips) and the rats were 
sacrificed according to a Schedule 1 method. All work was conducted in keeping 
with The Animals Scientific Procedures Act (1986), United Kingdom. Young, 
adult female Wistar rats (weighing 200 - 230 g) were anesthetized by inhalational 
of isofluorane (Abbott Laboratories). The left sciatic nerve of the rat was exposed 
and a section was removed to leave an 11 mm gap. Under an operating microscope 
(Zeiss), the proximal and distal nerve stumps of the transected nerve were secured 
within the 11 mm long, porcine acellular or recellularised scaffold (n = 6) using 
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two epineurial sutures (10-0 Ethilon) at the proximal end and one at the distal end. 
The muscle was closed using 3-0 sutures and the skin was closed using staples with 
antibiotic wound powder generously applied around the stapled area. The rats were 
returned to normal housing for three weeks postoperatively. Autologous grafting 
(n = 6); 11 mm of sciatic nerve was excised, reversed, and sutured with 10-0 Ethilon 
epineurial sutures. Each animal was housed in normal housing for three weeks after 
surgery and exposed to 12-hour light/ dark cycles, with food and water. After three 
weeks, all animals were euthanized and each scaffold harvested together with a 2 
mm excess length of nerve both proximally and distally. Paraformaldehyde (3.7 %; 
w/v) was used to fix the tissue for 24 hours. Tissues were processed and wax 
embedded as described in Section 2.2.3. Paraffin embedded tissue sections of 15 
μm were prepared longitudinally on slides for analysis. 
8.2.4 Micro CT of nerve tissues  
Micro-computed tomography or “micro-CT” can be used to image the internal 
structures of 3D specimens at a high resolution, in a non-destructive manner. The 
micro-CT uses a micro-focus x-ray source, which illuminates the object and a 
planar x-ray detector collects magnified projection images. Whilst the object 
rotates hundreds of angular views are acquired and the computer synthesises a stack 
of virtual cross section slices through the object. Using the cross section slices it is 
then possible to interpolate sections along different planes to examine the internal 
structure.  Micro CT of nerve tissues was carried out by Dr Adam Glen, University 
of Sheffield, UK. Micro CT was performed on a Skyscan 1272 (Bruker, Belgium) 
by securing samples in a polypropylene tube and scanned at 50 kV/200 µA 
(0.7° increments over 360°).   Images were reconstructed, analysed and rendered 
with Nrecon (v 1.6.9.8 Bruker, Belgium), CT analyzer (v 1.14.4.1 Bruker, 
Belgium) and CTvol (v2.2.3.0 Bruker, Belgium). 
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8.2.5 Immunolabelling nerve tissue  
Prior to staining, paraffin embedded samples were dewaxed, dehydrated and 
rehydrated as described in Section 2.2.3. The tissue sections were then 
permeabilsed in a 0.1 % (v/v) Triton X-100/PBS solution for one hour at room 
temperature. After three washes in PBS (five minutes each wash) samples were 
incubated with 7.5 % (w/v) BSA/PBS blocking serum for one hour at room 
temperature. Sections were then incubated with the primary antibody, axonal 
marker PGP9.5 (rabbit polyclonal 1:200 dilution) at 4 °C overnight. The following 
day, samples were washed twice in PBS for five minutes and incubated with a 
FITC-conjugated secondary antibody (anti-rabbit IgG 1:100 dilution) for one hour 
in the dark at room temperature. After further washes in PBS, samples were 
counterstained with 300 nM DAPI in PBS and incubated for twenty minutes in the 
dark at room temperature. Sections are then washed three times with PBS for five 
minutes and imaged using a Zeiss LSM510 META upright confocal microscope 
(xenon arc lamp to excite FITC (λex = 495 nm / λem = 515 nm).  
Images of the samples were “stitched together” to create a full length image 
of the nerve graft using Photoshop. The distance of the regenerating axons from 
the proximal to the distal end of the nerve were measured and quantified using 
Image J. 
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8.3 Results 
8.3.1 Macroscopic observation of xenografts 
At the time of tissue harvest, grafts were found to be intact in all groups, and there 
was no visual evidence of infection, inflammation, or problematic scar tissue. 
Macroscopically, autografts resembled an intact nerve; however, the porcine grafts 
had noticeably reduced in size and appeared translucent in colour (Figure 8.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1. Macroscopic evaluation of nerve grafts implanted in a rat sciatic nerve injury 
model. A; bridge-grafted acellular sural nerve. B-DD; autograft, acellular  and recellularised nerve 
three weeks after implantation.  The autograft resembles an intact nerve; however, the acellular and 
recellularised nerve appeared to be reduced in size and translucent in colour. P = proximal; D = 
distal.  
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8.3.2 Micro CT of grafts 
Micro-CT images of explanted nerve samples revealed well defined structures of 
the nerve fascicles at the proximal ends of the samples, and to a lesser extent in the 
distal end (Figures 8.2 and 8.3). The micro-CT of autologous nerve showed a 
homogenous and intact structure (Figure 8.2) whilst the acellular nerve showed 
evidence of a disordered structure with what reappeared to be differing tissue 
density (Figure 8.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2 Micro CT images of sciatic nerve autograft post implantation. Black arrows indicate the 
approximate locations of scans relative to position within the sciatic nerve. The coordinate planes are the 
XZ –plane (green), XY-plane (red) and ZY-plane (blue) which displays longitudinal and transverse 
sections of the nerve.  The proximal ends show well-defined and clear macro structures of the nerve 
fascicles, as indicated by the white arrows. There was little structure observed in the central portion, where 
the autograft was situated and the distal end of the nerve.   
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Figure 8.3 Micro CT images of acellular sural nerve post implantation. Black arrows indicate the 
approximate locations of scans relative to position within the sciatic nerve. The coordinate planes are the 
XZ–plane (green), XY-plane (red) and ZY-plane (blue) which displays longitudinal and transverse sections 
of the nerve.  The proximal ends show well-defined and clear macro structures of the nerve fascicles, as 
indicated by the white arrows. A disordered structure is observed in the central portion, where the acellular 
graft is situated and little structure is observed at the distal end of the nerve.   
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8.3.3 Immunolabelling nerve grafts with PGP9.5 
The autologous, acellular and reseeded grafts were labelled for PGP9.5, an axonal 
marker to investigate if the regenerating axons had bridged the injured gap. The 
axon distribution within the autologous graft was found to be evenly spread 
throughout the entire graft (Figure 8.4 A). Acellular and recellularised nerve grafts 
revealed the presence of regenerating axons; however, the axon distribution was 
not as continuous as observed in the autologous graft (Figure 8.4 B). In some of 
the allogeneic grafts only the proximal and central part of the grafts were filled 
with axons; fewer axons were present in the distal part of the grafts (Figure 8.4 C).  
Quantification of the regenerating axons from the proximal end of the nerve 
to the tip of the PGP9.5 immunolabelled axons demonstrated that nerve 
regeneration was significantly greater in the autologous grafts with an average 
regenerating distance of 14 mm.  The axon regeneration distance within acellular 
and recellularised nerve grafts were similar. The acellular nerve had a slightly 
greater regenerating distance of 8.5 mm whilst the recellularised graft had an 
average of 7.1mm. There was no significant difference between the two porcine 
grafts (Figure 8.4).  
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Figure 8.4. Axonal immunolabelling of nerve grafts. Overlapping (tiled) images showing the 
increased area of PGP9.5 label of regenerating nerves in acellular (B) and reseeded (C) sural grafts 
compared with autologous grafts (A). The images showed an increased area of PGP9.5 labelled 
regenerating axons in the autologous, acellular and recellularised scaffolds. (D) Nerve labelled with 
secondary antibody only to illustrate specificity. A1–A3, B1–B3 and C1–C3are magnifications of the 
corresponding boxed areas in A, B and C, respectively. Scale bar at 1 mm for A-D; scale bar at 100 
µm for A1-C1 
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Figure 8.5. Quantification of axonal regeneration within nerve grafts. Measurement of 
regenerating axons from proximal section to the furthest PGP9.5 tip. The autologous nerve had 
significantly higher axon regeneration with a mean distance of 14 mm (n=5) when compared to the 
acellular and recellularised grafts. The acellular grafts had a mean distance of 8.5 mm (n=4) and 
recellularised grafts had a mean distance of 7.1 mm (n =4). Data was analysed using the unpaired 
Students t-test and is presented as the mean ± 95 % C.I (p<0.01*)  
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8.4 Discussion 
Current research suggests that acellular grafts can increases reinnervation and 
improves clinical outcome when compared to commercial available NGCs 
(Whitlock, Tuffaha et al. 2009). Studies have also demonstrated that inclusion of 
Schwann cells into acellular grafts have shown improved regeneration (Hess, 
Brenner et al. 2007, Hu, Zhu et al. 2007, Zhang, Luo et al. 2010). A three week in 
vivo study was carried out using acellular and recellularised porcine nerve grafts to 
repair an 11 mm nerve gap in a rat sciatic injury model. The internal structures of 
the grafts post implantation were analysed using micro CT. The grafts were also 
stained with the axonal marker PGP 9.5 to assess the axonal regeneration 
throughout the nerve grafts. 
Post implantation it was noted that the physical appearance of the porcine 
nerve graft had altered. Visually the grafts did not appear to have a scar tissue 
formation and no visible inflammation was detected in the surrounding tissues post 
implantation.  It may be hypothesised that grafts had undergone remodelling, 
appearing smaller and translucent in colour. Similar findings were also reported in 
a nerve study conducted by Wang et al. (2015), where rat sciatic nerves and rabbit 
median nerves were decellularised using sodium dodecyl sulphate (SDS) and 
Triton X-100 and implanted in male Wistar rats (Wang, Itoh et al. 2015).  Analysis 
of the grafts internal structure through micro CT further demonstrated that the 
acellular graft had undergone remodelling. The internal structure of explanted 
acellular grafts appeared disordered and inhomogeneous when compared to 
autografts. To further determine evidence of remodelling histological examination 
of the grafts could be used to determine the composition of the tissue. The samples 
could be labelled for the presence of Schwann cells, which are known to help aid 
nerve regeneration (Hess, Brenner et al. 2007, Hu, Zhu et al. 2007, Zhang, Luo et 
al. 2010) as well as important ECM components including such as collagen, 
laminin and fibronectin.   
The remodelling process observed is due to the hosts’ response to the grafts. 
Biological scaffolds are capable of provoking either a constructive (so called M2) 
or pro-inflammatory (M1) cellular response mediated largely by macrophages 
(Badylak 2014). Constructive remodelling occurs when a biomaterial is gradually 
replaced by functional tissue whilst a dense scar tissue formation is associated with 
a pro-inflammatory macrophage and cellular response.  
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To determine the type and the extent of remodelling within the grafts the 
levels of the cell-mediated immune response and matrix remodelling components 
can also be investigated. The tissue can be stained for cells such as neutrophils, 
lymphocytes (CD4+ T and CD8+ T cells) and macrophages (Hudson, Zawko et al. 
2004, Zhang, Luo et al. 2010, Badylak 2014). Furthermore, growth factors such as 
transforming growth factor-β and matrix metalloproteinases contribute to matrix 
turnover. These components actively direct cells to increase matrix production, 
initiate angiogenesis and vasculogenesis, and migrate and proliferate to where they 
are needed (Hodde and Hiles 2007).  
The present data indicated that acellular and recellularised grafts can 
promote peripheral axonal regeneration. Longitudinal sections of the porcine grafts 
demonstrated that PGP9.5 positive regenerated axons displayed well-ordered 
arrangements in the porcine sural grafts, which correlates with previous studies that 
have studied axonal regeneration in nerve repairs (Wang, Pan et al. 2014, 
Mobasseri, Faroni et al. 2015).  
Quantitative analysis revealed that overall, the autologous graft was 
significantly better in promoting regeneration over a greater distance with evidence 
of re-establishment of neural connections from the proximal to the distal end of the 
nerve. Whilst the acellular grafts did promote axonal regeneration throughout the 
entire graft in some of the grafts, overall in both the acellular and acellular seeded 
grafts there were a lower proportion of axons observed in the distal end when 
compared to the autologous graft. A reason for this may be due to residing 
chondroitin sulphate proteoglycans (CSPGs) within the acellular grafts. CSPGs can 
inhibit axonal growth and negate the growth-promoting activities of extracellular 
matrix components such as laminin (Muir, Engvall et al. 1989, Zuo, Hernandez et 
al. 1998). Studies suggest that CSPG degrading enzymes such as 
metalloproteinases or chondroitinase can help restore the growth promoting 
properties of laminin within a nerve (Zuo, Ferguson et al. 1998, Ferguson and Muir 
2000, Krekoski, Neubauer et al. 2001). An in vivo study by Krekoski et al.(2001) 
discovered that acellular nerve grafts treated with chondroitinase improved the 
ability of axons to navigate across the host–graft interface and significantly 
increases the number of axons growing into acellular nerve grafts(Krekoski, 
Neubauer et al. 2001). This enzyme degradation method has also been applied to 
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Avance® Nerve Graft, the only commercially available acellular graft (Moore, 
MacEwan et al. 2011).   
 Several studies have also found the use of predegenerated nerves in rat 
models have shown superiority over autologous nerve graft treatments and a 
reduced delay period; the time interval before the axons enter the graft while the 
rate of regeneration is unaffected (Kerns, Danielsen et al. 1993, Danielsen, Kerns 
et al. 1994, Danielsen, Kerns et al. 1995, Frerichs, Fansa et al. 2002). A study by 
Danielsen et al. (1995) also demonstrated that pre-degenerated acellular nerve 
grafts had a significantly shorter initial delay period (2.7 days) when compared 
with freshly made acellular nerve grafts (9.5 days).  
 The mechanism behind this effect is not known. However, it is assumed 
that during the pre-degeneration period Schwann cells proliferate and the distal 
nerve stump, which is later to be used as the source for the pre-degenerated nerve 
graft, is invaded by inflammatory cells (macrophages). During Wallerian 
degeneration, these cells together with the Schwann cells interact to produce and 
release a variety of factors which influence regeneration and stimulate axonal 
growth, including neurotrophic factors such as nerve growth factor (NGF).  
Furthermore Schwann cells also produce basal lamina components, such as 
collagen IV and laminin, which has a strong neurite-promoting effect(Davis, Varon 
et al. 1985). Together, all these products change the composition and structure of 
the basal lamina and form endoneurial tubes (bands of Büngner).  The basal lamina 
and bands of Büngner then creates a pathway for the growth cone tips of the severed 
axons (Davis, Varon et al. 1985, Kerns, Danielsen et al. 1993). Therefore, at the 
time of grafting, many of these changes have already taken place in the pre-
degenerated nerve while they are just beginning in the non-degenerated nerve graft.  
  There was no significant difference between the axonal regeneration 
observed in acellular or recellularised. Previous studies using similar gap sized 
models have demonstrated little effect of adding Schwann cells to acellular graft 
material. A reason for this may be because migrating Schwann cells from the host 
stumps are able to cross such short distances and provide sufficient assistance to 
regenerating axons despite the addition of exogenous cells (Frerichs, Fansa et al. 
2002, Fox, Schwetye et al. 2005). When Schwann cells migrate over long distances, 
such as in the case of critical gap models (greater than 15 mm) nerve regeneration 
fails. This suggests that cell supplementation of acellular grafts may be clinically 
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beneficial for large gaps, rather than those with adequate host Schwann cell 
migration (Nadim, Anderson et al. 1990). As a further experiment it would also be 
of interest to carry out an experiment on autologous rat nerve versus acellular rat 
nerve as a comparison to determine whether cells play an important role in the 
nerve regeneration process.   
Other reasons for lack of axonal regeneration observed in the porcine grafts 
may have been due to the processing conditions of the nerves and the 
methodological assessment of nerve regeneration post implantation. Solutions used 
in the decellularisation process such as SDS detergent, are known to be cytotoxic 
(Newby, Barr et al. 2000). If the solutions were not removed efficiently it may have 
caused cell death to surrounding cells in vivo as well as the reseeded cells within 
the grafts.  Labelling the grafts with PGP 9.5 to identify regenerating nerve fibres 
may not have the greatest of accuracy in demonstrating regenerating nerve fibres. 
A lack of time frame for loss of PGP 9.5 antigenicity in degenerating axons may 
arise to false positive PGP 9.5 staining as observed in the distal ends of the nerves. 
To overcome this a control would be needed to demonstrate that PGP 9.5 labelling 
is absent if axons are prevented from regenerating.  For future work other forms of 
nerve regeneration assessment such as walking track analysis (Hare, Evans et al. 
1992) for longer term in vivo studies or the use of thy-1-YFP-H mice to enable 
visual analysis of axons regenerating through a nerve graft (Feng, Mellor et al. 
2000, Harding, Christmas et al. 2014) may also prove beneficial. 
  For future work other strategies to improve nerve regeneration may also 
be considered. These include the use of pharmacologic agents, immune system 
modulators and enhancing factors (Lee and Wolfe 2000).  Pharmacologic agents 
such as gangliosides and forskolin which are neurotrophic and neuritogenic and 
work on a molecular level to alter nerve regeneration (Horowitz 1989, Klein, 
Kilmer et al. 1989). Immune system modulators can also be implemented to 
decrease fibrosis and histiocytic responses to help promote neurite growth (Lee and 
Wolfe 2000). Additionally, other enhancing factors such as neurotrophins can also 
be introduced alongside Schwann cells. Neurotrophins such as Nerve Growth 
Factor are known to promote growth and survival of cells (Schmidt and Leach 
2003). 
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8.5 Conclusion 
In this present study acellular grafts were shown to promote axon regeneration 
across a 11 mm nerve gap injury. However, the outcome of the acellular graft was 
not as good as that of an autologous graft. Previous studies have suggested that the 
presence of CSPGs, a known inhibitor of axon growth may have impeded the 
axonal growth. Therefore, enzymatic treatment of the acellular graft with 
chondroitinase may be beneficial in enhancing axonal growth within the graft. 
Nonetheless, acellular porcine peripheral nerve grafts with or without seeded 
Schwann cells hold significant therapeutic potential as a replacement for 
autologous treatment in peripheral nerve repair.   
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Chapter 9 General Discussion 
The peripheral nervous system (PNS) is comprised of a vast network of spinal and 
cranial nerves that are linked to the brain and the spinal cord. The function of the 
PNS is to integrate various bodily processes and reactions of the organism to its 
environment (Schmidt and Leach 2003). When damaged the microenvironment 
surrounding the injury site in the PNS is permissive to axonal regeneration. Over 
relatively short distances (less than 5 mm), axons can spontaneously regenerate 
(Rangappa, Romero et al. 2000). Nevertheless if the nerve is transacted and the 
distance between injury and target is long (greater than 5-10 mm) the clinical, 
functional recovery is poor (Pfister, Gordon et al. 2011).   Several 
hundred thousand nerve injuries occur worldwide each year, with over 300,000 
cases reported annually in Europe (Mohanna, Young et al. 2003). Nevertheless, 
despite recent advances peripheral nerve injury remains a critical clinical issue with 
over 50,000 procedures performed annually to repair damaged nerves (Noble, 
Munro et al. 1998). For longer nerve gaps (greater than 10 mm) the current “gold 
standard” treatment is autologous grafting; using donor sensory nerve tissue, which 
is harvested from another site in the body to replace the injured tissue. Limitations 
using this method include donor site morbidity and chronic pain. Focus has 
therefore turned to the use of nerve guide conduits (NGCs) and acellular scaffolds 
as an alternative to treating larger nerve defects. A small number of clinically 
approved natural and synthetic based NGCs have been used to treat nerve gap 
injuries, however they are limited to treated gaps of up to 20 mm - 25 mm (Shin, 
Friedrich et al. 2009).  For larger gaps (greater than 20 - 25 mm) autologous nerve 
grafts are used.  Studies comparing autograft to conduit repair of digital nerve 
injuries concluded that conduits were limited to defects of up to 25 mm. It was 
noted that the quality of recovery decreased as the gap size increased and that a 
third of repairs for gaps between 5 and 25 mm had a poor clinical outcome (Weber, 
Breidenbach et al. 2000).   
One of the major reasons for the failure of NGCs to provide sufficient 
regeneration across larger gaps is that they lack substrate topography, which 
mimics the natural environment of nerve and functional biological motifs. Studies 
have shown that axon regeneration is more effective when presented in a 
surrounding that is similar to the nerves extracellular matrix (ECM) and basal 
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lamina (Smeal, Rabbitt et al. 2005). It is therefore hypothesised that as a 
prerequisite for efficient axon extension, next generation NGC’s and grafts should 
incorporate an ECM topography. 
The use of allogeneic or xenogeneic nerve tissue may provide an ECM that 
mimics the native nerve as well as offering the potential for clinically relevant 
diameter, length and motor versus sensory specificity (Moore, MacEwan et al. 
2011). Such grafts contain an endoneurial microstructure, which provides the same 
level of guidance and regenerative support as nerve autografts.  The immunogenic 
components of a tissue can be removed through a process called decellularisation, 
producing a non-immunogenic acellular tissue scaffold. Acellular grafts have been 
shown to retain the 3D structure and ECM components of the native tissue; such a 
graft may be used clinically without eliciting an adverse immune response. ECM 
components are generally conserved amongst species and are tolerated well by 
recipients in the absence of immunogenic cellular components. 
The aim of this thesis was to investigate whether a decellularised porcine 
peripheral nerve would have clinical utility as a nerve graft. Studies have shown 
porcine nerves to be anatomically similar to human nerves (Zilic, Garner et al. 
2015). Sciatic branches (peroneal and tibial) were chosen as the predominant 
nerves to be used throughout the study due to availability and ease of procurement. 
Sural nerves were used for the in vivo study due to their similar dimensions to the 
rat sciatic nerve model. 
Once decellularised the acellular nerve grafts were studied as an in vitro 
nerve model, as a basis for examining perfused flow within the tissue for 
introducing Schwann cells. The long-term goal of this work is to translate the in 
vitro nerve model for use in the clinic as a nerve graft to help repair critical nerve 
gap injuries (greater than 20 mm).  
During the course of this study porcine peripheral nerves, located in the 
lower limb were successfully identified and characterised. The study demonstrated 
that porcine nerves were comparable to human nerves in terms of anatomical 
structure and size, and therefore had the potential to be used as grafts for clinical 
use. Subsequently a decellularisation process was developed, using a combination 
of chemical and enzymatic treatments, based on the process developed by Wilshaw 
et al (2012) and modified for porcine peripheral nerve (Zilic, Wilshaw et al. 2016). 
This process removed all host cells from the porcine peripheral nerves with 
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minimum effect on the histioarchitecture. Histological characterisation revealed 
retention of the nerve fascicles, along with its connective tissues. The DNA 
reduction (by approximately 95 %) was comparable to the two most reported 
detergent based decellularisation procedures for peripheral nerves, the Sondell 
method (Sondell, Lundborg et al. 1998) and the Hudson method (Hudson, Liu et 
al. 2004).   
Following decellularisation, the acellular nerves were assessed in terms of 
their retention of key ECM components, in vitro biocompatibility and mechanical 
integrity. The decellularisation process can alter the ECM composition as well as 
the components of the nerve. The solutions used in the process such as SDS have 
been associated with ultrastructure disruption and GAG depletion (Kasimir, Rieder 
et al. 2003, Gilbert, Sellaro et al. 2006, Ott, Clippinger et al. 2010), whilst peracetic 
acid treatment has been shown to disrupt the collagen structure (Lomas, Jennings 
et al. 2004). It is therefore important to retain key ECM components and structure 
so that the acellular scaffold can provide a suitable microenvironment for cellular 
growth and nerve regeneration. Characterisation of the nerve ECM and basal 
lamina demonstrated retention of important structural components such as 
collagen, laminin and fibronectin, unlike other nerve decellularisation methods  
which have been known to fracture and damage the basal lamina (Ide, Tohyama et 
al. 1998, Sondell, Lundborg et al. 1998) and decrease the laminin and fibronectin 
content (Grauss, Hazekamp et al. 2005).  
The presence of an intact basal lamina and ECM components within 
acellular nerve grafts have been shown to contribute to their enhanced regenerating 
capacity to support axonal growth (Hudson, Liu et al. 2004, Whitlock, Tuffaha et 
al. 2009).  The importance of an intact basal lamina is further highlighted by the 
development of Avance ® Nerve Graft. This acellular graft with an intact basal 
lamina surpasses all the other commercially available NGCs in terms of nerve 
regeneration (Whitlock, Tuffaha et al. 2009). 
In vitro cytotoxicity testing demonstrated the biocompatibility of acellular 
porcine nerves. The biocompatibility of any acellular scaffold is important whether 
it is to be used as a clinical graft or in vitro model.  Solutions used in the 
decellularisation process such as SDS detergent, EDTA, aprotinin and the PAA are 
known to be cytotoxic (Koulaouzidou, Margelos et al. 1999, Newby, Barr et al. 
2000, Sagripanti and Bonifacino 2000). An in vitro cytotoxicity test using human 
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dermal fibroblasts and primary rat Schwann cells found both cell types were able 
to proliferate up to and in physical contact with the scaffold.  Both cell types 
maintained membrane integrity, a native phenotype and there was no sign of cell 
lysis, indicating the acellular nerves to be biocompatible. 
Biomechanical testing of the acellular nerves (peroneal and tibial) was 
undertaken as decellularisation solutions applied to biological tissues have 
previously been shown to affect the mechanical properties of the ECM (Courtman, 
Pereira et al. 1994, Palsson BO 2004). In terms of clinical applications, any changes 
in the biomechanical properties of the nerve grafts, can impede the regeneration of 
the nerve (So and Xu 2015). Unlike other decellularisation methods (Borschel, Kia 
et al. 2003, Ma, Sun et al. 2011) the process did not decrease the  mechanical 
properties of the acellular nerves. The biomechanical results showed a slight 
increase in Young’s modulus, ultimate tensile strength (UTS) and strain at UTS. 
These results were found to be similar in other decellularisation studies (Stapleton, 
Ingram et al. 2008, Williams, Liao et al. 2009, Abdelgaied, Stanley et al. 2015)  
 For clinical use it is important that nerve grafts maintain their suture-
holding ability as well as their ability to maintain a mechanically robust tissue 
interface with native nerve stump for axonal regeneration. This largely depends on 
the tensile strength of the tissue. It was therefore concluded that the 
decellularisation process did not impeded the function of the tissue  (Borschel, Kia 
et al. 2003).  
Through mechanical testing it was discovered that the porcine peroneal 
nerves had a higher UTS value in comparison to the porcine tibial nerves (Zilic, 
Garner et al. 2015). A previous study by Ugrenović et al. (2014) reported that the 
peroneal nerve tolerates a greater tensile strength during the leg movement than the 
tibial nerve, due to the anatomical position (Ugrenović 2014). A study was 
therefore conducted to evaluate the ultrastructure of porcine peroneal and tibial 
nerves to investigate whether differences in collagen fibril diameter could explain 
the observed differences in mechanical properties. The study concluded that the 
mechanical properties of nerves could not be determined exclusively by their 
ultrastructure or collagen fibril diameter. 
Once successfully decellularised and characterised, acellular nerves were 
used as an in vitro model for the introduction of primary Schwann cells. The study 
revealed that seeded Schwann cells under static and perfused conditions maintained 
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their phenotype and viability over a period of time. Furthermore, there are also 
indications of Schwann cells migrating towards the perineurium and entering the 
endoneurium where Schwann cells normally reside.  The behavior of the cells is 
dictated largely by the ECM. The ECM provides structural support for cells as well 
as fundamental cell processes such as cell growth, adhesion, migration, 
proliferation, differentiation and gene expression (Gao, Wang et al. 2013). It can 
therefore be assumed that the acellular nerves have retained a suitable ECM for 
Schwann cells to reside within.   
The viability of the cells under static and perfused conditions began to 
decrease by day 7. This could have been due to a number of factors including 
seeding density, injection method or lack of a suitable cell viability assay. It was 
however interesting to note that there was a lower rate of cell death under perfused 
conditions. A reason for this is that the survival of cells within a scaffold is 
dependent on the maintenance of nutrient diffusion (Sun, Norton et al. 2005) and 
under normal physiological conditions cells within the peripheral nerves receive 
constant nutrients from the surrounding vessels.    
The in vitro model allowed for a systematic controlled evaluation of the 
reseeded acellular grafts, and subsequently this led to further investigations using 
in vivo injury models. A three week in vivo study was carried out by implanting 
acellular and reseeded acellular grafts into a rat sciatic injury model to treat an 11 
mm nerve gap injury. Throughout the study there was no sign of graft rejection or 
signs of inflammation when the grafts were harvested. Upon visual inspection post 
implantation, the grafts appeared to have undergoing degradation, with a 
substantial loss of the tissue graft. This was also confirmed by Micro CT, which 
showed the internal structure of the explanted acellular grafts to be disordered and 
inhomogeneous when compared to an autograft. It has been previously described 
that ECM derived scaffolds rapidly degrade upon implantation (Badylak 2014). 
Studies using small intestinal submucosa for tendon and urinary bladder repair 
have reported that approximately 60% of the mass was degraded and resorbed 
within 4 weeks of implantation and completely degraded by 3 months (Record, 
Hillegonds et al. 2001, Gilbert, Stewart-Akers et al. 2007).  
It was not fully determined whether the grafts were undertaking a pro-
inflammatory or constructive remodelling response. Visually the grafts did not 
appear to evoke an adverse inflammatory response within the host or surrounding 
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tissue and there was no appearance of scar tissue which is commonly associated 
with a pro-inflammatory response. Never the less further investigation needs to be 
carried out to conclude whether constructive remodelling was taking place. This 
can include histological analysis of the grafts for lymphocytes, macrophages and 
matrix metalloproteinases which are known to be present during the remodelling 
process. 
Longitudinal sections of both acellular and recellularised grafts showed 
PGP9.5 positive regenerated axons. The axons were displayed in well-ordered 
arrangements and passed through the graft. This correlated with previous studies 
which investigated axonal regeneration in nerve repairs (Wang, Pan et al. 2014, 
Mobasseri, Faroni et al. 2015). A plausible reason for the axon regeneration 
observed in the grafts is the presence of the basal lamina which help guide 
regenerating axons. The basal lamina consists of continuous laminin tubes along 
with fibronectin, collagen type IV, heparin sulphate proteoglycans which help 
promote axonal outgrowth. The basal lamina also presents aligned, linear nano 
scale features to cells as well as guiding regenerating axons to grow through the 
basal lamina (Smeal, Rabbitt et al. 2005, Corey, Lin et al. 2007).  
When compared to autologous grafts, porcine grafts had a lower density of 
axons within the distal ends. Quantitative analysis demonstrated that autologous 
nerves also promoted axon regeneration over a greater distance when compared to 
the porcine grafts.  There was no significant difference between the acellular and 
recellularised nerve grafts in terms of axonal regeneration. The limited axon 
regeneration observed in the porcine grafts may have been due to the short period 
of time, short gap distance, chondroitin sulphate proteoglycans (CSPGs) and 
methodological issues.  
The grafts were implanted for 3 weeks in vivo. For a nerve regeneration 
study this is a relatively short period of time to gain a substantial amount of 
information on nerve regeneration such as walking track analysis. The in vivo study 
was not long enough to observe whether the grafts would have undergone 
constructive remodelling and be replaced with a more functional tissue. In addition, 
the Schwann cells may have also needed more time for growth and differentiation 
into growth supportive cells to help lead regenerating axons towards the distal 
nerve stump.  
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For the in vivo study an 11 mm graft was used to bridge the nerve gap injury. 
Previous studies using similar gap sized models have demonstrated little effect of 
adding Schwann cells to acellular graft material. This is due to the fact that 
Schwann cells migrating from the host stumps are able to cross such short distances 
and provide sufficient regeneration despite the addition of exogenous cells 
(Frerichs, Fansa et al. 2002, Fox, Schwetye et al. 2005). For future experiments it 
may be more feasible to increase the gap length to 15 mm, the critical gap length 
in a rat, where the addition of exogenous Schwann cells may prove more beneficial. 
Another reason for the limited regeneration observed in the porcine grafts 
may be due to chondroitin sulphate proteoglycans (CSPGs) within the porcine 
grafts. CSPGs can inhibit axonal growth and negate the growth-promoting 
activities of extracellular matrix components such as laminin (Muir, Engvall et al. 
1989, Zuo, Hernandez et al. 1998). Studies suggest that CSPG degrading enzymes 
such as chondroitinase can help restore the growth promoting properties of laminin 
within a nerve (Zuo, Ferguson et al. 1998, Ferguson and Muir 2000, Krekoski, 
Neubauer et al. 2001).  
The use of PGP 9.5 antibody to label axons within the grafts may not have 
been the most efficient method in identifying regenerating fibres. This is because 
there is no time frame for loss of PGP 9.5 antigenicity in degenerating axons to 
accurately assess nerve regeneration.   For future work if using the same method, a 
control would be needed to demonstrate that PGP 9.5 is absent if axons are 
prevented from regenerating. Alternatively other forms of nerve regeneration 
assessment such as walking track analysis (Hare, Evans et al. 1992), advanced 
magnetic resonance imaging (MRI) diffusion tensor imaging (DTI) (Hiltunen, 
Suortti et al. 2005), tractography (Khalil, Budzik et al. 2010) or the use of thy-1-
YFP-H mice to enable visual analysis of axons regenerating through a nerve graft 
(Feng, Mellor et al. 2000, Harding, Christmas et al. 2014) may also prove more 
efficient.  
The in vivo study concluded that the acellular and recellularised porcine 
grafts had the ability to promote axon regeneration across an 11mm nerve gap 
injury. The grafts, however, were still not equivalent to the autologous graft in 
terms of axon regeneration. This could be attributed to a number of reasons 
including time frame, gap size, the presence of CSPGs and methodological 
assessment. Nonetheless, the acellular graft and recellularised nerve grafts hold 
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significant therapeutic potential as a replacement for autologous treatment in 
peripheral nerve repair.   
 
9. 1 Future work 
The study of creating an acellular nerve graft and reintroducing cells back into the 
graft has created two possible pathways for the study of peripheral nerve repair. 
Principally the grafts can be further developed as a three dimensional in vitro nerve 
model to study reseeded grafts for potential use in vivo. Alternatively, the acellular 
nerve grafts can be further optimised and used as potential “off the shelf” nerve 
graft for clinical applications.  
As an in vitro nerve model, future challenges include attaining optimal cell 
attachment, viability, and migration across the graft. To improve cellular adhesion 
moieties derived from ECM proteins can be used. These are selective in cell 
binding and can be packed at higher density on the substrate leading to a more 
specific cell-substrate interaction (Hersel, Dahmen et al. 2003, de Luca, Lacour et 
al. 2014). Specific amino acids such as RGD (Arg-Gly-Asp) have been shown to 
facilitate the interaction between ECM proteins and integrins on cell membranes 
and enhance the adhesion and proliferation of neural cells (de Luca, Stevens et al. 
2013).  
To promote Schwann cell viability and growth enhancing neurotrophic 
factors such as neurotrophins can also be introduced alongside Schwann cells. 
Neurotrophins such as Nerve Growth Factor are known to promote growth and 
survival of cells (Schmidt and Leach 2003). 
Furthermore, for transplant therapies alternative cell types such as adipose 
derived stem cells (ADSCs) can also be considered. ADSCs are easily harvested 
and have the ability to differentiate into Schwann-like cells (Kern, Eichler et al. 
2006, di Summa, Kalbermatten et al. 2011, Kaewkhaw, Scutt et al. 2011).  
Once optimised the reseeded grafts can then be used for in vivo studies. 
Preliminary results have already shown that reseeded grafts are biocompatible with 
host rat tissue. Nevertheless, there was no substantial difference between the 
acellular and recellularised nerve grafts in terms of axonal regeneration. For future 
studies a longer in vivo study may prove more beneficial in assessing the porcine 
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grafts regenerating capacities. This may allow time for neurites to develop and 
reach the distal portion of the grafts. Immune system modulators can also be 
implemented to decrease fibrosis and histiocytic responses to help promote neurite 
growth (Lee and Wolfe 2000). For recellularised porcine grafts it has been 
suggested that using a larger gap size (greater than 15 mm) may be more beneficial 
in such a study (Frerichs, Fansa et al. 2002, Fox, Schwetye et al. 2005).  
The clinical use of acellular nerves is rather limited, with Avance® being 
the only commercially available nerve graft available. The Avance® graft which 
uses human donor nerve tissue has had reported success over the commercially 
available NGC’s (Whitlock, Tuffaha et al. 2009). Nevertheless, the supply of 
human nerve tissue for decellularisation and use as a graft material is extremely 
limited in the United Kingdom. Use of xenogeneic tissue has the advantage of 
unlimited availability in a range of different sizes as observed in chapter three. 
Therefore, there is an opportunity to create the first commercially available 
xenogeneic nerve graft.  
As a clinical nerve graft future consideration would have to include a 
terminal sterilisation step for the graft such as gamma irradiation or ethylene oxide. 
In addition, the graft may also have to undergo enzymatic degradation as 
chondroitin sulphate proteoglycans are known to inhibit axon regeneration within 
acellular grafts (Zuo, Ferguson et al. 1998, Ferguson and Muir 2000, Krekoski, 
Neubauer et al. 2001).  
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9.2 Conclusions 
In summary, the present thesis: 
 
1. Optimised a decellularisation method for porcine peripheral nerves which retained 
the nerves histioarchitecture whilst eliminating over 95 % cellular DNA.  
 
2. Validated through qualitative and quantitative analysis the retention of important 
extracellular matrix (ECM) proteins such as collagen, glycosaminoglycan’s, 
fibronectin and laminin. 
 
3. Established using an in vitro contact cytotoxicity assay and mechanical testing that 
acellular nerves were biocompatible and that the decellularisation process did not 
decrease the mechanical properties of the nerves. 
 
4. Verified using histological analysis and transmission electron microscopy (TEM) 
that porcine tibial nerves were significantly larger than the peroneal nerves and 
possessed larger collagen fibril diameters within the connective tissues.  
 
 
5. Developed a three dimensional in vitro nerve model and demonstrated that 
Schwann cells under perfusion maintained their phenotype and had a lower rate of 
cell death when compared to static conditions. 
 
6. Carried out an in vivo nerve regeneration study within a rat sciatic nerve injury 
model using acellular and recellularised nerve grafts and demonstrated that grafts 
could potentially support regenerating axons across a 11 mm rat sciatic nerve gap 
injury 
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